Health Tourism News

This Week in Medical Tourism: 27 August – 16 September 2026

editorial@health-tourism-news.com (Christian El-Khouri) — Wed, 23 Sep 2026 00:00:00 GMT

This is the Health Tourism News roundup for 27 August to 16 September 2026, a three-week period. ## Korea's growth moved to spending per patient South Korea treated 2.01 million foreign patients in 2025, up 71.9 per cent, in the Korea Health Industry Development Institute's annual report published at the end of August. Across the top 14 countries by card spending, the number of cards used for medical services rose 1.0 per cent in the first half of 2026 while average spending per card rose 30.1 per cent, on the institute's analysis of overseas-issued card data. Medical sector spending reached 1.4203 trillion won for the half, up 38.6 per cent. The monthly series turned in August, to 202.8 billion won, down 4.8 per cent on July and up 32.0 per cent on the year, in a DB Securities report. Seoul opened a certification scheme for lodging aimed at recovering patients, grading properties on proximity to medical centres, barrier-free access and emergency response. The Korea Tourism Organization pitched screening packages to Mongolian mining employers from 4 to 6 September, and Busan's consultations in Almaty on 8 and 9 September produced 107 meetings. ## India set a target twenty times its current intake Commerce and Industry Minister Piyush Goyal told two pharmaceutical industry events in New Delhi on 7 September that India should aim for 10 million international patients a year. He put the number who had used India's medical value travel services over the previous seven years at 3.5 million, an average of about 500,000 a year. Medical visa issuance has fallen in each of the last two years, from 643,541 in 2023 to 624,761 in 2024 and 508,330 in 2025, on figures given to Parliament by Minister of State for Health Anupriya Patel. The chair of the Federation of Indian Chambers of Commerce and Industry's medical value travel committee reported a 40 to 60 per cent fall in arrivals from conflict-affected regions, with airfares up 15 to 25 per cent. India spends 1.9 per cent of GDP on public health against its own 2.5 per cent target set in 2017, and has 1.3 hospital beds per 1,000 people against a World Health Organization recommendation of 3.5, on figures in the 2023-24 Economic Survey. Goyal's five-point plan covers caregiver certification, published treatment prices, faster reimbursement, interpreters, and treatment only at accredited hospitals. ## Three governments moved to export dentistry Tirana's metropolitan area holds close to 400 dental clinics for a population of around 600,000, with signage and websites in English and Italian, in BBC reporting from the city. Implants run at about €600 a tooth, comparable with Turkey and roughly a quarter of the price in the United Kingdom, France or Germany. Moldova's prime minister, Vasile Tofan, instructed his health minister on 26 August to bring deregulation measures for private dental clinics to cabinet. He criticised a 35-page licensing manual that applies hospital-grade requirements to two-chair practices, among them lifts, backup generators and three days of refrigerated food samples. Dental consultations there rose from 1.3 million in 2022 to 1.5 million in 2025 while total medical consultations fell by about 3 million, on National Bureau of Statistics figures. Vietnam's health ministry lists Australians among the top foreign nationalities treated in the country, where clinics recruit them through social media advertising, and wants to double international patient numbers within four years. Australia does not track how many of its citizens travel abroad for treatment. A prosthodontist speaking for the Australian Dental Association said he wished it collected data on adverse outcomes, as the United Kingdom does. The UK Foreign Office records seven British nationals dying in Turkey in 2025 following medical procedures. ## China's hospitals logged 1.28 million foreign patient visits Major Chinese hospitals recorded about 1.28 million visits by international patients in 2025, up 73.6 per cent on three years earlier, on National Health Commission figures, with visits from Europe and the United States doubling over the same period. In June the National Medical Products Administration approved the first CAR-T cell therapy cleared anywhere for solid tumours, a treatment that reprogrammes a patient's own immune cells. A 59-year-old New Zealander, told at home that his cancer treatment had failed, became the first foreign patient to complete the course, paying 990,000 yuan, about 138,000 US dollars, and flying home on 16 August, in reporting by Caijing magazine. The same regulator approved 76 innovative drugs and 76 innovative medical devices in 2025, both records. A county hospital in Yunnan's Xishuangbanna prefecture received more than 13,000 international patients in 2025 against about 500 in 2013, 97.5 per cent of them Lao nationals. ## African states costed the outflow before building for the inflow A state orthopaedic institute in Dar es Salaam treated 211,359 patients in financial year 2025/26, of whom 270 came from ten other African countries. It put the saving from treating 2,282 specialist cases domestically at 121.99 billion Tanzanian shillings, and said referrals abroad had fallen 98 per cent for orthopaedic and 97 per cent for brain cases. Nigeria's sovereign wealth fund said its healthcare programme has retained more than 200 million US dollars in foreign exchange. Its Lagos cancer centre has delivered more than 25,000 radiotherapy sessions and 10,000 chemotherapy treatments to about 15,000 patients since opening in May 2019. Ghana's tourism authority broke ground on 9 September for a medical city at Ada in Greater Accra, to hold about 30 hospitals. Kenya was absent from a June 2026 list of the top 50 destinations that placed South Africa 32nd and included Egypt, Tunisia and Morocco, in a column in The Star that blamed executive inaction. ## Arab states began drafting a common licensing framework An Arab League working group met in Cairo on 8 September to start drafting a regional framework for accrediting and licensing health tourism facilities, chaired by Algeria. It is being prepared with Bahrain under Resolution 362 of the Arab Ministerial Council for Tourism, and covers hospitals, specialised centres and health resorts. Thai authorities said on 9 September they were investigating whether a Bangkok clinic held a valid licence, after a London coroner ruled that the March death of a 43-year-old British businessman was caused by a hyaluronic acid injection given hours earlier. Nigerian police arrested four people in August, two of them nephrologists, over an alleged organ trafficking syndicate around Abuja and Nasarawa State. Lawyers and doctors in Vietnam called for cross-border cosmetic surgery brokerage to be regulated separately from medical advertising, after a revised Advertising Law in force from 1 January 2026 restricted advertised medical services to those licensed there. ## By the Numbers RM3.35 billion in Malaysian medical tourism revenue in 2025, up 23.2 per cent on 2024, on Malaysia Healthcare Travel Council figures. 527,176 foreign patients treated by Penang's 16 participating private hospitals in 2025, against 418,608 in 2024, on state government figures. 42.7 billion US dollars, Thailand's wellness economy in 2024, 0.63 per cent of the global total and 24th of 145 economies assessed, on Global Wellness Institute figures. 2 to 3 billion US dollars spent each year by Vietnamese nationals on treatment abroad, exceeding total inbound medical tourism revenue, on Ministry of Health estimates for 2026-2030. 21,500 Central Asian patients treated in Korea in 2025, up 12.5 per cent on 2024, on Busan Economic Promotion Agency figures. ## What to Watch Thailand hosts the Global Wellness Summit from 10 to 13 November 2026. Vietnam's Ministry of Health draft scheme for 2026 to 2030, targeting 750,000 international patients, is circulating for comment. The Arab League working group that met in Cairo on 8 September is preparing the licensing framework ordered under Resolution 362. Thailand's health ministry has not published its finding on whether the Bangkok clinic linked to the March death was licensed.

This Week in Medical Tourism: 20–26 August 2026

editorial@health-tourism-news.com (Christian El-Khouri) — Sun, 30 Aug 2026 00:00:00 GMT

This is the Health Tourism News roundup for 20 to 26 August 2026. ## India's medical arrivals fell in 2025 India recorded 507,244 foreign nationals arriving for medical treatment in 2025, about 5.5 per cent of 9.15 million foreign tourist arrivals, on Press Information Bureau figures. Bangladesh supplied 325,127 of them, ahead of Iraq at 30,989, Uzbekistan at 13,699 and Somalia at 11,506. Bureau of Immigration figures presented by India's Ministry of Tourism put foreign medical-purpose arrivals at 644,387 in 2024, of which Bangladesh supplied 482,336. The Bangladeshi figure was 499,951 in 2023 and 326,805 in 2022. On the sending side, the World Health Organization put Bangladesh's universal health coverage service coverage index at 54 out of 100 in December 2025, with 41.7 per cent of the population, around 70 million people, facing financial hardship from out-of-pocket health spending. A WHO assessment counted 9.9 doctors, nurses and midwives per 10,000 population in 2020, against a global median of 48.6. ## Ethiopia costs the outflow More than 10,000 Ethiopians travel abroad for treatment each year at a cost of up to 700 million US dollars, on figures cited at the opening of a private medical complex in Addis Ababa. The 3 billion birr, 13-storey building holds 110 beds and eight operating theatres, and is the second site in Ethiopia and the third in East Africa with a PET-CT scanner. Deputy Prime Minister Temesgen Tiruneh opened the 13th East African Healthcare Federation conference in Addis Ababa on 21 August. He put specialised care and local manufacturing forward as a way to stop spending foreign currency on treatment abroad while earning it from regional patients. The Ethiopian Healthcare Federation has drawn up a 10-year plan whose stated first objective is treatment at home rather than continental leadership. Girma Ababi, its vice president, named facility standards, equipment, professional certification and training as the requirements, with public-private partnerships covering the financing gap. Ethiopia and neighbouring East African states are separately setting joint strategies to localise manufacturing of medical supplies. ## Nigeria buys robotic surgery A faith-based 300-bed hospital in Lagos put 4 million US dollars into robotic surgical services and training, working with a diaspora-founded United States firm. Chief executive Ademola Dada said procedures would be priced at about 5 per cent of comparable treatment in the United States or Europe, and that training would cover biomedical engineers, nurses and anaesthetists rather than surgeons alone. A public-private centre in Imo State performed its first robotic operation, for prostate cancer, on 21 August. Iziaq Salako, Minister of State for Health and Social Welfare, said the private sector already provides more than half of Nigeria's health services, and tied robotic surgery to reversing the direction of medical travel. President Bola Tinubu approved a National Cancer Institute at a cost of 302.3 billion naira, to be completed within 36 months, with upgraded cancer centres in Katsina, Benin and Enugu already finished. ## Korea sells wholesale Seoul attracted 1.76 million foreign patients in 2025, 87.2 per cent of Korea's national total that year, on Ministry of Health and Welfare data. The city holds the eighth edition of its medical tourism travel mart on 8 and 9 September, bringing about 70 overseas buyers to meet 300 domestic sellers. Last year's edition drew 358 organisations from Korea and 17 other countries and generated 2,176 business consultations. Busan held its own buyer event on 26 and 27 August, organised by the Korea Health Industry Development Institute and co-hosted with Daegu, Gwangju and Jeju. Sixteen overseas buyers from 10 countries, including Thailand, China, the United States and Mongolia, met 41 Busan medical institutions and patient recruitment agencies. ## Four governments moved on the edge of the trade Australia's Department of Foreign Affairs and Trade published new travel guidance warning that standard insurance usually excludes elective procedures abroad and their complications. Research it conducted with the Insurance Council of Australia found 46 per cent of Australian international travellers had undergone or would consider a procedure overseas, from a June 2025 survey of 1,001 people who had travelled in the previous 12 months. The United States State Department said nearly 900 visas had been revoked since it established a birth tourism task force earlier in August, up from more than 600 when the task force was announced. Spokesperson Tommy Pigott said the department is targeting networks that present themselves as healthcare services. Delhi police arrested 17 people and seized counterfeit and diverted anti-cancer medicines worth 90 million rupees, about 688,000 pounds, in raids across Delhi and Navi Mumbai. Investigators said vials were refilled with sterilised water and sold under fake batch numbers. The United States Embassy in Peru advised American citizens not to take ayahuasca or kambo at all, after three deaths at psychedelic retreats in Costa Rica, Mexico and Peru within fourteen months. A New York Times investigation published this week found retreats that did not screen for cardiac conditions and staff who encouraged patients to stop psychiatric medication. ## Dental is the volume and the least covered Only 33 per cent of Australian travellers knew a procedure abroad might require extra insurance, and among those chiefly motivated by cheaper treatment that fell to 10 per cent, in the same research. Price was the main draw for 69 per cent of those considering any procedure and 80 per cent of those considering dental work. Costa Rica certified five dental clinic groups for international patients this month, requiring documented experience with foreign patients, bilingual licensed specialists and treatment guarantees. Central Bank figures cited by the Costa Rican Health Chamber put medical tourism at about 13 per cent of international arrivals, roughly 70,000 patients a year generating around 465 million US dollars, with dental work accounting for 42 per cent of demand. A report published in June by the CareQuest Institute for Oral Health found that about 4 per cent of American adults, close to 9.6 million people, had travelled outside the United States for dental treatment, and that roughly 69 million American adults carry no dental insurance. A comparison across seven industrialised countries put the average cost of a root canal at 838 US dollars in the United States, against 542 in Canada and 436 in France. ## By the Numbers 507,244 foreign nationals arrived in India for medical treatment in 2025, against 644,387 in 2024, on Press Information Bureau and Bureau of Immigration figures. 95.6 per cent, the year-on-year rise in foreign patients treated at Guangdong's 25 designated pilot hospitals since the province opened its international medical pilot in February 2026, on provincial health authority figures. 1.76 million foreign patients treated in Seoul in 2025, 87.2 per cent of Korea's national total, on Ministry of Health and Welfare figures. 9.6 million American adults, about 4 per cent of the adult population, have travelled abroad for dental treatment, in a June 2026 report by the CareQuest Institute for Oral Health. 66 per cent of second-quarter 2026 revenue came from non-Thai patients at a Bangkok-listed hospital operator, in results published on 20 August 2026. 23 per cent, the rise in revenue from Chinese healthcare travellers to Malaysia in the first quarter of 2026, with traveller volume up 17 per cent, on Malaysia Healthcare Travel Council figures. ## What to Watch Seoul's medical tourism travel mart runs on 8 and 9 September, with registration for domestic sellers closing on 3 September. Nigeria's National Cancer Institute is contracted for completion within 36 months of the Federal Executive Council approval granted in August 2026. Azerbaijan's Ministry of Health is required to prepare a health tourism strategy and action plan under the tourism state programme for 2026-2030, approved by presidential order on 20 August 2026. Iran's tourism minister has asked for a measurable roadmap to lift Iran-Iraq tourist exchanges to five million in each direction, against about 3.6 million Iraqis and 3.5 million Iranians now crossing each way.

This Week in Medical Tourism: 13–19 August 2026

editorial@health-tourism-news.com (Christian El-Khouri) — Sat, 29 Aug 2026 00:00:00 GMT

This is the Health Tourism News roundup for 13 to 19 August 2026. ## China inbound patient count Key foreign-oriented hospitals in China received 1.28 million international patients, a rise of 73.6 per cent over three years, on figures in the National Health Commission's 2025 report. The Boao Lecheng pilot zone on Hainan took more than 8,600 overseas medical tourists between January and July 2026, 5.4 times the same period a year earlier, from 14 countries and regions. Hainan admits citizens of 86 countries without a visa for up to 30 days, and the zone can import drugs and devices already approved in Europe or the United States before they complete mainland registration. Guangzhou introduced 12 supporting measures on 29 April covering visa support, remote pre-consultation and cross-border payment, and opened a service centre for overseas patients. Hong Kong's Secretary for Health, Lo Chung-mau, led a delegation to the Hainan zone on 13 August to discuss Chinese medicine and public hospital development. ## Latvia, Egypt and the counting problem Latvia's Centre for Disease Prevention and Control recorded 35,851 foreign patients receiving medical services in the country last year, down 25.9 per cent on the previous year. United States residents were the largest group at 3,843, ahead of Lithuania at 2,980 and the United Kingdom at 1,967. The centre published no explanation for the fall. Egypt's General Authority for Healthcare reported revenue above 10 million US dollars, up 37 per cent year on year, from close to 42,000 international patients treated at its own hospitals. Chairman Ahmed El-Sobky named cosmetic procedures, in vitro fertilisation, obesity treatment and advanced dental care as the priority specialties. The two counts do not measure the same thing. Latvia works from a stated definition: a person who travels specifically for care and pays out of pocket or through insurance, rather than through the host country's state budget. Egypt's figure covers one state authority's facilities rather than the country. Vietnam's health ministry, meeting on 13 August to advance its own scheme, said its statistics cannot separate foreigners living in Vietnam who use hospitals routinely from visitors who travel for treatment, and proposed a steering committee and a national association to sit alongside the plan. ## Telangana suites and hospital margins Telangana's decision to set aside elite suites for foreign patients at a public institute in Sanathnagar drew objections from senior doctors and public health specialists. They argued that foreign currency targets and international marketing panels change the purpose of a hospital built for local patients, and that waiting lists at the city's government tertiary hospitals come first. The institute was established during the pandemic to provide high-end care for poorer and middle-income families at low cost. Its critics put the case as sequencing rather than principle, contesting the argument that revenue from international patients will fund upgrades later. Industry executives told Business Today that operating margins run at 24 to 25 per cent on Indian hospitals' domestic business and about 30 per cent on international patients, with higher marketing and acquisition costs taking back part of the difference. ## Kerala medical value travel Kerala's tourism minister, P.C. Vishnunath, set a 2030 target for the state to become a global medical travel hub, working with private hospitals and facilitators and focusing on Arab visitors travelling with their families. He named regulation, classification and standardisation as the conditions, and a training programme for service providers is under consideration with the state travel and tourism institute. A summit in Kochi on 31 August and 1 September has drawn more than 175 Arab travel agents and tour operators from 11 countries, with more than 100 Indian hospitals, hotels and Ayurveda centres exhibiting. Organisers are targeting 300,000 additional Arab visitors and more than 250 billion rupees, about 2.9 billion US dollars, over five years. India's existing inbound sourcing was put more plainly in Kampala, where Sanjiv Patel of the Tomil Group told a trade expo running from 13 to 15 August that 86 per cent of Ugandan patients who travel abroad go to India. ## Johor Bahru and Singapore MediSave The only Johor Bahru hospital in Singapore's overseas MediSave scheme has seen patients using the scheme double since the pandemic, and treats 150 to 200 international patients a day, mostly Singaporeans and Indonesians. Nine in ten of its MediSave patients are women, with obstetrics and gynaecology the most common treatments, Channel News Asia reported. A 2025 study by the ISEAS-Yusof Ishak Institute found Singaporeans could save between 24 and 74 per cent on procedures done in Malaysia, with in vitro fertilisation at the top of that range. Treatment in Johor Bahru can run up to 10 per cent higher in nominal terms, the hospital's chief executive said, with the exchange rate accounting for the gap. Singaporeans and permanent residents have been able to use MediSave for elective hospitalisations and day surgery at accredited overseas facilities since March 2010, subject to clinical assessment and financial counselling. The Rapid Transit System link between the two cities opens in January 2027, with a five-minute crossing. ## Health councils and hotel groups Malaysia's Healthcare Travel Council signed a memorandum of understanding with Marriott International on 12 August, under the country's Year of Medical Tourism campaign. The council is mandated by Malaysia's health ministry to develop and promote the national healthcare brand. Marriott announced a separate alliance with Therme Group the following day, covering customer experience, hotel design, wellness research and development opportunities, with the first phase offering Therme sites to its loyalty members. Therme has 10 projects under way across four regions, including a 720,000 square foot site in Singapore due in 2030. ## By the Numbers 1.28 million international patients treated at China's key foreign-oriented hospitals, a rise of 73.6 per cent over three years, in the National Health Commission's 2025 report. 35,851 foreign patients treated in Latvia last year, down 25.9 per cent on the year before, on Centre for Disease Prevention and Control figures. 8,600 overseas medical tourists received by the Boao Lecheng pilot zone on Hainan between January and July 2026, 5.4 times the same period in 2025, on provincial figures reported by CGTN. 24 to 74 per cent, the range of savings Singaporeans could make on procedures performed in Malaysia rather than Singapore, in a 2025 study by the ISEAS-Yusof Ishak Institute. 86 countries whose citizens may enter Hainan without a visa for up to 30 days, including for medical check-ups and treatment, under the province's current entry rules. 86 per cent of Ugandan patients who travel abroad for treatment go to India, cited by an industry representative at a Kampala trade expo held from 13 to 15 August 2026. ## What to Watch Indo Arab Connect 2026 runs in Kochi from 31 August to 1 September, followed by a nine-day familiarisation tour for Gulf and West Asian delegates from 2 to 9 September. The Rapid Transit System link between Singapore and Johor Bahru begins operating in January 2027. Vietnam's health ministry has proposed forming a steering committee and a national medical tourism association, to be included in the scheme it submits to government. Egypt's General Authority for Healthcare has been instructed to open coordination with the Turkish medical centres it visited earlier this year.

South Korea Undercuts America but Not Turkey

editorial@health-tourism-news.com (Christian El-Khouri) — Sat, 22 Aug 2026 15:00:00 GMT

Medical travel is usually discussed a destination at a time. Turkey is cheap, Korea is expensive, Mexico is close. South Korea is the case that breaks the habit, because the country gives two opposite answers depending on which procedure you ask about, and both answers are correct. Health Tourism News runs two Seoul guides. One prices a procedure that undercuts the American equivalent by half. The other prices a procedure that costs more than the British equivalent and several times the Turkish one. Same city, same clinics district, same week of travel. ## Two procedures, two answers | Procedure | South Korea | US private | UK private | Turkey | |---|---|---|---|---| | Primary rhinoplasty | $2,100 - $7,000
$2,100 - $3,500 straightforward | $8,000 - $15,000 | $8,000 - $13,400
£6,000 - £10,000 | not on this panel | | Revision or rib-cartilage rebuild | $5,000 - $12,000 | $12,000 - $30,000 | from $10,700 | not on this panel | | Porcelain veneer, per tooth | $720 - $1,500
₩1.1m - ₩2.3m | - | $670 - $1,340
median £614 | $175 - $485 | | Composite veneer, per tooth | $260 - $520 | - | $270 - $670 | $95 - $270 | *Published Seoul clinic and platform prices from the two Health Tourism News guides, converted at about 1,530 won to the dollar, with UK and Turkish references from the corresponding country guides.* The [rhinoplasty guide](/treatments/rhinoplasty/south-korea/) puts a straightforward primary nose at $2,100 to $3,500 in Seoul, rising to $7,000 or more for complex primary work at premium clinics, against $8,000 to $15,000 in the United States. Platform averages across all types sit near $4,700 to $5,700. That is a genuine saving on a genuinely complex operation, and it is why Gangnam fills with foreign patients. The [veneers guide](/treatments/veneers/south-korea/) reaches the opposite conclusion from the same city. Seoul porcelain at $720 to $1,500 a tooth sits at the top of the British range and above it, against a UK median of £614. Against Turkey the gap runs the other way and further: the [Turkish veneers panel](/treatments/veneers/turkey/) lists from under $100 to about $485 a tooth, and a 20-unit set at $2,900 to $6,050. A full smile of eight to ten porcelain veneers in Seoul works out at roughly $5,700 to $15,000. Nobody flies eleven hours to save money on a smile, and Korean clinics do not pretend otherwise. ## Why the same country prices two ways Korea's dental sector competes on finish rather than fee. The larger Seoul clinics run their own laboratories, so design, shade matching and milling happen under one roof and inside one trip, and digital smile design is standard rather than an upsell. That is a coherent product with a reason to cost what it costs. It is not a discount, and a patient shopping on price is on the wrong continent. Rhinoplasty is a different market. Seoul runs the busiest cosmetic-surgery sector on earth, and the volume, the specialisation and the domestic competition do to the price what scale usually does. Korea still charges several times what Turkey or Thailand ask, and competes on precision and finish rather than on being cheapest. It simply happens to undercut America while doing so. Two things move the total that no price list shows. Foreign patients may be quoted above the domestic won figures through agency and facilitator markups, so the currency and the final total both belong in writing. And the 10 per cent VAT refund that once favoured foreign cosmetic patients ended on 1 January 2026, which takes a tenth off the saving that older comparisons still assume. ## The safeguard Korea legislated One thing the Seoul market has that others do not is a law written in response to its own scandal. Ghost surgery, the substitution of the chosen surgeon with a different and often junior operator once the patient is under anaesthetic, was reported by the country's own plastic surgeons to have affected roughly 100,000 patients between 2008 and 2014, with around five deaths during ghost surgeries recorded between 2014 and 2022. Korea passed a law in 2021 requiring closed-circuit cameras in operating theatres, and since 2023 a patient under general anaesthesia has held a legal right to request that the operation is recorded. That is a usable defence rather than a reassurance: name the operating surgeon in the consent form, and exercise the right to the recording. The practice is now rare in registered, reputable clinics and concentrated in the high-volume operations that compete hardest on price for foreign patients, which is the same tier the harm concentrates in everywhere else in this trade. ## What this means for patients The question worth asking is never whether a country is cheap. It is what this procedure costs here against what it costs at home, and what the local market is competing on when it sets that price. On that test Seoul is a strong buy for a nose and a poor one for a smile, and the two conclusions sit a few streets apart. A patient who books a destination and then chooses a procedure has already made the decision backwards. *Health Tourism News is a trade publication and sells no treatment. Prices are the figures clinics and platforms publish, held on file, with the limits of each panel stated in the guide it comes from.*

Spain and Greece Report IVF Success Differently

editorial@health-tourism-news.com (Christian El-Khouri) — Sat, 22 Aug 2026 13:30:00 GMT

A Spanish clinic and a Greek clinic can both advertise a 60 or 70 per cent success rate for donor-egg treatment. The prices they quote are within a few thousand dollars of each other, and both undercut a London list by half or more. What separates them is not the offer. It is whether there is anything to check the offer against. Spain runs a mandatory national activity registry. Greece does not publish detailed national outcome tables on the same model. That single difference changes what a quoted success rate means in each country, and it is the reason the Health Tourism News guides to [IVF in Spain](/treatments/ivf/spain/) and [IVF in Greece](/treatments/ivf/greece/) answer the success question in two different ways. ## What Spain publishes about itself The Spanish registry's 2022 tables put own-egg live birth per fresh transfer at 34.0 per cent under 35, 24.7 per cent at 35 to 39 and 12.2 per cent at 40 and over. Counted per cycle started, which is the honest denominator for a patient deciding whether to fly, the same registry shows 9.3 per cent overall. Those figures do something a brochure cannot: they place Spain against Britain. The UK regulator reports 25 per cent births per embryo transferred; Spain's registry shows 25.0 per cent per transfer. Two national registries, within a rounding error of each other. Spain does not win on own-egg success, whatever a marketing page implies, and a clinic quoting 60 or 70 per cent for own-egg treatment is describing selected good-prognosis patients or cumulative attempts across several transfers. Donor eggs are where the numbers genuinely change shape, and the registry shows that too. Live birth per fresh donor transfer holds at 47.0 per cent under 35, 46.5 per cent at 35 to 39 and 40.7 per cent at 40 and over, because embryo aneuploidy follows the donor's age rather than the recipient's. Cumulative clinical pregnancy per donation cycle reaches 64.2 per cent against 31.9 per cent with a patient's own eggs. For a British patient in her mid-forties, that near-flat curve, not the price list, is the argument for treatment in Spain. ## What Greece asks you to take on trust Greece asks for more trust because it publishes less. In the absence of national outcome tables on the Spanish model, the honest figures for Greek donor treatment are the pan-European ones: donor-egg clinical pregnancy running around 45 to 50 per cent per transfer across recipient ages, with live birth somewhat lower. Greek donors are young and screened, and there is no reason to think Greek laboratories underperform. There is simply no national denominator to hold a Greek clinic's own claim against. That is not an argument against Greece. It is an argument about what a number from a Greek clinic can and cannot prove, and it changes which questions are worth asking in the consulting room. ## The measure that flatters everyone Both countries share a reporting habit that does more damage than the registry gap. Clinics commonly advertise clinical-pregnancy rates, and clinical pregnancy is an earlier and higher measure than a baby. It counts a heartbeat on a scan. The two diverge by the miscarriage rate, and in donor treatment the Spanish registry puts pregnancy loss near 20 per cent at every recipient age, against own-egg miscarriage that climbs past 40 per cent after 40. The denominator moves the number as much as the clinic does. Per transfer is higher than per cycle started, because it drops every cycle that never reached a transfer. Cumulative across several attempts is higher again. A patient comparing 65 per cent at one clinic with 45 per cent at another may be comparing three different measures rather than two clinics, and neither figure is wrong on its own terms. Two questions settle it. Live birth, not clinical pregnancy. Per cycle started, not per transfer. ## The prices, which are checkable | Treatment | Greece, published | Spain, published | UK reference | |---|---|---|---| | Own-egg IVF cycle | $3,400 - $5,100
ICSI usually included | $5,600 - $6,650
ICSI included | $5,100 - $10,200
ICSI often extra | | Patient medication | + $1,140 - $1,710 | + $1,150 - $1,700 | + comparable | | Egg-donation cycle | $5,700 - $10,250 | $7,650 - $10,850 | $16,500 - $20,500
named London list | *Published clinic prices from the two Health Tourism News country guides, each with its own methodology note and dated exchange rate.* Greece is the cheaper of the two on the headline cycle, and both are roughly half a London donor price. Neither country folds the patient's gonadotrophin medication into the quoted figure, which is a market convention rather than a trick, and it is worth adding before the two are compared with anything at home. ## Two laws, one shared consequence Spain's 2006 statute makes donation anonymous by law: the clinic matches by phenotype and immunological profile, and the child will never be able to trace the donor. Greece is predominantly anonymous in practice, with a 2022 reform making open, identifiable donation optional at the donor's choice, a route reportedly little used. Britain went the other way in 2005, and a donor-conceived Briton can request identifying details at 18, with the first cohort eligible from October 2023. Each country has a feature the other lacks. Greece's legal treatment age runs to 54, raised from 50 by the same 2022 reform, with the national authority assessing cases between 50 and 54. Spain sets no numeric ceiling in statute at all; the figure of 50 that circulates is professional guidance and clinic practice. Greece's altruistic, court-authorised surrogacy route, long one of the few open to foreign patients, was effectively closed to non-residents by Article 46 of Law 5197/2025, which requires both the applicant and the surrogate to hold permanent residence in Greece before a court will approve an arrangement. The consequence they share arrives years later and appears in no quote. Embryos made with an anonymous donor generally cannot be imported to a British clinic, because the donor fails Britain's identifiability requirement. The feature that brought the patient abroad is the feature that strands the surplus embryos there, with storage fees running on and every future transfer meaning another flight. Where all transfers will happen is a decision for before the first cycle, in writing, with both clinics. ## What this means for patients The price comparison is the easy half and it is the half most patients spend their time on. The harder half is that a success rate is only as good as the system that publishes it. In Spain a patient can hold a clinic's claim against a national table. In Greece the honest anchor is the European band, and any figure above it should be read as a selected-patient number until the clinic explains its denominator. Ask for live birth per cycle started. Ask what the number excludes. Then compare the prices. *Health Tourism News is a trade publication and sells no treatment. Prices are the figures clinics publish, held on file, with the limits of each panel stated in the guide it comes from.*

Mexico and Turkey Price Against Different Home Markets

editorial@health-tourism-news.com (Christian El-Khouri) — Sat, 22 Aug 2026 12:00:00 GMT

A Tijuana hospital publishes its gastric sleeve package in US dollars, though it pays its staff in pesos. An Istanbul clinic publishes an itemised implant list in pounds sterling, though it buys its fixtures in lira. Hungarian and Polish clinics quote foreign patients in euros while their domestic prices sit in forint and złoty. In every case the currency on the page belongs to the buyer rather than the seller, and that is the first clue to how these prices are set. Health Tourism News runs country guides on both corridors. Read the Mexican and Turkish ones side by side and the same pattern shows in the numbers. ## Two corridors, one multiple | Procedure | Mexico | US reference | Turkey | UK reference | |---|---|---|---|---| | Gastric sleeve, all-inclusive package | $4,150 - $5,000
typical; market $3,900 - $7,500 | $15,000 - $25,000 | $3,600 - $4,500
panel median $3,850 | $13,000 - $18,000 | | Single implant, finished tooth | $1,200 - $1,730 | $3,500 - $5,500 | $940 - $1,140
premium brand | $3,355 median | | All-on-4, per arch | $8,110 - $9,900
border towns | $25,000 - $35,000 | from $2,150
budget brand, acrylic | $16,100 - $33,500 | *Panel prices from the four Health Tourism News country guides, each with its own methodology note and dated exchange rate.* Do the arithmetic on the sleeve and both corridors land in the same band. In Mexico, $15,000 against $5,000 is three times and $25,000 against $4,150 is six; the guide settles on a factor of three to five for the typical package. In Turkey, $13,000 against $4,500 is under three times and $18,000 against $3,600 is five. Different countries, different absolute prices, near-identical ratios. The finished tooth does the same thing. The [Mexican implant guide](/treatments/dental-implants/mexico/) puts the complete tooth at roughly a third of the American price. The [Turkish implant guide](/treatments/dental-implants/turkey/) puts a premium-brand fixture at roughly a third of the British median. Two markets with no reason to agree, agreeing to within a rounding error. The obvious reading is that both are pricing against the number the patient already carries, rather than up from a local cost base. Mexico's dollar prices sit consistently above Turkey's because the American benchmark sits consistently above the British one, not because surgery in Tijuana costs more to deliver than surgery in Istanbul. The [Mexican bariatric guide](/treatments/gastric-sleeve/mexico/) and the [Turkish one](/treatments/gastric-sleeve/turkey/) describe the same operation, the same registry mortality near 0.1 per cent, and two price lists denominated for two different audiences. ## Where the pattern breaks Two places, and both are instructive. The first is Cancun. All-on-4 in the Mexican border towns runs $8,110 to $9,900 an arch; the same operation in Cancun's resort packages runs $10,000 to $13,500 with travel services bundled in. Same country, same benchmark, twenty to fifty per cent more. That market is pricing against convenience and a holiday rather than against a Phoenix dental quote. The second is Turkey's entry tier. An implanted tooth at $270 to $535 is a sixth to a twelfth of the British median, not a third. No home benchmark explains that. It is a brand-tier decision, an Osstem or Neodent fixture rather than a Straumann one, and it is the point at which the price stops describing the same product. That is worth holding onto, because the multiple is only meaningful while both sides of it name the same thing. ## What the multiple never prices The ratio covers a list price in one country against a list price in another. It does not cover the second flight, and implants need one: osseointegration takes three to six months in both countries, and no pricing tier hurries it. It does not cover the complication that surfaces after the package ends, which for a sleeve means a leak in the days or weeks after a patient has flown, and aviation guidance sets about ten days after abdominal surgery against packages of five to seven. Above all it does not cover what happens at home. Most US dental plans stop at the border, though some preferred-provider schemes reimburse 50 to 80 per cent of out-of-network work against an itemised receipt carrying standard procedure codes, which is worth asking for in English before leaving the chair. US insurers frequently exclude complications of elective surgery obtained overseas. In Britain, the NHS treats emergencies from surgery abroad and does not fund revision or cosmetic correction, and the British bariatric society has published its own statement on going abroad for weight-loss surgery. Both corridors leave the return trip and the aftercare as the patient's line item, and neither prices it. ## What this means for patients A three-to-five multiple is a description of how a market quotes, not a measure of what a patient receives. The number is honest as far as it goes, and it goes as far as the list price. Everything the guides spend their length on, the finished unit rather than the component, the named surgeon and licensed hospital, the extra inpatient night, the second trip and the plan for the year after, sits outside it. Patients who spend part of the saving on the parts the multiple ignores get the deal the arithmetic describes. Patients who treat the multiple as the deal are buying a list price. *Health Tourism News is a trade publication and sells no treatment. Prices are the figures providers publish, held on file, with the limits of each panel stated in the guide it comes from.*

Turkey's Deepest Discounts Sit on Its Safest Procedures

editorial@health-tourism-news.com (Christian El-Khouri) — Sat, 22 Aug 2026 10:30:00 GMT

Turkey is the most heavily searched destination in medical travel, and it is usually discussed as one decision. It is not. Health Tourism News runs four Turkish guides, on dental implants, veneers, gastric sleeve and tummy tuck, and each of the four buys a different bargain against a different risk. Put the four side by side and the ranking by saving and the ranking by harm come out close to reversed. ## Ranked by the price gap | Procedure | Turkey, published | Home reference | Multiple | |---|---|---|---| | Single implant, entry-tier brand, crown included | $270 - $535 | UK median $3,355
£2,500 | 6x - 12x | | Gastric sleeve, all-inclusive package | $3,600 - $4,500
panel median $3,850 | UK named self-pay $13,000 - $18,000 | 3x - 5x | | Veneer, E-max, per tooth | $215 - $430
panel median $270 | UK median £614
about $825 | about 3x | | Single implant, premium brand | $940 - $1,140 | UK median $3,355 | about 3x | | Full tummy tuck | $3,900 - $4,950
panel median $4,500 | UK hospital groups $9,400 - $11,600 | 2x - 3x | *Published Turkish panel prices from the four country guides, each with its own methodology note and dated exchange rate.* An entry-tier implanted tooth is the deepest discount on the list, at a sixth to a twelfth of the British median. A tummy tuck is the shallowest, at a third to a half of what named UK hospital groups charge. Between them, the sleeve saves the most money in absolute terms: $9,000 to $14,000 on one operation. ## Ranked by what goes wrong Now reverse the question and ask what the record says about each. Abdominoplasty carries the highest serious-complication rate of the common aesthetic operations, 4 per cent in registry data against 1.4 per cent for other cosmetic surgery. A 2015 registry analysis of 25,478 abdominoplasties put major complications at 3.1 per cent for the operation alone, 4.6 per cent when liposuction and a breast procedure were added, and 10.4 per cent once liposuction and further body contouring joined, the shape most package upsells take. Roughly a fifth of those complications were clots, and the timing is the traveller's problem: most clots arrive within two weeks, one study found 87 per cent of pulmonary embolisms after abdominoplasty struck after discharge around day ten, packages issue fit-to-fly letters at day six to eight, and surgeons' guidance for long-haul flying after this class of surgery commonly says four to six weeks. The [tummy tuck guide](/treatments/tummy-tuck/turkey/) sets out that calendar in full. Veneers look benign and are not, because much of what is sold as veneers is crown work. A genuine veneer removes roughly 3 to 30 per cent of a tooth's structure and survives at 95.5 per cent over ten years in a review of about 6,500 veneers. A crown requires cutting the whole tooth, measured at 63 to 72 per cent of coronal structure by weight in a gravimetric study, and prospective work found pulp necrosis in about 9 per cent of teeth after full-crown preparation. Across a 20-tooth case that is one or two root canals in the years after. For a 2022 BBC documentary, 70 of 120 Turkish clinics that replied to an enquiry from a person with healthy teeth proposed veneer or crown treatment; all 34 UK clinics that replied said none was needed. In the British Dental Association's survey, 86 per cent of dentists had treated complications of dental work done abroad, with crowns the most likely to need remedial work. The [veneers guide](/treatments/veneers/turkey/) explains how to tell the two products apart before paying for either. The gastric sleeve is the operation with a death rate attached, and the registries put it low: 0.1 per cent 30-day mortality in a multicentre study of 3,983 patients, and 0.07 per cent across 41,241 bariatric operations in England's hospital data. Staple-line leaks ran 0.17 per cent within 30 days in a study of 692,554 operations and about 1.5 per cent in a systematic review of 40,653 patients. The number that matters to a traveller is not the rate but the clock: leaks surface days or weeks after discharge, when a package patient has already flown. Aviation guidance sets about ten days after abdominal surgery, and Turkish packages run five to seven. The [gastric sleeve guide](/treatments/gastric-sleeve/turkey/) sets the discharge checks against the schedule. Dental implants, the deepest discount of the four, have the mildest failure mode. Ten-year survival runs 93 to 96 per cent in the review literature wherever the work is done, the biology forces two trips months apart, and the thing that goes wrong at home is administrative rather than clinical: an unnamed fixture that no British dentist can service, or a warranty nobody will honour without a return flight. The [implants guide](/treatments/dental-implants/turkey/) covers the paperwork that makes a warranty travel. ## The two rankings do not line up The largest price gap on the list sits on the procedure whose worst case is a replacement tooth. The smallest sits on the procedure with the highest serious-complication rate and a clot window that opens after the flight home. A patient who picks Turkey and then picks a procedure is reasoning in the wrong order. The Foreign Office states that seven British nationals died in Turkey in 2025 following medical procedures. A surgical-association complications database logged about 200 returning cosmetic-tourism cases in its first two years, attributing some 76 to 80 per cent of them to surgery in Turkey. Those figures describe a large market, not a uniformly dangerous one, and the pattern inside them is consistent across all four guides: harm concentrates in the cheapest tier, in the multi-procedure bundle and in the compressed schedule, rather than in the country. Conservative plans, named surgeons and dentists, staged appointments and a flight booked for the far side of the risk window describe the good outcomes in every one of the four. The discount is not the risk signal. It never was. *Health Tourism News is a trade publication and sells no treatment. Prices are the figures providers publish, held on file, with the limits of each panel stated in the guide it comes from.*

Dental Implant Prices Abroad Hide Three Different Units

editorial@health-tourism-news.com (Christian El-Khouri) — Sat, 22 Aug 2026 09:00:00 GMT

Health Tourism News now runs six country guides on dental implants. Read across them and a single implanted tooth costs anywhere from $270 to $3,150. Some of that spread is genuine price. A good part of it is not price at all. The six markets do not headline the same product, and the number a clinic puts at the top of its list decides whether any comparison that follows means anything. Three units circulate. The implant alone, which is a titanium post and no tooth. The restored or complete tooth, which is the post, the abutment and the crown. And the arch, which is a bridge on four or more implants and may or may not be the final one. Quotes from different countries routinely put all three under the same word. ## What each market puts on the front of its price list Turkey prices by implant brand rather than by city, and the published panel figures are per implant with the crown on it. Entry-tier systems ran $270 to $535 in mid-2026, mid-tier brands $605 to $805, and premium Swiss and Swedish systems $940 to $1,140, as set out in the [Turkish implant guide](/treatments/dental-implants/turkey/). Poland does the same, headlining the restored tooth at $535 to $940 for standard systems and $735 to $1,340 for premium ones, which the [Poland guide](/treatments/dental-implants/poland/) breaks down by brand. Croatia and Hungary work the other way. Croatian lists usually headline the post, at $775 to $935, or $905 to $1,110 for a Swedish system, and the abutment and crown add $275 to $790 on top. The restored tooth lands at $1,050 to $1,715, which is the figure the [Croatia guide](/treatments/dental-implants/croatia/) uses. Hungarian lists run from $370 for a budget post to $1,415 for a Straumann one, with the restored mainstream tooth at $950 to $1,460 in the [Hungary guide](/treatments/dental-implants/hungary/). Mexico advertises a sub-$900 figure that is the surgical post alone. Border-town lists run $750 to $890 for it, and the restoration adds $450 to $720, so the complete tooth is $1,200 to $1,610 in the border cities and $1,730 at one Mexico City provider, as the [Mexico guide](/treatments/dental-implants/mexico/) records. Thailand mostly publishes complete-tooth rate cards, $1,050 to $1,950 for economy brands and $1,950 to $3,150 for premium ones, but two providers on the panel headline the implant body alone at $870 to $1,770 with the crown adding $750 to $900, a trap the [Thailand guide](/treatments/dental-implants/thailand/) flags. | Country | What the headline price usually covers | Restored or complete tooth | |---|---|---| | Turkey | implant with crown, by brand tier | $270 - $1,140
entry tier to premium | | Poland | restored tooth | $535 - $1,340 | | Hungary | the post alone | $950 - $1,460
mainstream systems | | Croatia | the post alone | $1,050 - $1,715 | | Mexico | the post alone | $1,200 - $1,730 | | Thailand | complete tooth, two panel exceptions | $1,050 - $3,150
by brand tier | | UK reference | restored tooth | $3,355 median
£2,500, 1,125-practice sample | | US reference | complete tooth | $3,500 - $5,500 | *Panel prices from the six Health Tourism News country guides, each with its own methodology note and dated exchange rate. UK median from TreatCompare's 2026 sample.* Line them up on the same unit and the ranking changes. A Croatian post at $775 and a Turkish premium tooth at $940 look about twenty per cent apart, and they are not comparable at all: put a crown on the Croatian post and the Croatian tooth costs more than the Turkish one. Poland, quoting restored teeth from $535, is the cheapest whole tooth on the panel outside Turkey's entry tier, which no headline suggests, because Poland is quoting the finished article while three of its competitors are quoting a component. ## The arch quotes are worse All-on-4 is the least comparable number in this market, because one label covers several different products. The Turkish panel makes the point on its own: one provider publishes an arch at $2,150 with a temporary bridge, another publishes $7,500 for both jaws in porcelain. A reader comparing the two without checking the unit is off by more than a factor of three, part unit and part material. | Country | All-on-4, per arch | Note | |---|---|---| | Turkey | from $2,150 | budget brand, acrylic, temporary bridge | | Poland | $5,700 - $8,900 | a zirconia arch in Kraków near $6,750 | | Hungary | $6,965 - $11,400 | low end leaves the final bridge unstated | | Croatia | $7,550 - $8,750 | all-inclusive lists; full band $5,150 - $10,950 | | Mexico | $8,110 - $9,900 | border towns; Cancun resort packages $10,000 - $13,500 | | Thailand | $9,900 - $13,200 | premium brand; one budget Korean system at $6,300 | | UK | $16,100 - $33,500 | per jaw, 2026 lists | | US | $25,000 - $35,000 | as reported by comparison guides | *Units as each provider publishes them. Full methodology in each country guide.* The cheap floors have something in common across all six countries: they leave the final bridge unstated. The transparent lists name the bridge, its material and the visit it arrives on. That single difference explains more of the spread in the table above than the country does. ## What does not vary The biology is the same in all six markets, and so is what the literature says about it. An implant fuses to the jaw over three to six months, which is why every one of the six guides describes two trips separated by months rather than one. Teeth in a day describes a temporary bridge, not the result. Ten-year survival sits at 93 to 96 per cent in the review literature wherever the work is done, and peri-implantitis, the inflammation that takes implants out later, is not a destination-specific risk either. What does vary, apart from the unit, is the paperwork. A named implant system with lot numbers can be serviced by a dentist at home; an unbranded fixture can mean removal and replacement at domestic prices. Warranty terms that say who pays for a redo, and where it happens, are worth more than a lower floor. The General Dental Council's guidance for British patients going abroad makes the same point in blunter language. ## Three questions that make a quote comparable Ask whether the price is the restored tooth or the post alone, and get the answer in writing with the abutment and crown itemised. Ask whether an arch price is per jaw or both, and which bridge and material arrive on which visit. Ask which implant system, by name, and whether lot numbers come home in the records. A patient who asks those three questions can put six countries on one line. A patient who compares headlines is comparing a post in Croatia with a tooth in Turkey and an arch in Thailand, and the cheapest number on that list is usually the one that covers the least. The six guides sit under the [dental implants section](/treatments/dental-implants/), each with the panel, the methodology and the local licence checks. *Health Tourism News is a trade publication and sells no treatment. Prices are the figures clinics publish, held on file, with the limits of each panel stated in the country guide.*

This Week in Medical Tourism: 6–12 August 2026

editorial@health-tourism-news.com (Christian El-Khouri) — Fri, 14 Aug 2026 00:00:00 GMT

This is the Health Tourism News roundup for 6 to 12 August 2026. ## Vietnam medical tourism targets Vietnam's Ministry of Health is targeting 750,000 international medical tourists and USD 1 billion in direct healthcare revenue by 2030, under a draft plan for 2026 to 2030 that went out for consultation this week. It puts current volume at about 300,000 international visitors using medical services each year, spending an estimated USD 1 to 2 billion including accommodation, travel and food. The plan also records the other direction. Vietnamese citizens spend an estimated USD 2 to 3 billion a year on treatment abroad, which the ministry states is more than the country earns from inbound medical visitors. Ho Chi Minh City accounts for about 40 per cent of international medical tourists, Hanoi second. The ministry lists what is missing: no dedicated legal framework, no standardised service packages, no national brand, and rules that stop public hospitals fully costing services for foreign patients. It wants at least 20 hospitals meeting international quality standards by 2030, five of them public, piloted in five to seven locations from 2026 to 2028 and extended nationwide from 2029. ## Nigeria outbound spending A Nigerian-domiciled company launched in Lagos on 7 August with plans to manufacture regenerative biologics locally, aimed at the USD 2.39 billion Nigerians spend each year on treatment abroad, Business Day reported. It pairs a United States manufacturing firm with a Nigerian hospital group. A Dangote Industries executive, delivering Aliko Dangote's keynote at a Lagos regenerative medicine summit, said the pandemic had shown what dependence on imported medical products costs. "Dependence is a vulnerability," she said. Enugu State's international hospital, due to open within weeks, has been set a target of cutting Nigerians' overseas treatment by up to 40 per cent within a year of opening, its chief executive told journalists touring the site on 12 August. It is to run cancer, cardiac, neurosciences, renal and nuclear medicine centres, with a cyclotron on site. A 250-bed hospital in Ogun State and a specialist centre in Abuja agreed a referral and training partnership on 2 August; the Abuja centre said it had treated patients from 23 countries in its first year. ## India inbound patient volumes Medical value travel to India from conflict-affected regions has fallen 40 to 60 per cent, with airfares up 15 to 25 per cent, the chair of the Federation of Indian Chambers of Commerce and Industry's medical value travel committee told Arab News. Airspace restrictions following the US-Israeli war on Iran have run for five months. India ranks 10th of 46 destinations on the 2025 Medical Tourism Index. One large Indian hospital group treated 32,000 foreign patients last year, 5,000 of them from the Middle East, and its sales director said similar numbers were unlikely in 2026. Elective and wellness clinics have seen the steepest falls; cardiac, renal and oncology volumes held up better, those cases being harder to defer. Bangladesh's High Commissioner to Pakistan told a meeting in Islamabad on 8 August that nearly 800,000 Bangladeshis travel abroad for treatment each year and spend more than USD 6 billion, and asked for visa facilitation and better air links. Those patients have historically gone to India, and The News tied the shift to strained Dhaka-New Delhi relations since the change of government in August 2024. Pakistan's National Health Tourism Working Group chair said a quarter of that market would be 200,000 patients and USD 1.5 billion. ## Medical tourism market estimates Two governments were given materially different estimates of the same market in the same week. Vietnam's health ministry told its own consultation that global medical tourism revenue in 2024 ran between about USD 40 billion and more than USD 100 billion, growing 8 to 16 per cent a year through 2035. Pakistan's Special Investment Facilitation Council was told by industry experts that the 2024 figure was USD 144.5 billion, reaching USD 704.8 billion by 2033 at an annual rate above 19 per cent. India's market was quoted twice in four days. A parliamentary standing committee report tabled in the Rajya Sabha on 7 August cited industry estimates of USD 8.7 billion in 2025, rising to USD 16.2 billion by 2030. On 10 August the FICCI committee chair put the sector at USD 13 billion. Neither government document names the research house behind its figure. The committee, which recommended that hospitals earning from international and wealthy patients cross-subsidise tertiary care for poor Indians, attributed its own figure to unspecified industry estimates. ## Egypt and Sarawak hospital investment A consortium led by Egypt's Inventure Group with Italy's Impresa Pizzarotti and China's CSCEC plans to invest nearly USD 5.3 billion in two Egyptian medical cities, discussed with the prime minister in Cairo on 5 August. One, at USD 2.8 billion, goes in the new administrative capital near Cairo and the other, at USD 2.5 billion, at El-Alamein, both with hotels and recuperation centres. The government expects nearly 3 million medical tourists within three years of the sites opening, AGBI reported. Sarawak attracted more than 100,000 medical tourists in 2025, which the state Premier told reporters on 10 August was double the previous year. He put Sarawak's own population at 2.5 million against 35 million in Borneo and 700 million across ASEAN, naming Indonesia and its 280 million people as the market. A Singapore-based operator broke ground the same day on a 300-bed private hospital in Kuching due for completion in 2029. ## Spa carbon measurement A typical spa visit produced about 5 kg of carbon dioxide equivalent at a large Bucharest wellness resort and about 3.5 kg at a smaller university-run sports-park spa, on measurements published on 22 July in the peer-reviewed journal Communications Sustainability. The calculator, SPA-DEC, was developed by Therme Group and the University of Surrey with co-funding from Innovate UK, and its authors call it the first standardised method for measuring a single spa visit's footprint in real time. On-site renewable generation cut per-visit emissions by about 33 per cent at the larger site and about 14 per cent at the smaller one during 2024. The method divides total emissions across every visit and covers all three scopes of the Greenhouse Gas Protocol. ## By the Numbers Rs 50,508 (about USD 529) average cost of a hospitalisation in an Indian private hospital against Rs 6,631 (about USD 69) in a government hospital, January to December 2025, on the 80th round of the National Sample Survey. 43.4 per cent of India's total health expenditure paid out of pocket in 2022-23, on figures cited by the Parliamentary Standing Committee on Health and Family Welfare. USD 1 billion in direct healthcare revenue from international patients, Vietnam's target for 2030, on the Ministry of Health draft plan issued for consultation in August 2026. About 5 kg of carbon dioxide equivalent per spa visit at a large Bucharest wellness resort during 2024, on measurements published by Therme Group and the University of Surrey. USD 5.3 billion committed to two Egyptian medical cities at a meeting with Egypt's prime minister on 5 August 2026, reported by AGBI. More than 100,000 medical tourists in Sarawak during 2025, on figures given by the state Premier. ## What to Watch Vietnam's draft medical tourism plan was open for consultation as of 12 August, its first phase running from 2026 to 2028 across five to seven pilot locations. The Global Conference on Medical Tourism runs in Yerevan from 21 to 23 September 2026, organised by Armenia's Tourism Committee with the United Nations World Tourism Organization. Pakistan and Bangladesh agreed on 8 August to expedite a health cooperation memorandum, unsigned on that date. The 300-bed private hospital that broke ground in Kuching on 10 August is due for completion in 2029. Currencies converted at mid-market rates on 14 August 2026.

Why Medical Tourism to Germany Declined

editorial@health-tourism-news.com (Christian El-Khouri) — Tue, 11 Aug 2026 18:32:06 GMT

For most of the 2000s and early 2010s, Germany was one of the premier destinations for [medical tourism](/medical-tourism/), drawing self-paying and state-sponsored patients from Russia, the former Soviet republics and the Gulf. That business has been shrinking since the middle of the last decade, and the common explanation, that cheaper rivals such as Turkey took the patients, covers only part of it. The larger part is internal. A series of billing scandals broke the trust of the state payers who funded the trade, two changes in German law closed the commercial channel it ran through, the hospital sector fell into a staffing and financing crisis that made foreign patients a burden rather than extra income, and a change in how senior doctors are paid removed the personal incentive that once drove clinicians to pursue the work. This article sets out those factors in turn. This report concentrates on the internal, legal and systemic causes. For the wider view of the fall, including the market data and the demand-side story, see our [companion overview of the decline of medical tourism in Germany](/news/the-decline-of-medical-tourism-in-germany/).

Text description of the diagram

Five forces, three mechanisms, one outcome.

Demand side. 01 Source-market shocks. Russia: EU sanctions, weak rouble, 2022 war. Gulf: budget cuts, VAT, embassy reform.

Systemic, Germany. 02 Billing scandals. Libyan war-wounded losses and the Kuwaiti embassy-patient affair erode payer trust. 03 Legal change closes the channel. §299a/b StGB (2016) can criminalise paid referrals. §138 BGB (LG Kiel 2011, LG Stuttgart 2024) makes brokerage contracts void.

Supply side. 04 Hospital staffing and funding crisis. Nurse and bed shortages and deficits turn foreign patients into a burden, not income. 05 Doctors' pay incentive removed. Liquidationsrecht gives way to Beteiligungsvergütung: the hospital keeps the fee.

Mechanisms. Forces 01 and 02 drive demand falls among premium non-EU patients. Force 03 closes the acquisition channel. Forces 04 and 05 collapse provider willingness. Competition, from Turkey and from Gulf states building their own capacity, is an accelerant rather than a root cause.

Outcome. The premium inbound business collapses. Low-value EU cross-border day-traffic masks the fall in the profitable core.

How the factors combined: demand-side shocks, German-specific systemic breaks, and supply-side withdrawal converging on the decline of the premium inbound business.

## The scale of Germany's medical tourism decline Germany's inbound patient numbers peaked in the middle of the last decade and have trended down since. The most-cited data comes from the Hochschule Bonn-Rhein-Sieg, whose researchers have tracked the German market for years. Their figures put the country at around 255,000 foreign patients in 2015, then [about 253,000 in 2016 and roughly 247,500 in 2017](https://www.aerzteblatt.de/archiv/medizintourismus-weniger-patienten-aus-dem-ausland-ceef08ef-c8d1-4bbb-a847-3fb542445d89), with revenue holding near 1.2 billion euros. On the surface that looks like a modest, gradual decline. Beneath it the picture is sharper. The headline count masked what was happening underneath. By 2018, [close to two-thirds of all foreign patients came from within the EU](https://www.aerzteblatt.de/nachrichten/133513/Medizintourismus-in-Deutschland-geht-zurueck), most of them from Poland, and much of that is low-value cross-border and day-case traffic. The consulting firm MESC frames the same split from the operator's side, noting that of up to 250,000 foreign patients a year, [only around 40 to 45 per cent are true medical tourists](https://www.mesc.com/en/blog/the-problem-with-patient-facilitators/), most from neighbouring Europe, followed by the Gulf and the former Soviet states. The premium segment, the non-EU inpatient business that hospitals built dedicated international departments to capture, is the part that collapsed. The aggregate number fell gently; the profitable core fell hard. That is why the sector is much diminished even where the raw statistics look only modestly lower. ## The source markets collapsed The two markets that made German medical tourism lucrative, Russia and the Gulf, both contracted for reasons largely outside German control. Russia was the single biggest source country. From 2014, the falling rouble, the low oil price and EU sanctions made treatment in Germany far more expensive, and the Hochschule Bonn-Rhein-Sieg reported that Russians increasingly [travelled only for urgent cases](https://www.h-brs.de/de/pressemitteilung/medizintourismus-nach-deutschland-stagniert). The 2022 invasion of Ukraine, with the banking cut-off, airspace closures and political rupture that followed, ended most of what remained. The Gulf decline was steeper in places and more instructive, because it was not only about money. Budget deficits, the introduction of VAT in Saudi Arabia and the United Arab Emirates, and general spending cuts reduced the funds Gulf governments set aside for foreign treatment. But the German trade press has consistently pointed to a change in behaviour as much as budget: the once-generous payers began scrutinising German invoices closely and sending fewer patients where they suspected overcharging. Kuwait, once a flagship market, fell by [62 per cent in a single year](https://www.aerzteblatt.de/archiv/medizintourismus-weniger-patienten-aus-dem-ausland-ceef08ef-c8d1-4bbb-a847-3fb542445d89), with Saudi Arabia and Oman also down sharply. That shift toward suspicion did not come from nowhere. ## Billing scandals broke payer trust The trust the trade depended on was broken by a series of billing scandals in the mid-2010s, and German commentators have named these directly as a cause of the Gulf pull-back. The most documented is the case of a Stuttgart teaching hospital, whose international unit treated around 370 Libyan war-wounded and ran up a [roughly nine-million-euro deficit](https://www.stuttgarter-zeitung.de/inhalt.umstrittenes-libyen-projekt-des-stuttgarter-klinikum-bargeld-im-koffer-und-chaos-in-den-buechern.a96bf7d4-62c7-4629-9d93-7ab0e86710b8.html), amid cash carried in suitcases and disordered bookkeeping. Analysts at the Hochschule Bonn-Rhein-Sieg listed that affair, alongside inflated billing of Libyan patients more generally and the disappearance of large sums in the treatment of Kuwaiti embassy patients, in a picture that Kuwaiti media called [one of the largest frauds they had seen](https://www.medical-tribune.de/meinung-und-dialog/artikel/medizintourismus-die-suche-nach-dem-spendablen-scheich), with a state commission examining hospital and agency contracts. The trade analysis was blunt about the effect. Reporting in the German sector press tied the collapse in Arab-region patient numbers from late 2016 to three things together: reduced Gulf funding, structural changes in the embassies and consulates, and [the scandal around the Stuttgart hospital's international department](https://www.mtdialog.de/artikel/stagnation-im-medizintourismus). When a business rests on a handful of foreign ministries and those ministries conclude they are being overbilled, they redirect the flow rather than renegotiate. ## The law closed the intermediary channel Two developments in German law removed the commercial machinery that the inbound trade ran on, and this is the internal factor most often overlooked outside Germany. The business depended on agents and facilitators who were paid a commission to steer patients to particular clinics. Since June 2016, that model has been legally hazardous, because [Sections 299a and 299b of the Criminal Code](https://www.gesetze-im-internet.de/stgb/__299a.html) extended anti-corruption law across the healthcare sector, so that demanding or granting a benefit for referring patients can, in the right circumstances, be treated as a criminal offence. The provisions are not a blanket ban on working with intermediaries, but they raised the level of scrutiny sharply, and with it the legal requirements for structuring these partnerships. MESC, which advises on exactly this problem, has set out how these provisions apply to patient brokerage in its explainer on the [Sections 299a and 299b question in medical tourism](https://www.mesc.com/en/blog/sections-299a-299b-german-criminal-code-patient-referral/). The civil law then closed the same door from the other side, and it did so long before the recent cases. The foundational ruling came from the Regional Court of Kiel in 2011, which held that a commission contract for referring patients to a hospital is [immoral and void under Section 138 of the Civil Code](https://www.gesetze-im-internet.de/bgb/__138.html). That case sits squarely on theme: a doctor with contacts in the Gulf had agreed with a university hospital's international department to channel private patients from Oman and the United Arab Emirates in return for a commission of 15 to 22.5 per cent of the hospital's income, and the court [dismissed his fee claim and extended the doctors' referral ban to the hospital itself](https://www.aerztezeitung.de/Wirtschaft/Urteil-Zuweiser-Provision-unzulaessig-264141.html). The Regional Court of Stuttgart confirmed and widened that line in November 2024, ruling that such commissions are void [even in federal states whose hospital laws contain no explicit prohibition](https://www.otto-schmidt.de/news/zivil-und-zivilverfahrensrecht/medizintourismus-klinikprivileg-rechtfertigt-keine-patientenvermittlung-2024-11-28.html), that the so-called hospital privilege does not save them, and that a brokerage arrangement bundled with interpreting or visa help is void in its entirety, denying a claim of 119,000 euros. MESC, which advises on exactly this problem, has argued that the compliant contractual constellations which remain tend to be [uneconomic enough that clinic and agency simply drop the cooperation](https://www.mesc.com/en/blog/the-problem-with-patient-facilitators/). For any provider still weighing the business, the message is that the standard way of acquiring international patients is now legally unsafe. ## Payment risk became a deterrent Even where a foreign patient did come, collecting the fee became a structural risk that pushed finance directors away from the trade. Once a self-paying patient has flown home, recovery is difficult and slow, and if the intermediary refuses to pay, the hospital is left litigating in a foreign jurisdiction. German case law shows how this plays out: in one 2023 matter, a hospital's claim of around 130,000 euros against an agency [failed because it could not prove the agency had agreed to cover the costs](https://www.med-juris.de/behandlung-auslandischer-patienten-mit-kostenubernahmeerklarung/). Cases like these taught hospitals to treat unsecured foreign-patient revenue as a bad-debt risk rather than easy income, and many concluded the margin did not justify the exposure. ## The domestic hospital crisis For years, international patients were presented internally as extra revenue on top of the case-based hospital budget, and that logic holds only when a hospital has spare beds and spare staff. Germany now has neither. The nursing shortage became acute enough to drive strikes for binding staffing ratios at major Berlin hospitals, and once beds and nurses are the constraint, a foreign self-payer stops being extra income and becomes a bed a domestic patient needs, with the added optics of queue-jumping. During the pandemic this became explicit and public. At Hamburg's university hospital, the drop in foreign patients was reported as [a board decision not to fill beds with them](https://www.aerzteblatt.de/nachrichten/133513/Medizintourismus-in-Deutschland-geht-zurueck) rather than a lack of demand, while at a large Munich university hospital the international business largely came to a standstill. The exits followed. Düsseldorf University Hospital [stopped targeting international patients, saying the revenue was no longer important](https://schengenvisainfo.com/news/medical-tourism-in-germany-experiences-sharp-decline/), and Berlin's Vivantes closed its central international-medicine unit, explaining that Gulf states were setting different priorities and signing contracts with other countries, so remaining non-EU patients would be handled directly by specialist departments. When institutions this large decide the business is not worth the beds, the market has already turned. ## The shift in doctors' pay incentives The final factor concerns how senior hospital doctors are paid, and it removed their personal reason to pursue foreign patients. Under the traditional model, a chief physician holding a personal billing right, the Liquidationsrecht, could invoice elective physician services directly to private patients under the German medical fee schedule and keep the income, paying the hospital only a usage fee. Foreign self-payers and embassy patients fall squarely into this, billed as private patients, so the senior doctor who attracted a Gulf or Russian patient was in large part billing for their own account. The German medical press has described private liquidation as making up a [large share of chief-physician pay](https://www.aerzteblatt.de/archiv/chefarztrecht-wahlleistungen-in-form-der-wahlarztbehandlung-732557cf-5bb3-43cc-b94e-74090e5f057f), and the trade literature of the era was explicit that treating foreign private patients could be [very lucrative for the chief physician](https://www.iww.de/cb/archiv/liquidationsrecht-teil-1-honorare-bei-auslaendischen-patientendurchsetzen-teil-1-diplomatischer-corps-f24721), especially where the hospital itself was under financial pressure. That personal upside has thinned out. New chief-physician contracts increasingly grant no personal billing right at all, only a share of the proceeds, a Beteiligungsvergütung, while the hospital holds the billing right and books the revenue itself. This is not one reform statute but a structural, contractual migration, [pushed by the German Hospital Federation](https://www.aerzteblatt.de/archiv/160512/Liquidationsrechte-fuer-Chef-und-Oberaerzte-Veraenderte-Rahmenbedingungen) and enabled by the fact that a chief physician has no enforceable right to be granted the billing privilege in the first place. The consequence for international patients is direct. The clinician most able to attract them, the specialist the patient travelled for, no longer captures the upside; the hospital does. And the hospital, as above, increasingly did not want the business. The two incentives that once pointed the same way, the doctor's private motive and the institution's revenue motive, weakened at roughly the same time. ## Competition as accelerant External competition then completed what the internal failures had started, though it is better understood as the accelerant than the root cause. For Arabic-speaking markets in particular, Turkey grew attractive because its surgeons were often [German- or US-trained and share the patients' faith](https://www.igp-magazin.de/medizintourismus-der-markt-ist-umkaempft/), while the Gulf states built their own tertiary capacity and, as Vivantes noted, signed bilateral treatment agreements elsewhere. The competition bit hard because Germany had already hollowed out its own trust, its legal channel, its payment security and its institutional appetite. With those foundations intact a market can absorb new competitors. Germany's could not, because they had already given way. ## What it means for the sector The German case shows how a high-value inbound market can be fragile beneath strong headline numbers. It depended on opaque, intermediary-driven flows from a small set of volatile state payers, and it had little professionalised base to fall back on when conditions turned. Only around 10 to 12 per cent of German hospitals ever ran the business seriously, and the Hochschule Bonn-Rhein-Sieg's standing point was that international work is [not a self-runner](https://www.aerzteblatt.de/archiv/medizintourismus-weniger-patienten-aus-dem-ausland-ceef08ef-c8d1-4bbb-a847-3fb542445d89), demanding trained staff, real relationships in the source countries and constant oversight. When the scandals broke payer trust, the anti-corruption law and the civil-law rulings closed the commission channel, the domestic system ran short of beds and staff, and the pay shift removed the clinician's private incentive, the lucrative core of the trade had nothing structural to stand on. The cross-border EU day-traffic that remains is real, but it was never the business anyone meant when they spoke of medical tourism to Germany. For destinations and providers elsewhere, the lesson is that trust, a legally sound acquisition model, secured payment and genuine institutional commitment are not optional extras. They are foundations, and the German experience shows what happens when they give way together. ## Frequently asked questions ### Why did medical tourism to Germany decline? It declined for several reasons at once, most of them internal. The high-value source markets in Russia and the Gulf contracted, a run of billing scandals broke the trust of the state payers who funded the trade, a 2016 anti-corruption law and a 2024 Stuttgart court ruling closed the commission-based channel that agents relied on, the hospital sector ran short of beds and staff, and a shift in how senior doctors are paid removed their personal incentive to pursue foreign patients. Cheaper competition abroad accelerated the fall rather than causing it. ### When did medical tourism to Germany peak? It peaked around 2015, at roughly 255,000 foreign patients and about 1.2 billion euros in revenue, according to data from the Hochschule Bonn-Rhein-Sieg. The headline count then fell only gently, but the profitable non-EU segment collapsed underneath it. ### Is Germany still a medical tourism destination? Yes, but the lucrative part of the business has shrunk. By 2018 close to two-thirds of foreign patients came from within the EU, most of them from Poland, and much of that is low-value cross-border and day-case traffic rather than the premium inpatient work the sector was built on. ### Which German laws affected medical tourism? Two are central. Sections 299a and 299b of the Criminal Code, in force since June 2016, mean that granting or demanding a benefit for referring patients can amount to a criminal offence in certain circumstances, and they raised both the scrutiny applied to these arrangements and the legal requirements for structuring them. On the civil side, the Regional Court of Kiel held in 2011 that commission-based patient brokerage to a hospital is void under Section 138 of the Civil Code, and the Regional Court of Stuttgart confirmed and widened this in November 2024, ruling that it applies even where a state's hospital law contains no explicit ban.

This Week in Medical Tourism: 30 July – 5 August 2026

editorial@health-tourism-news.com (Christian El-Khouri) — Fri, 07 Aug 2026 00:00:00 GMT

This is the Health Tourism News roundup for 30 July to 5 August 2026. ## South Korea medical spending composition Dermatology accounted for 67.5% of foreign visitors' medical card spending in South Korea in the first half of 2026 and plastic surgery for 21.3%, on BC Card figures released on 3 August. In the first half of 2024 the split ran the other way, plastic surgery at 46.2% against dermatology at 32.6%. The card company analysed transactions on 3.3 million foreign-issued cards. Medical services grew 98% on the first half of 2025, faster than any other category it reports, against 53.6% for foreign card spending overall. Seoul took 92.8% of foreign medical spending, and within the capital the Gangnam district's share fell 10.4 percentage points to 39.8% while Seocho's rose 6.7 points to 27.6%. The Korea National Tourism Organization put foreign spending on medical services at KRW 251.15 billion (about USD 176 million) in May 2026 alone, up 74.6% year on year. Against that, the Korean Dermatological Association counted about 3,000 dermatologists in 2025 and roughly 30,000 institutions offering cosmetic treatment, figures Nikkei Asia reported in coverage picked up by TravelMole on 1 August. ## Australian dental demand and South East Asian supply About 15,000 Australians travel abroad for healthcare each year, on Victorian government estimates, and dental work is the procedure travellers say they are most likely to consider, on a 2025 survey by the Insurance Council of Australia and the Department of Foreign Affairs and Trade. Australians spent AUD 12.5 billion (about USD 8.8 billion) on dental services in 2022-23, of which patients paid 61% directly and private health insurers covered 20%, on Australian Institute of Health and Welfare figures. In 2023-24, 28% of Australians aged 15 and over who needed dental care delayed or skipped it, and 18% gave cost as the reason. A single implant runs about AUD 1,200 to 2,000 (USD 840 to 1,410) in Vietnam and AUD 1,500 to 2,500 (USD 1,060 to 1,760) in Thailand, on indicative figures from a health economist at the University of Technology Sydney who has made no direct international fee comparison and cautions that most published prices come from medical travel businesses. Money put full-arch implant treatment at AUD 25,000 to 35,000 (USD 17,600 to 24,600) or more per arch in Australia against about AUD 6,000 to 12,000 (USD 4,200 to 8,400) in Vietnam. Ho Chi Minh City's tourism department puts Vietnam's dental visitor volume at about 100,000 a year on revenue of VND 3,500 billion, about USD 134 million, with roughly 80% of that traffic overseas Vietnamese returning home. Thanh Nien puts Thailand's dental volume at 1.2 million visitors a year on USD 900 million to 1.1 billion, and Malaysia's at 300,000 to 400,000 on USD 250 million to 300 million. ## India medical visa volumes India admitted 1,811,950 foreign nationals on medical tourism visas between 1 January 2023 and 31 December 2025, the Minister of State for Health and Family Welfare, Anupriya Patel, told the Lok Sabha in a written reply on 31 July. Ministry of Home Affairs data put 1,751,088 of those on medical visas, 56,908 on medical attendant visas, 3,375 on AYUSH visas and 579 on AYUSH attendant visas. The same reply recorded that e-medical visa validity has gone from 60 days to one year, that permitted entries have gone from three to multiple, and that the facility now reaches nationals of 176 countries. Uttar Pradesh has identified about 200 acres at Jewar for a medical hub costing an estimated Rs 5,000 crore (about USD 525 million), with a preliminary project report prepared by the World Bank, Medical Dialogues reported on 30 July. The Union Budget for 2026-27 proposed support for five regional hubs of this kind. ## African outbound spending About USD 7 billion leaves Africa each year with patients travelling abroad for treatment, and more than 300,000 Africans travel to India alone, on figures reported by BusinessDay on 31 July from a Lagos briefing given by the chief operating officer of a Nairobi teaching hospital. The World Health Organization sets 4.45 doctors, nurses and midwives per 1,000 people as the minimum for adequate care; Africa has about 1.5. Nigeria's federal government put the country's annual loss to medical tourism and preventable diseases together at NGN 4.8 trillion (about USD 3.5 billion). The Minister of State for Health and Social Welfare, Adekunle Salako, gave the figure at a diaspora awards dinner in Abuja reported by The Guardian on 30 July, alongside a diaspora health programme that he said had reached close to 10,000 people directly and trained more than 2,000 frontline health workers across the country's six geopolitical zones in a single season. ## Turkey operator licensing Turkish medical travel intermediaries have operated under a new licensing regime since a regulation published in the Official Gazette on 26 April 2025 repealed the 2017 framework. Agencies now hold an international health tourism authorisation certificate issued by USHAS, the health ministry's international services arm, rather than by provincial health directorates, and every treatment episode has to be registered on the state HealthTurkiye portal. Intermediaries already trading had until 26 October 2025 to comply, and USHAS reviews authorised operators annually against defined performance criteria. USHAS put Turkey's international health patient volume at 1,506,442 in 2024 and related revenue at about USD 3 billion, roughly 5% of the country's tourism receipts. ## Cosmetic surgery deaths in the Dominican Republic A 31-year-old United States police officer died in Santo Domingo after surgery to remove breast implants, the second recent death of an American law enforcement officer following cosmetic surgery in the Dominican Republic, Latin Times reported on 4 August. The country's National Institute of Forensic Sciences has not returned an autopsy, and police have named no clinic and identified no provider under investigation. The US Centers for Disease Control and Prevention recorded 93 American deaths after cosmetic surgery in the Dominican Republic between 2009 and 2022, with fat embolism and pulmonary thromboembolism the leading causes, and liposuction present in every fatal case it reviewed. A separate CDC study published in June 2026 examined more than 2,100 reports of US residents travelling for cosmetic procedures at home and abroad between 2014 and 2024, and identified 21 reports covering about 145 patients with adverse outcomes, four of those reports involving a death. ## By the Numbers 1,176.9% rise in pharmacy spending by foreign visitors to South Korea in the first half of 2026 against the first half of 2025, on BC Card transaction data. 1.28 million international patient visits at China's main foreign-facing hospitals in 2025, up 73.6% on three years earlier, on National Health Commission figures cited by Lianhe Zaobao. USD 1.26 billion medical tourism revenue in the Philippines in 2024, 23% of the country's health and wellness tourism revenue, on Department of Tourism figures. 7.1 million international arrivals to Ho Chi Minh City between January and July 2026, on the municipal Department of Tourism's count. 1,506,442 international health patients treated in Turkey in 2024, on USHAS figures. 3,375 AYUSH visas issued to foreign nationals in the three years to 31 December 2025, against 1,751,088 medical visas, on Ministry of Home Affairs data. ## What to Watch South Korea's second-half card data will show whether dermatology holds the 67.5% share of foreign medical spending it took in the first half. The World Bank presentation on the Jewar medical hub to the Uttar Pradesh chief secretary, postponed from 28 July, has still to be rescheduled. The Dominican Republic's National Institute of Forensic Sciences has yet to return the autopsy in the death reported on 4 August. Turkish intermediaries licensed under the April 2025 regulation face their first full annual USHAS performance cycle since the compliance deadline of 26 October 2025. Currencies converted at mid-market rates on 6 August 2026.

This Week in Medical Tourism: 22–29 July 2026

editorial@health-tourism-news.com (Christian El-Khouri) — Sun, 02 Aug 2026 00:00:00 GMT

This is the Health Tourism News roundup for 22 to 29 July 2026, an eight-day period rather than the usual seven. ## South Korea foreign patient volume South Korea treated 2.01 million foreign patients in 2025, up 71.7 per cent on the previous year, on Ministry of Health and Welfare figures reported by the BBC and CNA. Chinese patients supplied 618,973 of that total, or 30.8 per cent, and Taiwanese arrivals rose 122.5 per cent to about 186,000, on ministry data cited by Maeil Business. The BBC put the draw as the single-visit comprehensive check-up, with results returned in seven to 14 days under state price regulation. Seoul city government figures put international arrivals to the capital up 21.3 per cent to 8.23 million in the first half of 2026, with foreign card spending up 56.8 per cent to KRW 5.62 trillion. Medical and wellness services took 24.4 per cent of that spending, rising 63.3 per cent to KRW 908.4 billion. A Seoul startup exhibiting at the Shenzhen medical tourism expo from 16 to 18 July was selling WeChat-based hospital matching, and reported more than 100 new business contacts over the three days. ## Thailand longevity strategy Thailand's health minister set a three-year target for the country to lead Asia in wellness and longevity travel, VietnamPlus reported on 28 July. Pattana Promphat announced the plan ahead of a global wellness summit in Phuket from 10 to 13 November, which Thailand expects to generate at least THB 300 million. Thai wellness sector revenue reached USD 43 billion in 2024, ninth-largest in the Asia-Pacific region. Nation Thailand had reported on 25 July that Thailand has invested in genomic medicine and connected health data but lacks a national longevity strategy. Singapore restructured its system around preventive care in July 2023 and had registered about 960,000 people, roughly 40 per cent of its target population, by August 2024. Non-communicable diseases cost Thailand about THB 1.6 trillion a year, or 9.7 per cent of GDP, on 2019 data from a World Health Organization and Public Health Ministry study. Thailand earned THB 838.73 billion from international tourism in the year to date, which VnExpress put at USD 25.8 billion, on falling visitor numbers. China was the largest source market at 2.86 million, followed by Malaysia at 2.25 million and India at 1.31 million. ## Indonesia medical tourism pilot Indonesia has named 18 hospitals as medical tourism pilots, 15 in the Greater Jakarta area and three in Bali, with a promotional catalogue due in October 2026. The tourism ministry set the scheme out after a 22 July meeting in Jakarta with the health ministry, the Jakarta provincial health and tourism offices and two hospital associations, ANTARA reported. Hospitals that qualify receive promotion, training and fiscal incentives. Wellness activity accounted for 13.35 per cent of foreign arrivals to Indonesia on 2024 data, and the Global Wellness Institute put the country's wellness economy at USD 55.77 billion, the largest in South East Asia. In the same week a private Bangkok hospital told thephilbiznews it had studied where Indonesians go for treatment abroad, found Singapore and Malaysia, and is targeting Indonesia first for partnerships with embassies and foreign chambers of commerce. "Cost is not the only factor," one of its deputy managing directors said. ## Tanzania capacity investment Tanzania has spent TZS 283 billion over a decade on a government referral hospital in Dodoma and plans a medical tourism zone on university land. "It is no secret that India has made enormous progress," the chief government spokesperson, Gerson Msigwa, said in a briefing reported by Daily News. Staff numbers have risen from 20 in 2015 to more than 1,000, and the hospital now offers 20 specialist and 18 super-specialist services. An international clinic opened at the hospital in July 2025 has treated 18,607 patients, of whom 390 came from abroad. Across the hospital, 2,897 patients have come from Burundi and 526 from the Comoros. A TZS 32 billion cancer centre and a TZS 44.9 billion kidney centre are under construction, the second co-financed with Japan's development agency. ## Nigeria insurance coverage Insurance coverage rather than hospital capacity governs how many Africans travel abroad for treatment, the chief executive of a specialist hospital in Abuja told CNBC Africa at the Africa Social Impact Summit. "There's too much outbound medical migration," Brian Deaver said, describing approaches to health maintenance organisations and insurers in Nigeria and internationally so that covered patients can use his facility. Deaver said the Africa Life Sciences Foundation has raised USD 75 million, largely from Afreximbank, to subsidise care and fund research, and that only USD 75,000 of a separate USD 1 billion Afreximbank allocation for healthcare manufacturing in Nigeria has been drawn in two years. ## India medical travel intermediaries India recorded 507,244 foreign arrivals for medical treatment in 2025, about 5.5 per cent of all foreign tourist arrivals. Industry estimates cited by the Economic Survey 2025-26 put the market at USD 8.7 billion in 2025, rising to USD 16.2 billion by 2030, and medical visas now reach 172 countries, the Times of India reported. The 2026-27 budget proposes five regional medical hubs. Iraqi patients told Shafaq News they were billed for surgical technology they never saw used. One was quoted about USD 8,000 for spinal fusion, then paid a further USD 1,500 for robotic assistance. "I didn't see any robotic device in the operating room," he said. A Baghdad internal medicine specialist told the same outlet that the 95 to 99 per cent success rates advertised by some Indian hospitals function as marketing. India's tourism ministry recorded 30,989 Iraqi arrivals for treatment in 2025, second only to Bangladesh. When a fire killed 22 people, most of them foreign nationals, near a Delhi guest house on 3 June, it was translators rather than hospitals or medical travel companies who found beds and rebuilt treatment schedules, ThePrint reported. India counts foreign patients and does not count the translators. ## Uzbekistan patient origins A total of 35,401 foreign nationals travelled to Uzbekistan for treatment in the first half of 2026. National Statistics Committee data reported by Kun.uz put Tajikistan first at 19,096, Kyrgyzstan second at 9,552 and Kazakhstan third at 4,582, with 1,280 from Afghanistan, 772 from Russia and 119 from every other country in the world combined. More than 86,000 people travelled to Uzbekistan for treatment across the whole of 2025. On 23 July Uzbekistan's tourism committee and Iran's ambassador discussed medical travel, direct air links and, in the committee's account, an Iranian proposal to simplify visas for Iranian travellers, Trend reported. ## By the Numbers - 2.01 million foreign patients treated in South Korea in 2025, on Ministry of Health and Welfare figures. - 35,401 foreign nationals treated in Uzbekistan in the first half of 2026, on National Statistics Committee figures. - USD 8.7 billion Indian medical tourism market in 2025, on industry estimates cited by the Economic Survey 2025-26. - USD 21.49 billion global medical tourism market in 2025, on Astute Analytica figures. - 563 million wellness tourism trips taken in Asia in 2024, against 348 million in Europe, reported by VietnamPlus. - USD 47 trillion cumulative global economic loss from five groups of non-communicable diseases between 2010 and 2030, on World Economic Forum and Harvard School of Public Health estimates. ## What to Watch - Indonesia's promotional catalogue covering the 18 pilot hospitals is due in October 2026. - The Global Wellness Summit runs in Phuket from 10 to 13 November 2026. - Uzbekistan's full-year total will show whether the second half of 2026 matched the 35,401 recorded in the first. - Thailand's health minister has set a three-year horizon, to 2029, for leading Asia in wellness and longevity travel.

This Week in Medical Tourism: 14–21 July 2026

editorial@health-tourism-news.com (Christian El-Khouri) — Wed, 22 Jul 2026 00:00:00 GMT

This is the Health Tourism News roundup for the week of 14 to 21 July 2026. A Frost and Sullivan analysis put Malaysia's private hospital capacity second in Asean. The Malaysia Healthcare Travel Council said nearly 12,000 Cambodians came for treatment in 2025. Thailand hosted a trade fair for the medical industry in Bangkok. Aga Khan University Hospital in Nairobi put Africa's annual loss to medical tourism at $7 billion. In Kerala, police found a deal that paid a firm to send transplant patients to a hospital. Dubai and Uzbekistan both set out plans to make it easier for foreign patients to get in. ## Malaysia leads Asean on private hospital capacity Malaysia has about 290 private hospitals and nearly 19,000 private hospital beds, giving it the second-highest private bed ratio among major Asean markets at 0.58 beds per 1,000 people, behind Singapore on 0.75, CodeBlue reported. Rathanesh Ramasundram, who leads health care advisory for Asia Pacific at Frost and Sullivan, gave the figures at a Bursa Malaysia investment series in Kuala Lumpur on July 2. The Philippines has 0.52 private hospital beds per 1,000 people, followed by Thailand on 0.49, Vietnam on 0.39 and Indonesia on 0.28. Frost and Sullivan projects Malaysia will have about 27,000 private hospital beds by 2028. Health insurance claims paid in Malaysia rose six-fold over two decades, from RM960 million (US$235 million) in 2003 to RM6.75 billion (US$1.65 billion) in 2023. Medical tourism remains one of the sector's main growth drivers. Malaysia recorded 1.8 million medical tourists and RM3.35 billion (US$820 million) in healthcare travel revenue in 2025, according to the Malaysia Healthcare Travel Council, with about 60 per cent of those patients arriving from Indonesia. The country holds eight of the world's 30 accredited fertility centres, and its IVF success rate is 82.9 per cent against a global average near 50 per cent. A cycle costs US$4,000 to US$5,000 there, against US$12,000 to US$15,000 in the United States. Malaysia also has more than 30 heart centres, and ranks third in the Asia Pacific for cancer care readiness. Anwar Anis, honorary secretary of the Association of Private Hospitals of Malaysia, said the specialist numbers look adequate on paper but that 20 to 30 per cent of those aged 60 and above are now semi-retired. On nurses, he said: "if you don't have the nurses, you cannot open those beds." He also called for stronger primary care to cut needless hospital visits, citing a recent World Bank report ordered by the government. ## MHTC counts Cambodian patients and unveils two mascots Nearly 12,000 Cambodian patients sought treatment in Malaysia during 2025, generating RM30 million (US$7.4 million) in healthcare travel revenue, the Malaysia Healthcare Travel Council said in a statement carried by KLSE Screener. The council called Cambodia an emerging market next to its older ones. It said its 91 member hospitals draw foreign patients for cancer care, heart care, orthopaedics, fertility and health checks. The council held its first Malaysia Healthcare Expo in Phnom Penh this month, making Cambodia the first market outside Indonesia to host the show. Separately, the council unveiled two mascots, Dr Wira and Sister Manja, designed after the Malayan sun bear, Free Malaysia Today reported. The pair carry the Visit Malaysia 2026 campaign into the health sector. They sit alongside the singer Siti Nurhaliza, who is the council's brand ambassador. The public met them at a wellness fair at Taylor's University Lakeside Campus on July 16. ## Thailand hosts International Healthcare Week in Bangkok Thailand attracts more than a million foreign patients a year and hosted International Healthcare Week at the Queen Sirikit National Convention Center from July 8 to 10, The Manila Times reported. The event, organised by Informa Markets, brought together more than 1,200 companies from over 100 countries. Prime Minister Anutin Charnvirakul told the opening that the government means "to position Thailand as a world-class global medical hub" by lifting standards and pushing new services. Pattana Promphat, a Thai health ministry official, told Filipino reporters at the event that a package covers the medical visa, the scheduling, the hotel and the doctor. He said patients can also be booked back in for a check months later. The wider plan covers public and private hospitals, preventive care, rehabilitation and traditional Thai medicine, with support for medical devices, drugs and biotechnology. ## Aga Khan hospital puts Africa's medical tourism losses at $7bn Africa loses an estimated $7 billion a year to medical tourism, and more than 300,000 Africans travel to India annually for treatment, Aga Khan University Hospital in Nairobi said at a media roundtable in Lagos on Wednesday, Vanguard reported. Chief operating officer Khurram Jamal blamed a shortage of specialists, uneven quality, broken referral systems and a belief that better care is only found abroad. Africa has about 1.5 health workers per 1,000 people, against the 4.45 urged by the World Health Organisation, he said, and many African doctors who train abroad never come home. "A building cannot heal a patient," Jamal said, arguing that a specialist takes more than a decade to train. The hospital has more than 200 full-time specialists. It runs training posts in nine specialties and 16 fellowships, and was the first in East Africa to win international accreditation. Jamal said Africa carries about 25 per cent of the global disease burden but hosts around 4 per cent of clinical trials. The hospital plans a gene sequencing laboratory, and has a deal with Kenya Airways covering referrals, calls with doctors before travel, cheaper fares and follow-up once patients are home. Diplomats who visited Benjamin Mkapa Hospital in Dodoma on Friday called for wider international promotion of Tanzania's specialist services, the Daily News reported. Tanzania's ambassador to Burundi, Gelasius Byakanwa, met Burundian children treated there for congenital heart defects and said the hospital had exceeded his expectations. Burundi's ambassador to Tanzania, Leontine Nzeyimana, said: "Africa needs to know that such services are available here, close to home." ## Kerala organ trafficking probe uncovers referral agreement Police looking into an alleged organ trafficking network in Kerala have found a deal between a private hospital in Kochi and a medical tourism firm paid to refer transplant patients, Medical Dialogues reported. Under the deal, signed last year, the firm was to get up to Rs 1 lakh (US$1,000) a patient or 10 per cent of the hospital bill. That included Rs 1 lakh for each liver transplant sent over and Rs 50,000 (US$520) for each kidney case. Deccan Herald reported the same terms. Police said the network went after donors who were short of money and paid them between Rs 5 lakh and Rs 15 lakh (US$5,200 to US$15,600), while those receiving organs were charged as much as Rs 35 lakh (US$36,000). Officers also recovered forged papers, among them fake altruism certificates. The owner of Kallatharas Medical Tourism has been arrested, and the Enforcement Directorate is questioning doctors and hospital managers in a parallel money laundering case. ## Dubai, Uzbekistan and Bangladesh work on access Dubai's residency directorate and the Dubai Health Authority have agreed to link visas, insurance and hospitals in one digital system, and licensed providers will be able to file medical visa papers for patients still abroad. The account came in an opinion piece in Gulf News by a doctor, who argued that days lost to paperwork can cost patients, and that destinations will compete on the whole journey rather than the treatment alone. Uzbekistan's tourism committee chairman, Abdulaziz Akkulov, met business leaders to set priorities for medical tourism, UzDaily reported. Those at the meeting pointed to steady growth in patients from Tajikistan, Kazakhstan, Kyrgyzstan and Turkmenistan. Their list of priorities ran to simpler visas, telemedicine, tours for foreign operators, packages that mix treatment with travel, accredited local clinics and better support for family members who travel with a patient. In Dhaka, the medical travel agency Seok Healthcare said its patient numbers are growing 10 to 20 per cent a year, and that China has now passed Thailand among its clients, The Bangladesh Monitor reported. Founder and chief executive MM Masumuzzaman said a group from Bangladesh visited Chinese hospitals in March 2025. Several then took on bilingual staff, halal food, prayer rooms and Bangladeshi students as interpreters. "We recommended several practical measures to make Bangladeshi patients feel more comfortable," he said. India remains the largest destination for Bangladeshi patients overall. ## Saudi Arabia and Vietnam target higher-value segments The Gulf Cooperation Council medical tourism market was worth $9.6 billion in 2025 and should reach $22.5 billion by 2034, according to an Arab News opinion piece by Majid Rafizadeh, a political scientist. Saudi Arabia's own market is set to grow from $200 million in 2024 to about $680 million by 2030, helped by Vision 2030 money for hospitals and easier visas for medical travellers. The piece put the global market above $126 billion by 2035. Vietnam is drawing more foreign patients for facial rejuvenation, with demand shifting from single procedures towards combined treatment plans, DTiNews reported. Nguyen Quang Tuan, a plastic surgeon who works in Hanoi and Ho Chi Minh City, said patients now arrive better read up and ask hard questions about recovery time and how the work lasts. Cost may pull them in at first, he said, but safety and aftercare decide whether they tell others to come. ## What This Means Most of the week's news was about capacity and access, not new buildings. Malaysia has the region's second-largest private hospital base but too few nurses and specialists. Africa loses $7 billion a year. Dubai and Uzbekistan set out visa and coordination plans. Bangladesh's Seok Healthcare said China had passed Thailand among its clients. The Kerala inquiry went on, with one arrest so far and the Enforcement Directorate still questioning hospital staff.

Airlines Move To The Centre Of Medical Tourism

editorial@health-tourism-news.com (Christian El-Khouri) — Tue, 14 Jul 2026 00:00:00 GMT

This is the Health Tourism News roundup for the week of 7 to 13 July 2026. Nobody opened a hospital this week. Instead, the announcements were about distribution: an airline in Malaysia selling heart screenings with its boarding passes, a Thai campaign for Gulf travellers built on flight capacity, and a booking platform for Chinese hospitals cleared by two city governments. Wellness supplied the money figure, with data cited by USA Today putting wellness tourism at US$894 billion in 2024 and on course for US$1.4 trillion by 2029. In Dodoma, a Tanzanian clinic counted more than 28,000 patients in its first year. The sellers this week were airlines, tourism boards and platforms, and the hospitals stayed in the background. ## Malaysia puts medical tourism on the boarding pass Batik Air, the National Heart Institute of Malaysia and Tourism Malaysia have launched a year-long medical tourism partnership, according to an official statement issued in Kuala Lumpur and carried by The Island. Under the Fly High with a Healthy Heart campaign, which began on May 1 and runs until April 30, 2027, international passengers with a valid boarding pass receive 15 per cent off the institute's essential heart screening, priced at RM765 (US$190). The first 1,000 international passengers get 20 per cent off a premier screening package at RM1,760 (US$430). Patients travelling for treatment, and family members travelling with them, get a 10 per cent airfare discount on showing an appointment letter. IJN, as the institute is known, performs more than 4,400 cardiothoracic surgeries and 17,000 cardiac catheterisations a year. Batik Air chief executive Datuk Chandran Rama Muthy said Malaysia welcomed about 1.85 million healthcare travellers in 2025, generating RM3.35 billion (US$820 million) in revenue. Thailand still leads the region with more than 3 million medical tourists a year, he noted. It runs alongside Visit Malaysia 2026 and the country's Year of Medical Tourism. A tourism board on the other side of the Pacific worked the same seam. Los Angeles Tourism said it flew Australian lifestyle journalists to the city with Fiji Airways to present Los Angeles as a wellness hub. Part of the selling was done in the air, with the carrier's FlyWell programme offering red-light therapy and wearable technology on the long-haul legs. A screening discount on a boarding pass and red-light therapy in a lie-flat cabin are versions of the same idea. The journey is being folded into the health product, and the carriers have noticed there is margin in it. ## Thailand aims Healing is the New Luxury at the Gulf The Tourism Authority of Thailand launched a campaign called Healing is the New Luxury this week, aimed at Gulf travellers, and expects more than 600,000 GCC visitors by the end of 2026, Khaleej Times reported. More than 150,000 of them are expected from the UAE. Governor Thapanee Kiatphaibool said Thailand is "ready to welcome visitors from across the region with confidence" as the Middle East high season begins. Capacity is already in place. More than 140 flights a week link Dubai, Abu Dhabi and Sharjah with Thai destinations, and flydubai's new daily Dubai to Don Mueang service goes double daily from July 18, Biz Today reported. GCC visitors stay between 10 days and three weeks, UAE travellers spend more than 100,000 baht (US$3,000) per trip, and medical travellers from the region average 107,662 baht (US$3,200). Thailand counts more than 400 internationally accredited hospitals and clinics, and its health tourism sector generated about 125 billion baht (US$3.7 billion) in 2025. The Tourism Authority of Thailand is also promoting Khao Yai, Kanchanaburi, Chanthaburi and Trat to stretch trips beyond Bangkok, Phuket, Krabi and Chiang Mai. Ten days to three weeks is the detail that matters. A guest staying that long buys the treatment, the recovery, the resort and a second city, which is why the campaign bundles them, and why destinations chasing Gulf patients should measure length of stay rather than arrivals. That is what turns 600,000 GCC visitors into a health economy rather than a beach season. ## China adds booking rails to its medical tourism pull China supplied the medical tourism case study for the third week running. China Daily reported that Harrison James, an Australian diagnosed with a malignant pancreatic tumour, travelled to Chongqing for high-intensity focused ultrasound treatment after failing to find a surgical option at home, and was discharged the day after the procedure. "I never expected the surgery to be so quick and painless, without any incisions," James said. China Daily credited the country's 240-hour visa-free transit policy, which covers citizens of 55 countries, and the growing number of international insurers billing Chinese hospitals directly. Booking rails are being formalised too. City News Service, a Shanghai-based expat outlet, reported that MediPath China, a cross-border platform built by New Frontier, the owner of United Family Healthcare, launches officially this month. Shanghai and Beijing officials approved trial operations in June, the outlet said. The platform coordinated robotic surgery and tomotherapy across two Shanghai hospitals for a 60-year-old Canadian prostate cancer patient, whose main biomarker fell from 42.5 to 0.03. Managing director David Zeng said it matches international patients with "top public medical institutions primarily in Shanghai and Beijing". Readers of this digest will recognise the sequence: a New Zealander flying to Shanghai for CAR-T therapy in June, another beginning a solid-tumour first last week, and now the booking rails. The missing medical visa and the fragmented services that securities analysts flagged in June are being worked around piece by piece, and the pace deserves more attention from rival Asian hubs than it is getting. ## Wellness tourism heads for US$1.4 trillion USA Today sent a reporter to Hilton Head Health in South Carolina, an all-inclusive resort where seven-night stays start at just over US$3,900 and the programming now includes GLP-1 support seminars alongside a longevity-focused Blue Zones Experience. It cited Global Wellness Institute data, analysed by PhocusWright, showing wellness tourism more than doubled from US$438 billion in 2012 to US$894 billion in 2024, with US$1.4 trillion by 2029 projected. Region Illawarra reported Destination Wollongong citing Booking.com research that 42 per cent of travellers now seek trips focused on mental and physical wellbeing. Destination Wollongong has made wellness tourism a strategic priority while admitting it is short of eco-focused places to stay. Moneycontrol ran the consumer version of the same story, holidays judged by how rested people come home. Supply is moving upmarket to meet it. The Ozen Collection said in a statement that its two Maldives resorts now offer DNA-based wellness profiling with Muhdo Health and what the company calls bioenergetic scanning. It framed the move around longevity and pointed to the newly created Dubai Longevity Authority. AD HOC News profiled OneSpaWorld, the listed operator of spa facilities across cruise fleets and resorts, whose revenue rises and falls with passenger volumes and onboard spending. A detail worth keeping: the GLP-1 seminar. Weight-loss drugs were widely expected to hurt the wellness trade; instead the resorts are building programming around them, which is what a US$894 billion market tends to do with a disruption. ## Tanzania counts its first year as India studies trust Benjamin Mkapa Hospital in Dodoma marked the first anniversary of its international patients clinic on Friday, and Tanzania's Daily News reported that the unit treated more than 28,000 patients in its first year, over 200 of them from abroad. Opened in July 2025 by the late health minister Jenista Mhagama, the clinic gets patients in front of a specialist within 15 minutes and keeps diagnostics, pharmacy and payment under one roof. "The services were fast and well coordinated," said Sara Lenday, who travelled from Iringa with her mother and returned home the same day. Two hundred international patients is a modest number, and a believable one. India examined the softer end of the trade. The Economic Times reported a study by Payal Mehra of IIM Lucknow and Himanshu Tyagi, an orthopaedics director at Fortis in New Delhi, published in the Asia Pacific Journal of Health Management. It found India's medical tourism market skewed towards neighbouring countries with low cultural distance. Its authors recommended structured intercultural communication training for hospital staff, and Mehra told PTI the work sits where healthcare, culture and international business meet. A warning from the mature end of the market came from Seoul, where Nikkei Asia reported that record numbers of foreigners arriving for cosmetic procedures are adding to concerns about imbalances in Korean medical care, with doctors drawn away from hospital work. ## What This Means One thread connects the week: distribution. Malaysia put a screening discount on a boarding pass, Thailand measured its campaign in weekly flights, China switched on a booking platform, and the wellness industry priced the journey itself into the product. Hospitals used to wait for patients. The sellers of seats and platforms now go out and fetch them, and they own the customer relationship earlier than any clinic does. Three things to watch over the coming months: whether flydubai's double daily Bangkok service holds past the Middle East high season, how many patients MediPath China reports once formal operations begin, and whether the first 1,000 international passengers take up IJN's discounted screenings before the campaign ends in April.

Medical Tourism Records Concentrate In Penang And Seoul

editorial@health-tourism-news.com (Christian El-Khouri) — Wed, 08 Jul 2026 00:00:00 GMT

This is the Health Tourism News roundup for the week of June 29 to July 7 2026. Malaysia and South Korea both reported record medical tourism figures this week, and both governments spent the week worrying about how concentrated those figures are. Penang alone generated 45 per cent of Malaysia's medical tourism revenue, while Seoul received 87.2 per cent of South Korea's 2.01 million foreign patients. Private equity firms moved on Malaysian hospital assets, and new hospitals in Abuja, Hanoi and Tashkent reported early progress in keeping patients at home. A cancer centre in Shanghai began treating its first international patient with a therapy available nowhere else. ## Penang supplies 45 per cent of Malaysia's medical tourism revenue Penang's tourism chairman Wong Hon Wai said in a statement on Tuesday that Malaysia had been ranked the world's sixth best medical tourism destination by Travel and Tour World, behind Turkey, Thailand, India, Mexico and South Korea, The Star reported. National medical tourism revenue rose 23.2 per cent to RM3.35 billion in 2025, and the number of foreign patients grew from 1.6 million to 1.85 million. Penang remained the country's largest centre. Its 16 participating private hospitals treated 527,176 foreign patients last year, up 25.94 per cent, and earned RM1.14 billion in medical tourism revenue, according to the Penang Centre of Medical Tourism. The state is already looking for new markets. PenangToday reported that a Qatari delegation led by Ambassador Salah bin Mohammed Al-Sorour toured Island Hospital, Northern Heart Hospital Penang and Sunway Medical Centre Penang after Qatar Airways resumed its Doha to Penang service under its winter schedule. Wong said the Middle East would reduce Penang's dependence on Indonesian patients. The Business Times reported that Bain Capital, KKR and KV Asia Capital have been shortlisted for a minority stake in Avisena Healthcare, valuing the Malaysian hospital group at about US$368 million, citing two people with direct knowledge of the matter. Binding bids are due by the end of July. CodeBlue, a Malaysian health policy site, published an anonymous piece asking what share of the cost of hotel-style lobbies, concierge services and premium suites is carried by Malaysian patients. Those costs, the author argued, are folded into room rates and bundled charges rather than shown on the bill. The site withheld the author's name because civil servants are barred from writing to the press. The questions are reasonable ones, and whether the Malaysia Healthcare Travel Council engages with them will show how seriously the industry takes the point. ## South Korea records 2.01 million foreign patients South Korea counted 2.01 million foreign patients last year, the highest figure since records began in 2009, and the industry spent the week discussing what to do with them. The Korea Times reported that the K-Medical Tourism Roundtable met on Thursday to examine the shape of the sector. The Korea Institute for Industrial Economics and Trade says the industry generated 22.8 trillion won, about US$14.6 billion, in wider economic effects last year. Kim Jin-kuk, who heads the country's medical tourism promotion body, told the paper in a separate interview that Seoul alone received 87.2 per cent of foreign patients and that language remains their biggest obstacle. "There is a strong desire among foreigners to go to Korea and become beautiful," Kim said. He proposed certified medical interpreters and a tiered qualification that would let foreign beauty professionals refer patients from their home countries. Hong Seung-wook of the Korea Health Industry Development Institute told the roundtable that dermatology and plastic surgery account for 68 per cent of foreign patients, and the greater Seoul area for 90 per cent of visits, a structure he called fragile. The Korea Times reported that foreign card spending passed 2 trillion won in May for the first time, with pharmacy spending up 206.1 per cent and dermatology clinics up 85.5 per cent on a year earlier. A sector in which two procedures account for two thirds of patients and one urban area for nine tenths of visits can be upset by a single policy change or a diplomatic row. Of the reforms discussed at the roundtable, the interpreter shortage is the cheapest to fix, and whether Kim's scheme is running before next year's figures appear will be a fair test of intent. ## Abuja, Hanoi and Tashkent report progress on keeping patients at home Businessday reported that George Elombi, the president of Afreximbank, visited the African Medical Centre of Excellence in Abuja on Friday, a year after the hospital opened with backing from the bank and King's College Hospital, London. The centre has treated more than 5,000 patients from over 20 countries, delivered West Africa's first stereotactic body radiotherapy for lung cancer, completed its first triple bypass and processed 40,000 laboratory tests. "The success of this Centre reflects the depth of talent assembled here," Elombi said. Laodong reported that Hanoi intends to retain the US$2 billion to US$3 billion that Vietnamese patients spend abroad each year. Its health department plans cancer, heart and dental care packages and a coordinating office. In Tashkent, President Shavkat Mirziyoyev toured the US$30 million Global International Hospital and told officials to "combine medical and tourism services in a balanced way" and to build more hotels near hospitals, Trend reported. The projects are small against the sums their governments hope to keep, but radiotherapy delivered in Abuja removes one of the procedures that once required a flight to London. The limit of every such plan appeared in the same week. Jiahui Health announced that a 59-year-old New Zealander with advanced gastroduodenal cancer had become the first international patient to begin Satri-cel, the first approved CAR-T therapy for a solid tumour, which is available only in China. He is the second New Zealander in a month to travel to Shanghai for CAR-T treatment. Programmes like these can compete on price and quality. They have no answer yet to a therapy that exists in one country. ## Cosmetic tourism grows faster than its safeguards The Bali Sun reported research from the medical device firm idsMED showing Indonesia's aesthetic market growing at about 15 per cent a year, led by skin tightening. One clinic in Surabaya performed about 500 treatments in the three months after installing a Korean radio-frequency device, the paper said. Türkiye's health tourism sector received about 1.4 million foreign visitors in 2025 and earned US$3.3 billion, the country's tourism ministry told a D-8 webinar, according to APP. Türkiye Today published a detailed warning for prospective patients: a before-and-after photograph is not a medical evaluation, a package price says nothing about who performs the procedure or what a free revision covers. Patients who pay foreign intermediaries with no Turkish authorisation, it warned, may find no clear legal party to sue if the work fails. It advised patients to verify the clinic, the doctor and the intermediary through the Turkish Ministry of Health before paying anyone. The advice applies well beyond Türkiye. Unlicensed intermediaries who collect payment abroad are a known weakness of the trade. Destinations arriving late to the boom, Bali among them, could make verified providers their selling point rather than repeat the familiar cycle of growth, scandal and regulation. ## Wellness travel demand keeps growing A Priority Pass survey of 12,000 travellers in 20 countries, carried by CBN, found that 47 per cent now travel for wellness at least once a year and that a third combine wellness with sporting events. Just over half said the journey itself shapes their view of a holiday. The wellness travel market is projected to pass £718 billion by 2030. Nomad Lawyer published an enthusiastic account of a thermal bath revival across Hungary, the Czech Republic and Slovakia, claiming savings of 40 to 60 per cent against Switzerland, though the piece named few sources and its figures could not be verified. When nearly half of travellers report at least one wellness trip a year, wellness has stopped being a niche. ## What This Means The week's pattern is plain enough. Success in medical tourism concentrates, and the governments and investors who hold it are working to spread it before it turns into a liability. Penang is recruiting new source markets, Korea wants patients beyond Seoul and beyond dermatology and plastic surgery, and private equity is buying into the operators that concentration has already rewarded. Three things over the coming months will show how far this goes: the binding bids for Avisena due by the end of July, whether Korea's interpreter and visa reforms move from roundtable to regulation, and the second-year figures from the African Medical Centre of Excellence in Abuja.

Nigeria, Iran And Seoul Redraw Medical Tourism

editorial@health-tourism-news.com (Christian El-Khouri) — Wed, 01 Jul 2026 00:00:00 GMT

This is the Health Tourism News roundup for the week of 24 to 30 June 2026, and it read less like a sales pitch than a stocktake of leaks. Nigeria wants its people to stop leaving. Iran wants to sell abroad instead of waiting at home. A British man's ruined teeth supplied the week's price tag for getting it wrong. The word I kept waiting for was cost, and it barely came up; the talk was all workforce, quality and digital plumbing. ## Nigeria moves to stop its medical tourism outflow Nigeria spent the week trying to plug an outflow rather than chase an inflow. Vanguard reported Professor Smaranda Olarinde, Vice Chancellor of Afe Babalola University, using the hospital's 50th kidney transplant to argue that medical tourism shrinks only when health workers are paid, protected and given room to grow, not when another scanner arrives. Her hospital also signed a deal with Manipal Hospitals of India, where urologist Dr Rajeev Sood recalled the pandemic teaching governments that flying a patient out can vanish overnight. Akwa Ibom made the bigger gesture, covered by Businessday. Governor Umo Eno unveiled a 100-hectare medical city, a ten-storey block of 62 specialities, built expressly to keep patients from boarding planes. The state says it has hired 2,844 health workers since March 2025 and will train 100 more abroad before the doors open. Nobody on the podium said the awkward part out loud. A tower full of equipment is worthless if the people meant to run it have already emigrated, and Olarinde was the only speaker pointing at that risk instead of the ribbon. Copy the partnership, skip the tower. Manipal drops skills into a hospital that already works, costs a sliver of a medical city, and any state could do the same next year. Concrete is the easy part. Keeping the surgeon is the hard one. ## Iran, Korea and Malaysia turn medical tourism outward Three other governments looked outward, not in. Tehran Times reported Iran's chamber of commerce tourism commission, through Seyyed Mostafa Mousavi, arguing the country has run the import model too long. The new plan is to export: build joint clinics in Iraq, Afghanistan, Azerbaijan and Pakistan, post Iranian specialists abroad, and consult patients before they cross a border. Mousavi admits Iran is bleeding share of the Iraqi market, its biggest, for want of a local presence. His colleague Mohammad Jahangiri sketched a Shiraz, Mashhad and Qom golden triangle aimed at the Muslim-majority pilgrimage-and-treatment market, citing meeting-floor figures that put the global sector above $50 billion in 2024 and near $200 billion within a decade. Two more deals pointed the same way. The Asia Business Daily reported the first Korea-China service trade council in Beijing, which pledged to smooth medical-tourism information for rising Chinese patient numbers, while DayakDaily caught Malaysia and Vietnam in Macau agreeing to push medical and halal tourism together. So which of these is real strategy, and which is a press release? Iran's reads like strategy. Exporting clinicians hedges against the two things that strand its inbound model, sanctions and shut borders, and any facilitator working Iraqi patients can expect an Iranian-run clinic nearby within a year or two. Halal is the part worth watching. Pair certified halal hospitality with a credible operating theatre and you reach a devout, high-spending market the big Asian hubs barely court. ## Dental tourism's £40,000 warning and the workforce answer The week's grimmest number came from dental tourism. Streamlinefeed told the story of Danny Tomlinson, 47, from Southend-on-Sea, who flew abroad in 2020 to have healthy teeth filed to pegs for a set of Turkey Teeth crowns. The £3,900 he paid became a £40,000 rebuild at home, after nine return trips and a parting £12,500 quote to patch work already failing. Kenya's dental regulator, the report noted, keeps warning as East Africans chase cut-price cosmetic work in Turkey, India and the Middle East. Bulgaria went the slow way instead. BTA covered a cooperation memorandum between the country's rheumatology professionals and its balneology and spa-tourism union, signed in Sofia, to lift staff qualifications to European standards and make proper use of its mineral springs. Tomlinson's final bill settles the argument. It does not land on the clinic that filed his teeth down. It lands on him, then on the home system that has to rebuild his mouth. Every cut-price cosmetic destination is quietly subsidised this way. Is the saving worth the gamble? Is the clinic still there when the work fails? Who pays when it does? Tomlinson now knows all three answers. Dr Vladimira Boyadzhieva's pitch in Sofia, certify the workforce before you sell the springs, is slower, less photogenic, and the only version of this trade that survives a complication. ## Wellness tourism climbs the longevity and luxury ladder Wellness tourism kept climbing the price ladder. Luxury Travel Magazine pegged the global wellness economy at $6.8 trillion, twice its 2013 size, the travel slice growing about a tenth a year to 2028, as high-end retreats swap scented candles for genetic testing, metabolic profiling and hyperbaric oxygen. The premium guest, it argued, now treats health as an investment rather than a luxury. The same trend reached the cabin. BriefGlance reported EVA Air winning a drinks award in a brand-new wellness, no and low category for a non-alcoholic sparkling, courting the sober-curious traveller as the Taiwanese carrier opens a Washington route. The longevity push quietly changes who a wellness resort is up against. A spa that sells massage competes with the spa next door. A retreat that sells diagnostics, a resident physician and a healthspan programme is competing with clinics, and prices like one. Without that clinical backbone, a property keeps the weekend guest and loses the high-value patient to one that hands them data. EVA Air's small trophy sits in the same logic. In-flight wellness is becoming a booking reason, and a carrier on long-haul treatment routes would do well to treat the cabin as part of the cure. ## Jordan and Seoul bet on AI-driven medical tourism The digital layer is where the contenders separated this week. Ammon News ran an opinion piece by Lubna Hanna Ammari arguing Jordan could become the region's smart medical-tourism hub by marrying AI, with a nod to diagnostic studies in The Lancet Digital Health, to its assets at the Dead Sea and Ma'in Hot Springs. The Korea Times reported Seoul readying its International Tourism Forum, where some 900 delegates will debate a turn from sheer visitor volume toward higher-yield trade, medical tourism among it, on the back of faster visas, quicker payments and AI-run event marketing, while keeping the overtourism that hollowed out Kyoto and Venice at bay. Ammari's piece is an aspiration, and that is its weakness. Any ministry can commission the same essay. Whoever ships working software first wins; the prose counts for nothing. Seoul is further along because it named the dull obstacle, the visa queue and the payment that will not clear, instead of the scenery. That is the unglamorous part of it. The destinations that moved this week were fixing paperwork and data pipes, and a health ministry still selling mountains and low prices is a decade behind. ## What This Means One thread holds the week together, and it is not price: medical tourism has stopped being a simple race to gather the most patients. Nigeria is trying to keep its own. Iran is trying to sell abroad. Korea wants to vet who arrives, Seoul wants fewer and richer visitors, and a man in Essex is the warning stapled to all of it. Everyone is steering the flow, in opposite directions, with the same instrument: the quality of their people and their systems. Price has slipped to the back of the room. I would watch the next six months for which wager clears first, Akwa Ibom's tower, Iran's clinics in Iraq, or Seoul's faster visa lane. I would put money on the country that fixes the dull machinery over the one that opens the grandest building.

Health Tourism As Badge, Escape Hatch And Disguise

editorial@health-tourism-news.com (Christian El-Khouri) — Wed, 24 Jun 2026 00:00:00 GMT

This Week In Health Tourism 16.06.26 - 23.06.26. Three governments spent the week calling medical tourism a pillar of national economic strategy, while a sitting US Congresswoman said she had flown to Mexico for stem cell therapy because she carries no health insurance. Together, those two facts tell one story: the supply side keeps dressing up as triumph what the demand side lives as failure. Every patient gained is, somewhere else, a system that lost them. ## Egypt, Jordan and medical tourism as state policy Three states put medical tourism on the balance sheet this week. At the fifth Africa Health ExCon in Cairo, Egypt's health minister Khaled Abdel Ghaffar told delegates Egypt had built a National Council for Medical Tourism and a national digital platform meant to act, as Daily News Egypt reported, as the official gateway for international patients. Jordan put a figure on the same idea: AGBI reported, citing the Jordan Times, that it earned almost a billion dollars from 230,000 foreign patients in 2025, up four per cent on the year, with Fawzi Hammouri of the country's private hospitals body naming obesity surgery, orthopaedics and IVF as the draws. Uzbekistan went looking for the machinery, sending a delegation to Suzhou to talk pharmaceutical plants and patient flow with Chinese partners, UzDaily reported. A gateway is only as good as what waits behind it. A next step could be to publish outcomes and complication rates by procedure, so it becomes more than a brochure with a login. These are early bets, and the receipts are real enough. The trust takes longer to build than the platform. ## Dental tourism and the American escape hatch The clearest demand signal of the week came from Washington, not from a clinic. Marjorie Taylor Greene said on X, as The American Bazaar reported, that she had travelled to Mexico for stem cell therapy, that she has no health insurance, and that rising costs are pushing more Americans abroad. A member of the United States Congress could not get a treatment at home and left for it. That is the symptom thesis in one news cycle. People do not cross borders for fun; they cross because home failed them on price, on access, or on what the law there allows. Mexico catches much of that traffic. Vocal, citing Renub Research, put the country's dental implant market at 87.88 million dollars in 2024, rising to a forecast 161.02 million by 2033, with an implant costing roughly 650 dollars against nearly 5,000 in the United States. Two of the five drivers are doing the work: cheaper, and unavailable at home. A warning sits inside that. An implant is well understood and well evidenced. The stem cell therapy Greene described is, by the US regulator's own account, unapproved for most uses. The risk for Mexico's clinics is letting the sound bargain and the unproven punt ride on the same trust. The CDC already named what counts: regulation, infection control, and continuity of care once the patient is home. That list is the floor, and the price does not move it. ## Singapore, wellness tourism and the cost of being premium While Mexico sells cheaper, Singapore spent the week selling the opposite. At the ITIC APAC conference, as ITIJ reported, the chief executive of one of the city's largest private hospital groups argued that Singapore wins international patients not because they lack alternatives, but because its private hospitals compete against some of the world's best public ones. He pointed to the country's compactness and tourism receipts above thirty billion Singapore dollars a year. The counterweight came from the insurance side of the room. An assistance-industry executive walked delegates through the bill: specialist fees that can exceed hospital charges, and a laparoscopic appendectomy costing several times more in Singapore or Hong Kong than in Thailand or Malaysia for a clinically similar result. Set that beside the wellness figures. VnExpress, citing the Global Wellness Institute, reported Singapore's wellness economy above 23 billion dollars, with spending of 3,845 dollars a head. Singapore's pitch is best, not cheaper, and that holds only as long as outcomes justify the multiple. Insurers will keep steering clinically identical cases to cheaper neighbours, and they are right to. If Singapore's operators want the premium, they must publish the outcome data that earns it. An address is not evidence. ## K-aesthetic medicine becomes an export engine South Korea posted a record month with a quieter, more interesting trend underneath it. The Asia Business Daily, citing DB Financial Investment, reported foreign medical tourism spending of 251.2 billion won in May, up 44 per cent on the year across 597,000 cases, dermatology taking the largest share. The number that should catch an operator's eye is pharmacy spending, up 172 per cent year on year to a record share of the total. Korea is no longer just treating visitors; it is selling them a brand that follows them home, in creams and cosmetics bought after the procedure. Exports of medical and aesthetic products hit 480 million dollars in May, fillers alone 336 million. The inbound spend is the shop window; the export line is the till, and that is the number to model. ## AI and the experience layer in medical tourism Two stories cast technology as the thing patients will next judge destinations on, with mixed credibility. Nomad Lawyer described a humanoid robot called Alter-Ego, tested in a Milan rehabilitation hospital, that guides patients and fetches supplies, and attached a global market figure of around 130 billion dollars to the trend; treat that as the source's, not settled fact. CBN's Cyprus story was steadier, the country's chief scientist Demetris Skourides and the head of the global thalassaemia patients' federation, Androulla Eleftheriou, on using AI to put trusted information within reach of patients who would otherwise go without. The real thread is not the robot. Experience technology differentiates only where the clinical basics are already trusted, and a machine in the corridor does nothing for a thin outcomes record. Operators buying the shiny layer before the boring one have the order backwards. ## The organ trafficking case wearing the industry's name The week's ugliest story is also its most important. India's Enforcement Directorate alleged, as Telangana Today reported, that an organ trafficking racket in Kerala ran for five years behind a registered medical tourism company. The agency says the network paid financially distressed donors five to fifteen lakh rupees, charged recipients twenty to thirty-five lakh or more, forged altruism certificates, and arranged illegal transplants at hospitals in Ernakulam. Several people have been arrested, accounts frozen, six police cases registered. The same two words three governments wore as a badge this week, a criminal network used as a costume. That is the trouble with a label that means everything and guarantees nothing. The industry's representative bodies cannot prosecute fraud, but they can stop pretending the term protects anyone. Backing donor-protection registries and withholding the medical tourism label from unverified operators would cost little and say a great deal. Do nothing, and the next such case is already being written. ## What This Means One phrase did three jobs this week. Health tourism was a badge in Cairo, Amman and Tashkent, an escape hatch in Washington and Tijuana, and a disguise in Kerala. It stretched that far because the industry still has no shared floor, no agreed standard of proof separating a Singapore outcomes claim from a Mexican price tag from a forged altruism certificate. Everyone sells trust; almost no one publishes it. So, what to watch: which government pairs its glossy booking platform with real outcome data, procedure by procedure. The first to publish that gradient, from genuine care to salesmanship, will own something no rival can buy with a conference stage.

Jordan's Medical Tourism Revenue Reaches $1 Billion in 2025, Patient Numbers Hit 230,000

editorial@health-tourism-news.com (HTN Editorial Team) — Wed, 17 Jun 2026 00:00:00 GMT

Jordan generated almost $1 billion from medical tourism in 2025, marking a 4 percent increase year-on-year, with 230,000 foreign patients receiving treatment. Fawzi Hammouri, president of the Private Hospitals Association, told the Jordan Times that a quarter of these patients were treated in hospitals, while the remaining three-quarters sought care in clinics and specialised medical centres across the country. ## In-Demand Services and Patient Origins The medical services most sought after by international patients include: - Obesity and cosmetic surgery - Orthopaedic and neurosurgical procedures - Cardiology services - Obstetrics and gynaecology treatments, including IVF procedures Patients from Iraq, Saudi Arabia, Palestine, Syria, Yemen, and Libya account for the largest proportion of medical tourists visiting Jordan. ## Sector Investment and Recognition Investment in Jordan's private hospital sector has reached $4 billion. This sector directly supports 40,000 healthcare jobs and an additional 60,000 jobs in supporting industries, according to Hammouri. In 2023, UN Tourism recognised Jordan as an accredited destination for medical and wellness tourism. ## Why this matters Jordan's consistent growth in medical tourism revenue and patient volumes underscores its established position as a regional healthcare hub. This performance highlights the ongoing demand for specialised medical services from neighbouring countries, particularly those with developing healthcare infrastructure. The significant private sector investment and job creation reinforce the economic contribution of medical tourism to the Jordanian economy.

This Week In Health Tourism 08.06.26 - 15.06.26

editorial@health-tourism-news.com (Christian El-Khouri) — Mon, 15 Jun 2026 00:00:00 GMT

This is the Health Tourism News roundup for the week of 8 June 2026, and the clearest signal across it is that the contest in medical tourism has moved past price toward control of the whole patient journey. Governments spent the week building the administrative layer that clinical quality alone never solved: South Korea legalised telemedicine for foreign patients, Telangana put its public hospitals into the trade, Thailand moved to lengthen its medical visa, and a new service centre opened in China's Hainan pilot zone. A harder story ran underneath, set out by Medscape and US health officials: who pays when the journey is left unmanaged. The week rewarded coordination over capacity. ## China's advanced-treatment play in medical tourism The Business Times reported the case of Stuart Lye, a 58-year-old New Zealander who travelled to Shanghai for CAR-T therapy that cost about US$65,000 including airfare, against more than A$500,000 in Australia. While Thailand, South Korea and Malaysia compete on cosmetic surgery, fertility care and screening, China is selling procedures few others offer: a CAR-T infusion runs US$300,000 to US$475,000 in the United States against US$150,000 to US$180,000 in China, which already has seven approved commercial therapies and more trials under way than anywhere else. PR Newswire reported a new full-chain service centre at the Boao Lecheng pilot zone in Hainan, which drew nearly 10,000 foreign medical tourists from 14 countries in 2025 and has cleared more than 560 innovative drugs and devices. The science is not the constraint; regulators are. pharmaphorum's point, that cancer patients care only that a breakthrough reaches them, is the bottleneck: China's ivonescimab took the first China-developed plenary slot at the ASCO meeting, yet the United States declined a China-only trial for sintilimab in 2022 over how far the data carried. Agencies such as Joyful Medical and SinoUnited Health will shape this early market, but the missing medical-visa scheme and fragmented services flagged by China Renaissance Securities are the openings Thai and Singaporean operators should press now. ## India, Thailand and Egypt build medical tourism infrastructure Three governments treated medical tourism as infrastructure to build, not a slogan to market. EdexLive and The Hans India reported that Telangana has formed a high-level committee, ordered on 6 June, to bring international patients into Hyderabad's state-run hospitals: a dedicated block at TIMS Sanathnagar, procedures with fixed package rates, translators and attendant services, with recommendations due within a month. Nation Thailand described a parallel push by the Department of Health Service Support to lengthen the medical visa and amend the 1998 Medical Facilities Act so private hospitals can run their own research centres, alongside a global insurance-claims platform aimed at the longevity market. Thailand already counts more than 500 private hospitals, many internationally accredited. Clinical capacity stopped being the binding constraint years ago; the work that wins referrals now sits in pricing transparency, visa duration and dispute resolution. Telangana's one-month deadline is the near-term thing to watch, since a public-hospital pricing schedule that undercuts private rivals would reset expectations across southern India. The hazard of moving fast showed in Egypt, where Al Manassa reported the health ministry launching its national platform under a name, "Tour for Cure", already used by a Turkish competitor, after quietly treating around 250 patients in a pilot. Nomad Lawyer noted a different lever in Portugal, where Lagoa used a 1,500-delegate internal medicine congress to push into year-round medical-conference tourism. ## Telemedicine and integrated care redraw the patient journey South Korea made the week's most consequential regulatory change. Digital Health News reported an amendment letting registered providers consult, diagnose and prescribe for foreign patients remotely, including first-timers, both before they fly in and after they return home. With foreign patient visits near two million a year, it attacks the structural weakness of medical travel: the short stay that ends the moment a patient boards the plane. The demand shows in the data: The Asia Business Daily reported Korean medical tourism spending up 48.7% year on year in April, Chinese spending alone up 141.5%; in Malaysia, BIMB Securities Research read first-quarter results the same way, IHH Healthcare's core earnings up 8% and revenue per inpatient up 12%. Continuity of care ran through the week's commercial stories too. Vietnam Investment Review reported that Taipei Fertility Center, a cross-border fertility care specialist, has treated more than 2,300 international families, the over-40s now near 30%, using a one-stop remote model. Business Insider Africa described Medicana's Nigeria strategy in similar terms, an international patient department handling second opinions, costs, accommodation and post-return contact. Newsweek carried the same account from Colombia's Hospital Internacional de Colombia, where an integrated model and a Mayo Clinic Care Network tie-up are turning Bucaramanga, an intermediate city, into a destination for complex cardiac and paediatric cases. The margin is moving to whoever owns the consultation before and the follow-up after. ## The safety reckoning in cosmetic surgery tourism The counterpoint to all that coordination came from the operating theatre. Medscape, translating its French edition, reported plastic surgeon Flore Delaunay telling the French Society of Aesthetic and Plastic Surgeons' congress in Biarritz that cheap cosmetic surgery in Tunisia, Turkey or Thailand hides a chain of failures: no mandatory waiting period, thin consent, untraceable implants, and flights taken days after surgery that raise the risk of clots. A breast augmentation averaging €4,500 in France costs about €2,000 in Tunisia, and Turkey's cosmetic-tourism market, valued near $3.5 billion, is projected to reach $17 billion by 2035. When it fails, patients come home in sepsis with multidrug-resistant infections, and a Marseille team put the average cost of complications at €8,500 per patient, increasingly billed back by French Social Security. Nomad Lawyer relayed the same pattern from the United States, where a health alert linked a surge of drug-resistant infections in Los Angeles to cut-price cosmetic surgery abroad. Unmanaged cosmetic surgery tourism pushes its costs onto home health systems, and destinations that lead on volume, Turkey most of all, carry a reputational liability they cannot discount away. The remedy is unglamorous: implant traceability and a real aftercare pathway. The integrated-care operators above are, in effect, selling the absence of this exact risk. ## Wellness tourism borrows the clinic's tools Wellness tourism kept closing the gap to medicine. Nine.com.au pointed to Saint Haven in Sydney and Melbourne, where city dwellers book short urban recovery stays built on hyperbaric oxygen, cryotherapy, infrared saunas and nutrient drips, clinical kit in a spa wrapper. The Traveler made the case for Puerto Rico, whose pitch rests on a medical base: as a United States territory it offers care to US standards, English-speaking clinicians and familiar insurance, with new sites such as Sabanera Health in Dorado pairing advanced medicine with resort comfort, which is what lets it outpace Belize, Saint Lucia and Barbados. Travel Daily Media traced the same convergence across the Asia Pacific, from Thailand's Chiva-Som, open since 1995, to the Philippines' Farm at San Benito. The spa and the clinic are merging into one product, and the high-spend traveller goes to operators with a clinical spine. Puerto Rico's regulatory umbrella and the Farm's medical staffing are the moat, not a detail. Destinations selling wellness tourism without that depth will keep the casual visitor and lose the patient who actually spends. ## What This Means The single thread through every one of these stories is that medical tourism is being re-priced around coordination rather than the procedure itself. China can offer a therapy no one else has and still lose patients at the visa desk. Korea, Medicana and a hospital in Bucaramanga win not on surgical skill alone but on owning the weeks before and after. And the cosmetic-surgery casualties filling French and Californian wards are what an uncoordinated journey produces. For the back half of 2026, watch whether the new state-backed entrants, Telangana, Thailand and Egypt, can build the dull administrative layer, pricing, visas, follow-up and mediation, fast enough to turn clinical capacity into trusted referrals, because that, not another accredited hospital, is what now separates a destination patients reach from one they only read about.

This Week In Health Tourism 31.05.26 - 07.06.26

editorial@health-tourism-news.com (Christian El-Khouri) — Sun, 14 Jun 2026 00:00:00 GMT

This is the Health Tourism News roundup for May 31–June 7, 2026. This week's signals highlight a dual trend: destinations are aggressively pursuing growth in medical and wellness tourism through strategic initiatives, while simultaneously, the industry faces increasing scrutiny over patient safety and the critical role of trust. Policymakers and providers must balance ambitious expansion plans with robust patient protection measures to sustain long-term sector development. ## Strategic Expansion and Digitalisation Drive Medical Tourism Medical tourism destinations globally are intensifying efforts to attract international patients through strategic investments in infrastructure, digital solutions, and integrated patient services. Malaysia, for example, demonstrated strong demand at its Malaysia Fair 2026 in Jakarta, reporting RM2.2 billion in revenue from Indonesia in 2025, a 23% year-on-year increase, with over 970,000 Indonesian healthcare travellers, up 16% from 2024. The Malaysia Healthcare Travel Council (MHTC) views Jakarta as a crucial high-potential market, an initiative supported by MHTC’s brand ambassador, national songstress Siti Nurhaliza Tarudin, as Freemalaysiatoday reported. In the Middle East, Jordan's Health Minister Ibrahim Al Bdour highlighted continuous royal support for the healthcare sector, establishing the country as a regional hub for medical treatment and education. Istiklal Hospital, marking its 25th anniversary, has treated patients from 97 nationalities and launched an "Istiklal Medical Tourism Platform" to bolster Jordan's reputation, according to Petra. This illustrates how national commitment and private sector investment are vital for developing regional leadership. Further east, Ethiopia is executing an extensive plan to digitise over 80% of its government hospitals and clinics by 2030, aiming to become a premier medical tourism centre in the Horn of Africa. Dereje Duguma, the State Minister for Health, noted that more than 50 facilities have already adopted paperless systems and are implementing AI-based digital radiology and diagnostic tools, TV BRICS reported. This digital push seeks to elevate service quality and attract patients from nearby nations. Dubai is also advancing its patient journey with a 'smart medical visa,' a collaboration between the General Directorate of Identity and Foreigners Affairs and the Dubai Health Authority. This agreement seeks to create a cohesive experience for medical tourists, encompassing visa, residency, and healthcare services from pre-arrival to post-treatment, Khaleej Times stated. Such policy integration, including companion visas and sponsorship via licensed healthcare facilities, is fundamental for streamlining access. Meanwhile, Bangkok Health Service in Thailand has introduced a USD pricing page for its medical tourism packages, providing US and international patients with clearer cost estimates for a range of procedures, from health checks to cardiovascular surgeries, as reported by The National Law Review and Businessinsider. This transparency in pricing, though initially estimated, is a key factor in patient decision-making. Beyond general medical tourism, specialisation drives significant growth. Belarus is emerging as a leading medical tourism hub in the Commonwealth of Independent States (CIS), appealing to Russian citizens with its innovative treatments, according to State Secretary Sergei Glazyev. BelTA News Agency indicated plans to double tourism's share in the national GDP and open a second Union State tourist information centre by 2027. Similarly, Turkey's hair transplant sector exemplifies highly specialised medical tourism, generating $3 billion from 1.3 million medical tourists in 2025. Streamlinefeed detailed how Turkey achieved global leadership through aggressive innovation, accessible pricing, and the standardisation of microsurgical techniques, transforming corporate hospitals into advanced medical academies. These varied approaches demonstrate that both broad strategic investments and focused specialisation are effective pathways for national and regional medical tourism development, requiring operators and policymakers to adapt strategies to their specific market strengths. ## Prioritising Patient Trust and Safety Amidst Growing Risks While the medical tourism market is projected to exceed $100 billion by 2032, expanding at 15% to 25% annually, growth in awareness has not translated proportionally into patient conversion, according to Business Insider. This publication highlights that 97.2% of medical tourists consider trust paramount in their decision-making, yet many programmes focus on visibility rather than trust-building systems. A new advisory service from JCH Digital, drawing on nursing leadership experience, aims to help policymakers and healthcare organisations strengthen patient trust and improve international positioning by framing it as a clinical credibility exercise rather than solely a branding effort. This approach is critical given that 5% of US medical tourists report unexpected outcomes from care abroad, with 67% of those seeking follow-up treatment upon return, reinforcing hesitation among prospective patients, Business Insider noted. Concerns over patient safety are further underscored by new research from the Centers for Disease Control and Prevention (CDC). The CDC documented serious complications, including difficult-to-treat infections and, in some cases, deadly outcomes, tied to cosmetic surgeries performed during medical tourism trips. A study published in the CDC's Emerging Infectious Diseases journal reviewed reports spanning a decade, identifying 21 reports involving approximately 145 patients who experienced adverse outcomes, including four patient deaths, between 2014 and 2024. Lead author Kiara McNamara, a CDC nurse epidemiologist, emphasised the importance of patients being informed and prepared before seeking cosmetic surgery abroad, Laredo Morning Times reported. The study also highlighted infection-control concerns at some facilities, citing shortcomings in cleaning, hand hygiene, personal protective equipment use, and surgical instrument processing. British surgeons have issued a stark warning regarding individuals travelling overseas for procedures such as leg-lengthening, noting the significant burden placed on the National Health Service (NHS) for extensive follow-up care. A study by specialist limb reconstruction surgeons at the Royal National Orthopaedic Hospital NHS Trust calculated that addressing complications from just seven cases cost the NHS over £36,000, with the true financial impact likely far greater, reported The Independent. Complications observed include implant failure, inadequate bone healing, and severe limb deformities. Most patients sought these procedures abroad due to lower costs and availability, with five of the seven studied cases travelling to Turkey, one to Russia, and one to South Africa. The Royal College of Surgeons of England noted a growing trend of patients seeking surgical treatments outside the UK, with the incidence almost doubling from 230,000 patients in 2021 to over 430,000 in 2023. These findings collectively urge policymakers and healthcare providers to collaborate on stronger surveillance efforts, enhance patient education on risks, and prioritise clinical credibility and safety measures to mitigate adverse outcomes and build enduring trust in cross-border care. ## The Expanding Scope of Wellness Travel Beyond traditional medical treatments, the wellness travel sector is gaining considerable momentum, shifting focus towards preventative health and holistic wellbeing. Preventative wellness travel is increasingly replacing conventional leisure vacations, driven by a broader recognition among employers, insurers, and healthcare decision-makers that employee health outcomes are influenced by lifestyle, stress, sleep, and recovery practices. As reported by Corporate Wellness Magazine, this trend addresses issues like burnout and chronic stress, offering structured activities such as stress reduction programmes, sleep optimisation, mindfulness, and nutrition education, distinct from acute medical interventions. This reflects a proactive approach to longevity and aligns with evolving workforce expectations for experiences that contribute to mental clarity and emotional resilience. South Korea is capitalising on this trend by deploying legislative and financial support to position itself as a premier global wellness destination. Under its newly enacted Healing Tourism Industry Act, the Ministry of Culture, Sports and Tourism has selected 20 premier wellness sites nationwide, providing each with up to 50 million won (approximately $36,300) in government funding. This initiative, detailed by The Korea Times, aims to institutionalise and regulate the domestic sector, establishing an official bureaucratic framework to manage service quality, train professionals, and designate specialised "healing tourism zones." The funding will support multilingual digital infrastructure, global advertising campaigns, and localised content across areas like traditional Korean medicine, high-tech beauty spas, and forest retreats, reflecting Korea's unique blend of modernity and ancient tradition. In Southeast Asia, Bintan is strengthening its position as a wellness and sports travel hub. Safariindia reported on the return of the Bintan Triathlon 2026, an event that attracts professional athletes, fitness enthusiasts, and wellness travellers seeking to combine endurance activities with a tropical island escape. The triathlon, just a 60-minute ferry ride from Singapore, exemplifies how destinations are curating experiences that blend movement, relaxation, and nature immersion, aligning with modern travel preferences for physical activity and mental wellbeing. These developments indicate a clear industry shift: wellness travel is not merely a leisure pursuit, but a strategic component of health tourism, demanding tailored infrastructure, regulatory frameworks, and integrated experiences to meet sophisticated consumer and corporate demands. Investors and operators should look to these examples for models of sustainable, high-value tourism development. ## What This Means The industry is clearly at a crossroads, balancing ambitious growth with the imperative of patient confidence. While countries like Malaysia, Jordan, Ethiopia, and Dubai are making strategic investments in digital infrastructure, specialised services, and policy reforms to attract medical tourists, the persistent warnings from bodies like the CDC and the Royal College of Surgeons highlight critical gaps in patient safety and trust. The rise of preventative wellness travel, as seen in South Korea and Bintan, offers a complementary path, but it too requires careful regulation and credible offerings. The overarching message is that sustained expansion in health tourism, whether medical or wellness-focused, will depend less on aggressive marketing and more on demonstrable clinical credibility, robust patient protection, and transparent, integrated service models that prioritise the traveller's wellbeing at every stage. Industry stakeholders must now focus on harmonising these diverse elements to build a truly resilient and reputable global health tourism offering.

Iran Crisis Cuts Gulf Medical Travel to Asia

editorial@health-tourism-news.com (Christian El-Khouri) — Thu, 21 May 2026 00:00:00 GMT

A sharp escalation of the conflict in West Asia has cut into cross-border medical travel across more than thirty countries, Nomad Lawyer reported. Closed airspace and rerouted flights over the region have reduced patient arrivals in South Korea, Japan, India and Thailand, the report said, as Gulf patients postpone planned procedures rather than travel through disrupted corridors. Bookings for oncology, cardiac, orthopaedic and paediatric care have slipped alongside the cosmetic surgery and fertility work that first built these corridors. ## India reports the steepest fall The fall was steepest in India. Hospitals in Delhi, Mumbai, Bangalore and Hyderabad reported drops of 50 to 75 per cent in patients from West Asia, Nomad Lawyer reported, with oncology, cardiac and orthopaedic bookings the most affected. Nomad Lawyer is a general-interest publication rather than a medical-travel data source, and the 50 to 75 per cent figure should be read as indicative rather than audited. Slower arrivals reached South Korea, where clinics in Seoul and Busan handle cosmetic surgery and fertility treatment for Gulf patients, and Japan, where oncology and regenerative medicine centres in Tokyo, Osaka and Fukuoka logged postponements. In Thailand the recovery resorts of Bangkok and Phuket recorded the same postponements, and in China the diagnostics and fertility centres of Beijing, Shanghai and Guangzhou began steering their outreach toward Southeast Asia. India's own hospitals put similar numbers on the fall. The New Indian Express reported medical tourism arrivals down 30 to 40 per cent across the country's principal medical hubs. Those hubs run from the National Capital Region to Maharashtra, Tamil Nadu, Karnataka and Telangana, and at some hospital chains overseas inflow dropped 50 to 75 per cent over a single fortnight, the paper said. The same contraction was reported [across India's medical hubs](/news/geopolitical-tensions-rattle-india-s-medical-tourism-a-deep-dive-into-declining-patient-inflow-and-strategic-shifts/) as the conflict widened, and the two accounts agree on the direction and the scale. ## Gulf source markets slow The Gulf source markets carried much of the fall. Outbound medical travel from Oman, Saudi Arabia, the United Arab Emirates and Qatar slowed as families delayed surgery, fertility treatment and paediatric care, the report said. Volatility around the Strait of Hormuz and rising conflict-risk premiums on travel insurance made the journeys expensive and uncertain. Iran itself turned inward, its hospitals absorbed by conflict-related care while foreign bookings froze, and patients in Iraq and Yemen who depend on hospitals in India and Turkey lost their route out. Some diverted demand moved toward Turkey, though the report described that flow as unstable. The disruption widened beyond the operating theatre. Airspace closures and rerouted flights lengthened and raised the price of long-haul journeys for patients with urgent needs, Nomad Lawyer reported, and travel insurers added conflict-risk premiums to policies covering the affected corridors. The secondary trade that medical tourism carries with it, the recovery hotels, the interpreters, the private transfers and the rehabilitation services, saw the same fall in occupancy as the clinics they serve. ## The fourth risk of medical travel There is a settled way to read a quarter like this. Medical tourism carries four standing risks, and most coverage names only the first three: the clinical risk that the treatment goes wrong, the legal risk that redress is hard to win abroad, and the continuity risk that follow-up care falls to a home system that never saw the operation. The fourth is the one on display now. It is the logistical risk that the corridor itself closes, and the patient never reaches the accredited clinic at all, whether the booking is orthopaedic, oncological or paediatric. A cardiac programme in Delhi can be excellent and still lose 50 to 75 per cent of its Gulf patients to an airspace map over the Strait of Hormuz that it does not control. That fourth risk is really a concentration problem. The destinations most exposed this quarter are the ones that built their medical tourism arrivals on a single source market, and across Asia that source market has been the Gulf. When one region supplies a large share of the high-paying patients, its politics become the destination's politics. The pressure reaches the demand side as well as the supply side: Thailand's tourism ministry expects up to three million fewer foreign visitors in 2026, blaming the Middle East conflict and the cost of fuel, a shortfall its operators are answering by [pivoting toward luxury and regional markets](/news/thailand-s-strategic-pivot-navigating-global-headwinds-with-medical-tourism/). Nomad Lawyer reported the standard remedies, that hospitals diversify their source markets toward Southeast Asia, Africa and Central Asia and lean on telemedicine for the parts of care that do not need a flight. Telemedicine covers the consultation and the follow-up, but telemedicine does not fly a patient to a cardiac theatre, and a source market is not built in a quarter. ## What operators should watch The test is measurable and close. Destinations that widened their source markets before this quarter will show it in their next arrival figures, and destinations that leaned on the Gulf will show the gap. For operators the specific move is dull and correct: hold the deposits, keep the scheduling flexible, and count how much of the book depends on a single corridor before the next corridor closes. A hospital that cannot answer that last question does not yet know how exposed it is to the fourth risk.

Longevity Travel Market Valued at $18 Billion, $48.2 Billion by 2033

editorial@health-tourism-news.com (Christian El-Khouri) — Tue, 19 May 2026 00:00:00 GMT

Us Weekly reported that the global market for longevity travel is now worth about $18 billion, a figure the magazine reported would reach $48.2 billion by 2033 as luxury hotels and clinics rebuild their offerings around guests who want to live longer rather than simply rest. The premise is prevention. Those guests now book for advanced diagnostics, sleep work and recovery therapies, well past the spa treatments that defined the earlier wellness holiday. Longevity travel, in the magazine's account, has become a reason to pick one hotel over another. ## Longevity inside the hotel Luxury hotels are folding health technology into the guest stay, Us Weekly reported, from IV drips and mineral soaks to red-light therapy beds and dedicated recovery suites. At the Santa Monica Proper Hotel, the Ammortal Chamber blends electromagnetic fields, red light, sound and hydrogen therapies into a single treatment. Brian De Lowe, president and cofounder of Proper Hospitality, told Elle that wellness once sat at the edge of hospitality. "Now longevity is literally how people choose where they stay," De Lowe told Elle. Guests still want design, food and social energy, he said, but they now weigh sleep, recovery and metabolic health alongside them. ## Longevity clinics in the United States About 800 longevity clinics now operate across the United States, Us Weekly reported, offering full-body scans, genetic testing, hormone work and regenerative therapies. Prices vary widely. They run from a few hundred dollars for basic tests to five-figure annual memberships, the magazine reported. The clinics aim to catch disease early and to keep people well rather than to treat symptoms that have already arrived. Most programmes open with a long workup, and that workup can take in CT, MRI and DXA scans, blood panels, cognitive testing and genome sequencing. The results feed a plan built around each guest's genes, lifestyle and risk. Olga Donica, director of longevity innovation at Clinique La Prairie, told Elle that the audience has changed. "We've seen a big shift to a much younger audience, in their late thirties or forties," Donica told Elle. Clinique La Prairie runs weeklong longevity programmes with more than 50 specialised doctors on staff, and it warns that heavy screening without expert reading can push patients toward overtreatment. Medical oversight, the clinic says, is the line between prevention and needless intervention. ## What the programmes cost Longevity travel now reaches well beyond the United States, Us Weekly reported, with Lanserhof Sylt, SHA Wellness Clinic and Clinique La Prairie all running multi-day clinical programmes in resort settings. At Canyon Ranch Tucson, the LONGEVITY8 programme packs 18 consultations, 15 diagnostic tests and more than 200 biomarker readings into four days, and it costs about $20,000. Palazzo Fiuggi sells a six-night "Hiking for Longevity" stay that pairs medical testing with guided walks in the Apennine Mountains, priced at just over $4,000 before a room. Other resorts have joined them. Carillon Miami, The Ranch Malibu, YO1, Three Forks Ranch and Castle Hot Springs have all added longevity travel of their own. The typical buyer sits in midlife. Phyo Han of Chi Longevity at the Four Seasons Hotel Singapore told Esquire that clients run in age from 18 to 90. "The sweet spot is between 45 and 60," Han told Esquire. Many in that band start to see the illnesses that run in their families as they watch their parents age, he said, and want to hold their health steady for the decades ahead. That midlife demand, the magazine reported, is the clearest driver of the growth in longevity travel. ## What to watch The reporting rests on one general-interest source, and the $18 billion value and the $48.2 billion projection both lean on prices supplied by the clinics and hotels themselves. They are market estimates, not audited accounts. Longevity travel sells prevention through advanced diagnostics, sleep work and recovery therapies, and prevention is easier to price than to prove. That leaves it open to the same question as the wider wellness market, of whether the tests and memberships change outcomes or only spending. Destination policy is moving the same way, from [Thailand's push into healthspan tourism](/news/thailand-targets-healthspan-tourism-from-2026-streamlines-medical-visas/) to the case that [longevity is reshaping health travel](/news/longevity-tourism-reshapes-global-healthcare/). The clinics have set the price of prevention. The next set of figures will show whether they can also publish the outcomes, and whether the $48.2 billion projection holds once memberships are counted rather than forecast.

Grenada Expands Wellness Tourism With Two Resorts

editorial@health-tourism-news.com (Christian El-Khouri) — Mon, 18 May 2026 00:00:00 GMT

Grenada now has two luxury wellness resorts that opened in the same year, and the island is presenting that as the start of a sector. Forbes reported that the Spice Island's wellness travel offer expanded in 2024 with the opening of Silversands Beach House and Six Senses La Sagesse, as global wellness tourism reached the 894 billion dollars the Global Wellness Institute measures for 2024 and more travellers booked trips built around replenishment rather than sightseeing. Grenada, long known for its nutmeg and cinnamon groves, is extending its pitch beyond the tropical beach holiday toward holistic experiences, health-focused dining and eco-luxury resorts. ## Grenada positions wellness tourism on the Spice Island Forbes reported that Stacey Liburd, chief executive of the Grenada Tourism Authority, sees a rise in wellness travellers looking for authenticity, balance and a sense of connection on the island. The two 2024 openings anchor that positioning. Silversands Beach House arrived as an intimate counterpart to the collection's flagship at Grand Anse, a 28-room property built around privacy, indoor-outdoor living and a small set of signature experiences. The flagship at Grand Anse remains the larger, family-oriented resort, with villas for groups, an extended spa programme and the sort of amenities that fill a week-long stay. Together the two Silversands properties give the collection a range from quiet retreat to family base, all under one sustainably minded brand. Wellness tourism sits at the low-intervention end of the health tourism spectrum, the model this publication uses to separate medical travel from wellness travel. Wellness travellers carry little or no clinical involvement and go to improve an already-sound state rather than to treat illness, and they choose resorts and spas over hospitals. That places Grenada's expansion firmly in the wellness rather than the medical column, which matters for how the claims should be read. Wellness is a borrowed-authority domain for a health publication, so the promise of replenishment and balance is best treated as marketing language until outcomes are measured, and the honest question is whether two openings amount to a sector or simply to two very good hotels. ## Six Senses La Sagesse and the longevity turn Forbes reported that Six Senses La Sagesse is the brand's first property in the Americas, set between a lagoon and the sea, and built around wellness screenings and tailored programmes spanning fitness, meditation, breathwork, sleep therapies, digital detox and recovery. The resort also reaches into longevity and biohacking, with hydrotherapy facilities and signature rituals drawing on local bush tea and cacao. In 2025 the property earned a Michelin Key, and its restaurants are organised around a farm-to-table philosophy that prioritises fresh, seasonal and responsibly sourced ingredients grown close to the kitchen. The longevity framing is the part to watch, and to hedge. Longevity and healthspan travel is an emerging hybrid that borrows medical language, meaning screenings, biomarkers and recovery protocols, and applies it in a resort setting rather than a clinic. It sits between the medical and wellness ends of the spectrum, and the evidence base thins quickly once the marketing gets specific. A screening at a lagoon resort is not the same as a diagnostic pathway with clinical follow-up, and readers weighing a longevity package should treat it as wellness with medical styling rather than medicine. That is not a criticism of the resort. It is the distinction the category depends on, and the one glossy coverage tends to blur. ## Grenada's island-wide wellness and cacao economy Forbes reported that the resorts sit on top of an island already rich in the raw material of wellness travel. Grenada has natural sulphur springs fed by geothermal, mineral-rich water, waterfalls set in rainforest, and hiking through its national park, alongside guided sessions that combine yoga with plant-based food. The Spice Island's cacao heritage runs through the offer as well, from estate tours of traditional chocolate production to a chocolate festival built around the island's organic cacao. These are the assets that let two luxury openings read as part of a place rather than as imported boxes on a beach. That distinction carries the real risk in Grenada's strategy. A destination economy built on a few international luxury brands can trickle down to local operators, or it can wall the spending off inside the resort gates, and which of the two happens depends on how deliberately the island links its guides, farms and springs to the properties. Grenada's advantage is that the cacao, the springs and the culture are already local and already distinctive. The task for the tourism authority is to make sure the wellness spending reaches the estates and operators outside the resort, so that the sector Liburd describes is broader than two hotels and a marketing line. ## What This Means Grenada has two strong luxury wellness properties, a genuine wellness inheritance in its springs and cacao, and a tourism authority framing all of it as an emerging sector in a wellness travel market the Global Wellness Institute measures at 894 billion dollars. The pieces are real, and the differentiation from the wider Caribbean is real. The caution is one of category. Wellness is a borrowed-authority domain, the longevity and biohacking claims sit ahead of their evidence, and two openings in a single year are a start rather than a sector. The signal I would watch is not the next resort but the spread, meaning whether Grenada's wellness spending reaches the estates, springs and guides beyond the resort gates. A destination that keeps the money inside two properties has two hotels. One that pushes it out to the island has a sector. **Correction, 3 September 2026.** This article twice stated that global wellness travel had passed one trillion dollars, once as reported context and once in the closing analysis. That was wrong when written rather than superseded: the Global Wellness Institute measures wellness tourism at 894 billion dollars for 2024, and its trillion figure is a projection for 2026 rather than a count. Both statements now give the measured figure, and the meta description has been corrected with them.

Malaysia Medical Tourism Stays Strong Despite Tax

editorial@health-tourism-news.com (Christian El-Khouri) — Mon, 18 May 2026 00:00:00 GMT

Malaysia has put a new tax on the same private hospitals it wants foreign patients to fill, and its finance minister used a factory visit to argue the two can coexist. Bernama reported that Finance Minister II Datuk Seri Amir Hamzah Azizan said on 18 May that Malaysia continues to attract foreign medical tourists and remains competitive, even after a six per cent sales and service tax took effect on private healthcare services. Speaking after a visit to Intel in George Town, the minister said private hospitals in Penang, Johor and the Klang Valley are drawing international patients because the country still offers "reasonable and very good healthcare." ## Malaysia defends medical tourism after the SST Bernama reported that Amir Hamzah pointed to strong overseas demand at private hospitals across Penang, Johor and the Klang Valley, citing a major private hospital in Penang where a large share of patients travel from abroad. He described the inflow as a growing space that the government should continue to support. The minister confirmed the six per cent SST on private healthcare services is in force, but said the government has granted exemptions so the tax does not unduly burden the population. Bernama reported that collections from the healthcare SST flow into the Consolidated Fund to support general government spending, and the minister explained the measure is designed to strengthen revenue and widen the country's fiscal capacity. He cited last year's increase in the sugar tax as a comparable case of targeted revenue raised to address health problems such as diabetes and kidney disease. The claim worth testing is the one the minister made directly, that a new tax on private healthcare and a competitive medical tourism offer can hold together. Medical tourism sits at the clinical end of the health tourism spectrum, the model this publication uses to separate medical travel from wellness travel, and it is judged on outcomes, safety and price rather than on lifestyle. Malaysia has built its position at the value end of that market, competing on the driver patients feel most directly, which is cost. When the decision to fly is driven by price, a six per cent input added to the bill is not a rounding error. It lands on exactly the calculation a cross-border patient makes. ## The six per cent tax meets a price-led market Patients choosing medical tourism weigh a small set of drivers: better care, the best specialist, cheaper treatment, faster access, or a procedure unavailable at home. Malaysia's private hospitals have long sold the cheaper-and-faster combination to patients from the region. The country's reputation rests on delivering hospital care that is credible and affordable at once. A tax that raises the sticker price sits in tension with that reputation, and the minister's reassurance is really a claim that the exemptions and the underlying value will absorb the increase before patients notice it. That is plausible for now, because a six per cent rise on a bill that is already a fraction of Western prices still leaves a wide gap. It is less comfortable as a trend, because every future increase eats into the one advantage that brought these patients in the first place. The stakeholders who carry that risk are the private hospitals themselves, not the ministry. Bernama reported the minister framing the SST as a revenue and fiscal-capacity measure, with the healthcare take pooled in the Consolidated Fund rather than ring-fenced for health. The hospitals in Penang, Johor and the Klang Valley absorb the competitive consequences while the revenue funds general spending, which is a defensible fiscal choice but not a neutral one for the medical tourism trade. If foreign demand stays strong through the tax, the minister's confidence is vindicated. If margins tighten and price-sensitive patients drift to lower-cost neighbours, the hospitals will feel it before the treasury does. ## Why the exemptions matter more than the headline rate The detail that decides the outcome is the exemption structure the minister mentioned but did not spell out. A blanket six per cent on all private healthcare would hit the patient at the point of sale. Targeted exemptions can shield the treatments and patients that matter most and still raise revenue elsewhere. Bernama reported only that exemptions exist to protect the population from undue burden, which leaves open whether foreign patients and the specialities that draw them sit inside or outside the net. That is the number to watch, because it determines whether the SST is a tax on medical tourism or merely a tax collected near it. The distinction is the whole argument. ## What This Means Malaysia is trying to hold two positions at once, a new tax on private healthcare that strengthens the treasury and a medical tourism sector that stays competitive on price. Bernama reported the finance minister insisting both are true, and for now they can be, because a six per cent increase on already-low bills leaves Malaysia's value advantage intact and the exemptions blunt the edge. The pressure is directional rather than immediate. Malaysia competes at the cheaper end of medical tourism, and every future cost added to private care narrows the margin that makes patients in Penang, Johor and the Klang Valley worth pursuing. The signal I would watch is not this year's arrivals but the shape of the exemptions and whether the rate stays at six per cent. Value-led destinations rarely lose their advantage in one step. They lose it one tax and one increase at a time.

Thailand Targets Wellness Tourism As Arrivals Fall

editorial@health-tourism-news.com (Christian El-Khouri) — Mon, 18 May 2026 00:00:00 GMT

Thailand is planning for fewer visitors and higher spending, a trade-off its tourism authority now states openly. Travel Voice reported that Thapanee Kiatphaibool, Governor of the Tourism Authority of Thailand, revised the country's 2026 forecasts downward at the Thai Festival Tokyo, citing recent geopolitical risks in the Middle East. International arrivals for the first four months of 2026 totalled around 12 million, a reduction on the same period a year earlier. Japanese visitors fell 2.6 per cent to 365,360 over those four months, and the Governor tied the wider revision to conditions that tourism authorities cannot control. ## Thailand revises 2026 visitor forecasts downward Travel Voice reported that the Tourism Authority of Thailand now expects around 32 million international visitors in 2026, a slight reduction on earlier projections. The forecast for Japanese visitors was cut to approximately 1 million, down from an initial estimate of 1.2 million. Despite the lower headcount, the authority expects international tourism spending to hold at 2025 levels, an outcome it credits to promotions aimed at luxury travellers. "Thailand is offering values beyond prices," Kiatphaibool said, naming golf, high-end gastronomy and wellness as the high-priced offerings the country wants to sell. The logic here is a deliberate trade of volume for value, and it deserves to be read as such. A destination that expects flat spending on fewer arrivals is betting that the visitors it loses are the price-sensitive ones and the visitors it keeps are the high spenders. The bet is coherent. It is also a concentration bet, because Thailand is leaning harder on Japanese luxury travellers and on wellness at the exact moment Japanese arrivals are falling, which places a great deal of weight on a single source market behaving as the plan requires. A tourism strategy that concentrates on one contracting market is exposed to that market twice over, once on volume and once on yield. ## Wellness tourism and the value-over-volume strategy Wellness tourism sits at the low-intervention end of the health tourism spectrum, the model this publication uses to separate medical travel from wellness travel. Wellness travellers carry little or no clinical involvement and travel to improve an already-sound state rather than to remedy illness, and they book resorts and spas rather than hospitals. The distinction matters for Thailand's plan because wellness demand is discretionary and reputational in a way that surgical demand is not. Practitioners in the wellness field argue that repeat wellness visitors rank among the most loyal and highest-spending cohorts in travel, which is precisely the segment a value-over-volume strategy needs to capture and keep. Travel Voice reported that the Tourism Authority of Thailand is promoting healing and anti-ageing as components of its wellness offering, and that it plans to spread international traffic into local areas by developing tourism content rooted in 55 regions. After 2027, the authority intends to select recommended areas tailored to each market. For the Japanese market specifically, the authority will promote the waterfront areas of Ayutthaya. These are demand-distribution measures, moving visitors off the crowded core rather than adding to it, and they fit a strategy built on yield per visitor rather than raw arrivals. The risk is that spreading content across 55 regions dilutes the very focus that a premium wellness positioning depends on. ## Phuket hosts the Global Wellness Summit Thailand secured Phuket as the host city for the 20th Global Wellness Summit in November 2026, an event Travel Voice reported is expected to draw more than 600 experts and generate an economic impact of 10 billion Baht. The Governor framed Phuket as a centre of wellness and sustainability rather than a beach resort alone. A recent report from the Global Wellness Institute, which organises the summit, ranked Thailand seventh in the world in 2024 for wellness market growth rate. Winning a summit is not the same as building an industry, and the distinction is the one Thailand now has to prove. Hosting the Global Wellness Summit puts Phuket in front of the people who allocate wellness capital and route wellness itineraries, which is worth a great deal in a market where reputation compounds slowly. The harder work sits underneath the event. A destination pursuing high-value wellness has to fix the dull machinery first, meaning the airport, the transfers, the licensing of practitioners and the standard of the spas that carry the promise. Thailand's seventh-place growth ranking suggests the momentum is real, and the summit is a credible signal, but a single high-profile event cannot substitute for the operational depth that keeps high spenders coming back. The follow-through after November matters more than the headline in November. ## What This Means Thailand has chosen yield over volume, and the 2026 forecasts make the choice explicit: around 32 million arrivals, roughly a million Japanese visitors, and spending held flat by design rather than by growth. The bet rests on wellness and luxury travellers replacing the value lost from a shrinking headcount, and it rests heavily on the Japanese market at the moment that market is contracting. Hosting the Global Wellness Summit in Phuket gives the strategy a genuine showcase and a genuine deadline. The number I would watch is not arrivals but spend per visitor. If total tourism spending holds at 2025 levels on fewer visitors, the value-over-volume thesis is working. If it slips with the headcount, Thailand will have traded away volume without capturing the premium it was chasing, and a shrinking source market will have taken both.

Korea Medical Tourism Surges On K-beauty Demand

editorial@health-tourism-news.com (Christian El-Khouri) — Fri, 15 May 2026 00:00:00 GMT

Korea's medical tourism boom now runs through two travel and beauty platforms as much as through its hospitals. Maeil Business Newspaper reported that medical tourism consumption in Korea rose 5.8 times to 491.1 billion won in the first quarter of this year, up from 84.15 billion won in the same quarter of 2019, driven by demand for K-beauty. That growth came even as foreign tourist spending slowed overall, with medical and wellness travel helping to improve the country's tourism balance. It has also pulled platforms such as MyReal Trip and Healing Paper deeper into the business of serving foreign patients. ## Korea's medical tourism runs on K-beauty demand Maeil Business Newspaper reported that the Ministry of Health and Welfare recorded about 2.01 million foreign patients in Korea last year, part of a climb the ministry traces from 610,000 in 2023 to 1.17 million in 2024. Since 2009, the cumulative number of foreign patients has reached 7.06 million. Demand concentrates heavily in K-beauty medical care, meaning dermatology and plastic surgery, alongside wellness experiences. That concentration is worth naming plainly, because it defines both the opportunity and the exposure. K-beauty medical care is cosmetic tourism, which sits across the line between medical and wellness travel. These procedures are medically performed, in clinics and by clinicians, but the motivation is aesthetic rather than the treatment of illness. That places Korea's boom in a segment judged on visible results and on trust as much as on clinical outcomes. When demand runs this hard through a single category, the destination inherits that category's volatility, because aesthetic demand tracks fashion, social media and disposable income far more than a hip replacement ever will. Korea's 5.8-fold jump is real, and its dependence on one driver is the risk that sits underneath it. ## MyReal Trip moves from travel into beauty and wellness Maeil Business Newspaper reported that MyReal Trip, a domestic travel platform, has launched lifestyle categories covering beauty and wellness, letting users browse beauty and wellness products the way they already book travel. It applies the partner-verification criteria it uses in travel to the new categories, and recommends products from user behaviour data. A 'beauty check-in' promotion running until the 20th of the month spans pre-travel preparation and post-return recovery across themed offerings from spas and aesthetics to hair and nails. The platform intends to build the categories for domestic users first, then extend them to K-wellness experiences for foreign visitors to Korea. It pointed to Korea Tourism Data Lab figures projecting a 40.4 per cent year-on-year rise in foreigner spending in the beauty and health sector in 2025. This is a facilitator widening its remit, and the direction matters more than the promotion. The standing critique of medical travel facilitators is that many sell visibility rather than trust, ranking clinics that pay rather than clinics that perform, and leaving the patient to carry the risk. A platform that extends its own partner-verification into beauty and wellness is at least gesturing at the harder job, which is vetting. Whether MyReal Trip's curation reduces the information asymmetry a foreign patient faces, or simply repackages a booking funnel with a wellness label, is the question its foreign-visitor expansion will answer. ## Healing Paper adds interpretation for foreign patients Maeil Business Newspaper reported that Healing Paper, which runs a global K-beauty medical platform, has strengthened its support for foreign patients by adding an offline interpretation function to its one-to-one guidance service. That extends the platform's help from booking assistance into hospital visits and direct communication on site. The service is built to reduce language barriers and information asymmetry for foreign patients. It covers the whole path from choosing a procedure and a hospital through to the reservation, and pairs a counselling function with interpretation. Hong Seung-il, chief executive of Healing Paper, said the aim is to build "a standardized K-beauty medical experience" that satisfies both patients and hospitals. Interpretation and on-site guidance address the two risks that hurt cosmetic patients most, and neither is clinical. The first is the language barrier, which turns consent, aftercare instructions and complication management into guesswork when the patient and the clinician do not share a language. The second is continuity of care, the gap that opens when a patient flies home days after a procedure with no clear route back to the clinic that performed it. A facilitator that puts an interpreter in the room and stays involved through the hospital visit is working on the continuity-of-care risk directly, which is a more useful contribution than another discovery app. The value of these platforms will be judged on whether foreign patients are better protected, not on how many bookings they process. ## What This Means Korea's medical tourism has grown 5.8 times in a single quarter on the strength of K-beauty, and the response from MyReal Trip and Healing Paper shows where the competition is moving, which is away from pure booking and toward interpretation, verification and end-to-end support for foreign patients. That is the right direction, because cosmetic tourism lives or dies on trust and continuity, and platforms that reduce language and information risk earn a place the clinics cannot fill alone. The exposure is the concentration. A boom carried this heavily by one category, K-beauty, rises fast and can fall fast, and the platforms betting on it are betting on aesthetic demand holding. The signal I would watch is not the next consumption figure but the mix, meaning whether Korea's foreign-patient growth broadens beyond dermatology and plastic surgery. A medical tourism sector resting on one driver is only as durable as that driver's fashion.

Albania's Dental Tourism Grows 400%, Eyes 100,000 Patients by 2026

editorial@health-tourism-news.com (Christian El-Khouri) — Thu, 14 May 2026 00:00:00 GMT

Briefglance, a travel and lifestyle site, reported that Albania has become one of Europe's fastest-growing dental tourism destinations, citing official figures of 400 per cent growth since 2020. More than 80,000 international patients travelled to the country for dental care in 2024, the piece said, and it projected that the number would pass 100,000 by 2026. Most come from the United Kingdom, Germany and Italy. The draw is price. The piece framed the growth as part of a wider European shift, with rising treatment costs pushing patients across borders for essential care, and it named Alba Med Health, a specialist dental clinic in Tirana, as a business scaling up to meet the demand. ## The cost gap The pull toward Albania is the cost gap with Western Europe, Briefglance reported. A single dental implant runs from £1,500 to £3,000 in the United Kingdom and from €2,200 to €3,800 in Germany, the piece said, while a full-arch "All-on-4" restoration can exceed £12,000 per arch in Britain. Albanian clinics advertise the same work for far less. Alba Med Health lists single implants with a crown from €750 and All-on-4 restorations from €3,990 per arch. Those packages often fold in consultations, materials, post-operative care, a hotel and airport transfers, the piece said, for patient savings of 50 to 80 per cent. Jon Joro, the owner of Alba Med Health, tied the gap to running costs. The clinic can "price procedures significantly below Western European clinic rates", Joro said, while buying from the same implant makers and material suppliers. Direct flights from major European cities, Briefglance reported, make the trip short enough to book around a fortnight's care. These are advertised clinic rates rather than audited averages, and the piece named few sources beyond the clinic itself. ## Standards and the EU bid Albania's rise rests on investment in dental tourism infrastructure, Briefglance reported, with the dental sector leading it. The country's status as an EU candidate nation has pushed clinics to line up their practices with European standards. Many facilities in Tirana run 3D imaging, CAD/CAM systems and digital impressions, the piece said. The workforce is part of the pitch. Many Albanian dentists trained at universities in Italy, Germany and the United Kingdom before returning home, and clinics present that training as the basis for patient trust. Reputable clinics also point to the paperwork of safety. Those linked to Alba Med Health follow ISO sterilisation protocols and use EU CE-certified materials and implants from brands such as Straumann and Nobel Biocare, Briefglance reported. Patients receive a written treatment plan and a warranty before they travel. Some clinicians hold membership of the International Team for Implantology. Support runs in English, Italian, German and French, and post-operative care continues by secure messaging once patients are home. ## First principles Dental tourism follows the oldest driver in medical travel, which is price. It moves when a routine, high-cost, largely elective procedure costs several times more at home than abroad, and implant work fits that description in Britain and Germany. Implant work is largely elective and only partly covered by state health systems in the United Kingdom and Germany, which is why patients weigh a flight to Tirana against the bill at home. That makes the flow real but also fragile, because a destination built on price competes with every other low-cost destination on the same axis. Albania is not the only European cluster selling implants at a discount. [Türkiye is fighting European rival campaigns](/news/turkiyes-strategic-ascent-in-medical-tourism-navigating-global-competition-and-perception-challenges/) on cost and perception, and [Vietnam is drawing implant patients](/news/elevating-dental-tourism-in-vietnam-integrated-care-models-attract-global-patients-seeking-quality-and-predictability/) with the same integrated-care pitch. The standards work, the ISO protocols and the CE-certified materials and the warranties, is what separates a durable dental tourism hub from a price war. ## What to watch The test is the 2026 figure. Albania's dental tourism claim rests on passing 100,000 international patients that year, up from the 80,000 the piece reported for 2024, and that count will show whether the growth held or the projection ran ahead of it. Two other markers are worth tracking. One is whether Albanian clinic standards keep converging with EU rules as the candidacy advances. The other is whether the advertised savings of 50 to 80 per cent survive once complications and revision work are counted rather than quoted. The figures come from a promotional source and from the clinics, and the hub that publishes independent outcomes will be the one that keeps the patients it wins.

Celebrities Drive Beauty Tourism to Seoul and Dubai

editorial@health-tourism-news.com (Christian El-Khouri) — Thu, 14 May 2026 00:00:00 GMT

A cluster of famous names has made beauty tourism impossible to ignore. Charlotte Observer reported that Kim Kardashian, Gwyneth Paltrow, Rachel Brosnahan, and Eva Longoria have all travelled abroad for aesthetic and wellness treatments, and that their trips have drawn fresh attention to beauty tourism destinations from Seoul to Dubai to luxury retreats in Italy and California. The practice is simple to describe. Patients fly abroad specifically for cosmetic and aesthetic care, from skincare and injectables at one end to surgical work such as rhinoplasty and body contouring at the other. Charlotte Observer reported that South Korea and Turkey rank among the most recognised beauty tourism hubs, while the United States still draws international patients for highly specialised care. A Chicago facial plastic surgeon told the outlet that his practice sees many patients from western Europe, including Spain, Ireland, Italy, and Greece, and added that "People are willing to travel for a super-specialist." The common thread across the trend is that patients want specialist expertise, privacy, and treatments they believe are more advanced or more exclusive than what they can find at home. The celebrity examples follow the same pattern. Kim Kardashian documented a visit to a high-end clinic in Seoul's Hannam-dong district, sharing steps of a multi-stage aesthetic protocol on social media alongside her sister Khloé Kardashian. Gwyneth Paltrow has tied her wellness brand Goop to a luxury longevity retreat in Italy that blends medical-grade aesthetics with spa and nutrition. Rachel Brosnahan described a week at a California wellness retreat built around hiking and plant-based food as a restorative reset. Eva Longoria makes repeat trips to a Dubai aesthetic clinic for injectables and laser treatments, and has said publicly that she returns for the doctor and the staff rather than for any single procedure. ## Cosmetic tourism and the celebrity effect Beauty tourism is really two segments wearing one label, and the distinction matters. Most of what these trips involve is cosmetic tourism, which is medically performed but aesthetically motivated, and which sits across the line between medical and wellness travel. Injectables, lasers, rhinoplasty, and body contouring are clinical procedures with clinical risks, even when the motive is appearance rather than illness. Cosmetic tourism belongs at the medical end of the health tourism spectrum, and it should be judged on the same terms as any medical travel, on outcomes, on the operator, and on what happens when something goes wrong. The celebrity layer changes the marketing, not the medicine. When a public figure shares a clinic visit with millions of followers, the clinic gains a form of advertising that no accreditation can buy, and the destination gains a halo. That visibility is powerful and largely unearned in clinical terms. A social-media post shows the topical anaesthesia and the facial mask, but it does not show the surgeon's complication rate, the redress available if a result disappoints, or the follow-up care once the patient flies home. The gap between the visible glamour and the invisible clinical detail is where beauty tourism gets risky for the people who copy it. ## Where wellness retreats sit on the spectrum Not every celebrity trip in this story is cosmetic. Some sit at the wellness end of the spectrum, where the traveller is already well and is buying rest, fitness, and reset rather than treatment. The Italian longevity retreat and the California wellness ranch are wellness tourism, low in clinical intervention, high in hospitality, and sold on lifestyle. Wellness and longevity are borrowed-authority domains, so the honest framing is to report what these retreats promise and let them own the science they claim. A week of hiking and plant-based meals is a pleasant and probably healthy holiday. It is not a medical intervention, and the longevity language wrapped around some of these stays runs well ahead of the evidence. The two ends often blur inside a single trip, which is exactly why the spectrum is more useful than a binary. A Seoul visit may combine regenerative and aesthetic procedures with spa-style dermatology. An Italian retreat may pair medical-grade skin treatments with nutrition and recovery. The traveller experiences one continuous stay, but the clinical risk lives only in the parts where a needle, a laser, or a scalpel is involved, and that is the part a glossy social-media post is least likely to show. ## What the trend means for patients and clinics For clinics in Seoul, Dubai, and beyond, celebrity beauty tourism is a gift and a trap. The gift is demand, because affluent international patients follow the destinations that famous clients make aspirational. The trap is that a business built on discretion and celebrity endorsement is not the same as a business built on verifiable outcomes, and the two can drift apart. A clinic that markets on who visits rather than on what it can prove is selling visibility over trust, and that is the oldest weakness in the whole medical travel trade. For ordinary patients tempted to follow, the source's own caution is the right one. Charlotte Observer reported that clinic choice, doctor credentials, and independent research matter most for safety in international treatment, and that advice deserves repeating. A celebrity can absorb a bad result with private aftercare and a publicist. A regular patient who flies home to a different health system carries the clinical risk, the redress risk, and the continuity-of-care risk alone. Beauty tourism is a real and growing market, and Seoul, Dubai, Italy, and California will keep drawing patients who want what the famous appear to have. The sensible ones will buy the specialist and the safety record, not the social-media caption.

Fiji Airways Launches FlyWell In-Flight Wellness Programme

editorial@health-tourism-news.com (Christian El-Khouri) — Thu, 14 May 2026 00:00:00 GMT

Fiji Airways is turning the long-haul cabin into a wellness product. Travel Nine Australia reported that the airline will launch a programme called FlyWell next month for passengers on long-haul flights to the USA, with the stated aim of improving passenger and crew well-being in the air. FlyWell brings together wearable technology, mental performance drinks, red light therapy, and what the airline calls electromagnetic protection, and Fiji Airways describes every component as science-backed. The products will go first to Business Class guests, free for the first two months, and then move to paid purchase in the third month. Once on board, Travel Nine Australia reported, Business Class guests receive a wellness menu and choose items to suit them. Two offerings anchor the launch. One is a device worn on the lower leg that is meant to promote circulation, cut fatigue, and speed recovery on long flights. The other is a pair of glasses called Sunset Lenses, which the airline says regulate cabin light exposure to support natural sleep cycles and encourage rest in flight. Fiji Airways will also fit its Premier Lounge with electromagnetic field protection, which the airline says reduces exposure from phones, laptops, and WiFi that can affect the nervous system. Fiji Airways managing director and chief executive Paul Scurrah said FlyWell reflects a belief that "the journey should be part of the experience". The programme was built with Da Rulk, a performance and recovery specialist who works with elite athletes, and Da Rulk framed the goal as giving travellers practical tools that support the body in flight. ## Where FlyWell sits on the health tourism spectrum Health tourism is a spectrum, not a binary, and FlyWell sits firmly at the wellness end of it. There is no clinician, no diagnosis, and no treatment of a medical condition. The traveller is already well and is buying comfort, recovery, and the feeling of arriving in better shape. That places FlyWell in wellness tourism, the low-intervention part of the spectrum where the setting is a cabin or a lounge rather than a hospital, and where the promise is lifestyle rather than cure. Wellness is a borrowed-authority domain for anyone who reports on medical travel, so the honest framing is to describe what the airline offers and let the airline own its claims. That distinction matters because the vocabulary of FlyWell borrows heavily from medicine. Circulation, recovery, circadian rhythm, and the nervous system are clinical terms, and red light therapy and electromagnetic protection carry a clinical air. None of that makes the amenities clinical care. A leg device that aids circulation on a long-haul flight is a comfort product, not a treatment, and the airline is careful to call the components science-backed rather than clinically proven. The gap between those two phrases is the whole story of consumer wellness. ## The science-backed question The science-backed label is doing a lot of work in this announcement, and it deserves scrutiny rather than applause. Some FlyWell elements rest on reasonable ground, because compression and movement do help circulation and lower the risk of deep-vein thrombosis on long-haul flights, and managing light exposure does influence melatonin, circadian rhythm, and sleep. Red light therapy, known in the research literature as photobiomodulation, shows promise in some studies but remains far from settled medicine. Other elements are softer. The claim that electromagnetic field protection in a lounge meaningfully reduces a health risk from phones and WiFi sits well ahead of the evidence, and mental performance drinks live in a category where marketing tends to outrun the trials. Fiji Airways is not unusual here. The wider wellness tourism market runs on exactly this blend of plausible physiology and confident language, and the operators who last are usually the ones that claim least and deliver most. For travellers, the sensible test is simple. Ask whether a wellness product would still be worth buying if the science-backed label were removed and it were sold purely as comfort. A leg-circulation device and better cabin light pass that test on their own merits. An anti-electromagnetic lounge does not, and pretending otherwise is where consumer wellness loses trust. ## What in-flight wellness signals for medical tourism FlyWell is a wellness launch, not a medical tourism story, but it matters to the medical tourism trade as a demand signal. When a national carrier packages recovery, sleep, and biohacking into a cabin, it is confirming that health-conscious travel has moved from niche to mainstream expectation. Patients who fly abroad for surgery, dental work, or fertility treatment increasingly expect the journey itself to be managed for well-being, and they judge a destination on the whole experience, not only the operating theatre. Hospitals and facilitators that treat the flight and the recovery stay as part of the product, rather than an afterthought, are reading the same signal Fiji Airways is reading. The caution for medical tourism operators is to keep the two categories clear. Wellness amenities are a fine complement to clinical care and a poor substitute for it. A patient choosing a hospital abroad should still weigh outcomes, accreditation, and continuity of care first, and treat the in-flight red light therapy as a pleasant extra rather than part of the medicine. FlyWell is a smart piece of experience design and a useful barometer of where travel is heading. It is not, and does not claim to be, healthcare.

Thailand and Bahrain Discuss Medical Tourism Cooperation

editorial@health-tourism-news.com (Christian El-Khouri) — Thu, 14 May 2026 00:00:00 GMT

Thailand and Bahrain used a meeting in Bangkok to put medical and wellness tourism near the heart of their economic agenda. Pattaya Mail reported that Thai Prime Minister Anutin Charnvirakul met the Bahraini Ambassador, Khalil Yaqoob AlKhayat, at Government House on 14 May. The two sides agreed to deepen ties across trade, investment, medical and wellness tourism, and food security, and they reviewed progress in bilateral relations as the two countries approach the 50th anniversary of diplomatic relations next year. The meeting framed Bahrain as an important partner for Thailand in the Middle East. Pattaya Mail reported that the economic talks aimed to raise trade volumes, encourage two-way investment, and promote private-sector exchanges, and that Bahrain was named as a potential gateway for Thai goods into the wider Middle Eastern market. On tourism, both sides noted that Thailand keeps drawing Bahraini visitors, including those who travel for medical services, and both backed further work in healthcare. Prime Minister Anutin also spoke to regional developments in the Middle East, and he urged dialogue and de-escalation to hold the peace. Both parties affirmed their readiness to keep up cooperation for mutual benefit and long-term relations. ## Medical tourism and the Gulf source market The healthcare line here matters more than a routine diplomatic readout suggests. Thailand has spent two decades building one of the most developed medical tourism sectors in Asia, and the Gulf has become one of its most reliable source markets. Bahraini patients sit inside a wider Gulf pattern, where patients cross a border for care that is better, faster, cheaper, or simply not on offer at home. Gulf patients travel for orthopaedic surgery, cardiac work, fertility treatment, and cosmetic procedures, and Thai hospitals have built service lines around exactly that demand. Thailand competes hard for it. A standing diplomatic tie is part of how a destination keeps a patient corridor open, and the Bahraini corridor is one more that Thailand wants to guard. Medical tourism and wellness tourism are not the same trade, and the meeting named both. Medical tourism sits at the clinical end, where Bahraini and other Gulf patients travel for care delivered in hospitals and accredited clinics and judged on outcomes and safety. Wellness tourism sits further along the spectrum, where the traveller improves an already-sound state through resorts, spas, and prevention rather than treatment. A Bahraini visitor may arrive for a hospital procedure, a resort recovery stay, or a package that blends the two. When a joint statement bundles medical and wellness tourism together, it is naming a real feature of how Thai destinations sell to Gulf patients. ## Bahrain, patient volume, and concentration risk Bahrain is a small market by Gulf standards, and its outbound patient volume is modest next to larger neighbours. One meeting will not move Thai hospital admissions on its own. The value of these talks is slower and structural. Steady bilateral contact reinforces the Bahraini patient pathways that already exist, keeps visa and travel arrangements predictable, and tells Thai operators that a Bahraini source market has official backing. Patient corridors are built on this kind of repeated, low-glamour work, and the destinations that hold their share tend to be the ones that keep up the diplomatic machinery behind it. There is a strategic reason for Thailand to court smaller Gulf states rather than lean on one big one. A destination that draws most of its foreign patients from a single source market carries concentration risk, and any shock to that market, whether economic, political, or regulatory, lands straight on hospital revenue. Spreading demand across several Gulf states, Bahrain among them, is a hedge against that exposure. The healthcare paragraph in this readout fits a broader Thai effort to widen the base of its medical tourism trade rather than deepen a reliance on any one country. ## What Thai operators should take from the talks For Thai hospital groups and the facilitators who route Gulf patients, the signal is continuity, not novelty. Nothing here changes a clinical pathway or a price. No new programme was announced. What the talks confirm is that medical and wellness tourism stay on the official agenda between the two governments, and that healthcare will keep travelling alongside trade and investment in the relationship. Operators that already serve Bahraini and other Gulf patients gain a modest reassurance that the policy setting is stable. Facilitators weighing whether to fund Arabic-language services, Gulf-facing marketing, or recovery packages for Bahraini and other Middle Eastern visitors can read the meeting as a small vote of confidence in the corridor. The larger lesson is one Thailand has learned over twenty years of selling medical travel. A destination brand is only as strong as the dull machinery underneath it: the visas, the flights, the bilateral goodwill, and the accredited hospitals that hold their standards. Meetings like this one in Bangkok rarely make headlines. They should not. They are the maintenance work that keeps a medical tourism corridor open, and Thailand has stayed a leading destination in part because it keeps doing that quiet work while its rivals chase the announcement.

Lagos Mandates Health Insurance to Curb Medical Tourism

editorial@health-tourism-news.com (Christian El-Khouri) — Wed, 13 May 2026 00:00:00 GMT

Lagos State's government has set out a package of healthcare reforms built around wider health insurance, a smaller funding gap and a reversal of outbound medical tourism, The Nation reported. Its commissioner for health, Akin Abayomi, announced the plan at the 2026 Ministerial Press Briefing at the Bagauda Kaltho Press Centre in Alausa, Ikeja, part of the events marking the seventh year in office of Governor Babajide Olusola Sanwo-Olu and Deputy Governor Kadri Obafemi Hamzat. Its stated route is mandatory health insurance and public-private partnership, and the aim is a Lagos that keeps its own patients at home. ## A financing gap behind the outbound flow Lagos allocates about eight per cent of its budget to health, The Nation reported, below the 15 per cent benchmark of the Abuja Declaration, and the commissioner put the gap between current allocations and projected need at an estimated N100 billion. Abayomi said the shortfall came from dwindling donor support and a growing population, and he said the remedy was two things, health insurance and public-private partnership. He said Nigeria's financing model was unsustainable, with about 77 per cent of health spending coming straight from patients' pockets and only two per cent routed through insurance. The push has a legal spine. Governor Sanwo-Olu domesticated the National Health Insurance Authority Act through an Executive Order signed on 16 July 2024, The Nation reported, making cover mandatory for every Lagos resident. Ministries, departments and agencies have begun enforcing it, asking residents to show evidence of accredited health insurance when they seek government services. More than 1.46 million residents have enrolled under the state's Ilera-Eko scheme, run by the Lagos State Health Management Agency, though universal coverage remains some way off. ## Reversing medical tourism through home capacity The reversal is the plan's headline. Under the Lagos 2052 Development Plan the state wants to rank among the top three healthcare destinations in Africa within a decade, The Nation reported, and Abayomi was blunt about the motive. Lagos does "not want Lagosians travelling abroad to seek healthcare," he said, naming Dubai, London, India and South Africa as the destinations it means to displace, and he set the goal of providing every speciality and subspeciality at home. Much of it rests on people. Approval has been granted for a standalone University of Medicine and Health Sciences in Lagos to lift the output of doctors, nurses, pharmacists and other health workers, The Nation reported. It will decentralise clinical training across primary, secondary and private facilities, and it will draw on diaspora specialists alongside the existing workforce. State officials are also redesigning and modernising infrastructure across facilities to improve patient experience and service delivery. ## Regulation and patient safety Patient safety carried its own warning. A special adviser to the governor on health, Kemi Ogunyemi, said the Health Facility Monitoring and Accreditation Agency, known as HEFAMAA, was central to policing standards across hospitals, cosmetic medical spas and other facilities, The Nation reported. She said residents should avoid any facility that does not display the HEFAMAA accreditation sign, and should report substandard practice. Dayo Lajide, permanent secretary at the state health ministry, commended health workers for holding up under mounting pressure on the system. ## The driver behind the outbound flow There is a clean way to read a plan like this. Patients leave home for one of five reasons, that care abroad is better, is the best available, is cheaper, is faster, or is simply not to be had at home. Nigeria's outbound flow runs mostly on the last of those. Lagosians travel to Dubai, London, India and South Africa for procedures and specialities the home system cannot yet supply at volume or with confidence. The maths here is stark. Outbound medical tourism on this scale is a symptom of underinvestment, and the figures Abayomi cited, eight per cent of budget against a 15 per cent benchmark and 77 per cent of spending out of pocket, describe the shortfall that sends patients to the airport. None of this is new. Read plainly, the reversal is an import-substitution of care. That framing sets the order of work. A destination is built from the inside out, and the dull machinery has to run before the brand can be sold. The brand comes last. Financing, workforce and regulation are that machinery, and they are what the plan names, the Ilera-Eko enrolment, the medical university and the accreditation regime. The ambition to rank among Africa's top three destinations is downstream of keeping Lagosians at home, and the sensible sequence is retention first and inbound marketing second. A state that has not yet reached universal coverage for its own residents is not ready to advertise for other countries' patients. ## What to watch The tests are specific. Enrolment under Ilera-Eko past 1.46 million, and the share of health spending it shifts away from patients' pockets, will show whether the financing plank holds. The first graduating cohorts from the University of Medicine and Health Sciences, and how many stay in Lagos rather than joining the diaspora the plan hopes to recruit back, will show whether the workforce plank holds. Enforcement is the third test, in whether ministries and agencies actually turn away residents who cannot show accredited cover. Reversing outbound medical tourism is a decade-long claim, and the arrival and departure figures, not the press briefing, will settle it.

Full Moon Tourism and Astrotourism Reshape Luxury Wellness Travel

editorial@health-tourism-news.com (Christian El-Khouri) — Wed, 13 May 2026 00:00:00 GMT

NSSG Club reported that a growing part of the wellness tourism market now plans travel around the lunar calendar, in a trend it called full moon tourism. Holidays are being booked to fall on the full moon rather than around weather or price, the piece said. Luxury hotels, spa resorts and astronomical glamping sites are building whole experiences around lunar cycles. The Global Wellness Institute forecasts that the wellness tourism market will pass $1.4 trillion by 2027, and NSSG Club placed lunar wellness travel inside that growth. ## What full moon tourism books Full moon tourism means timing a trip or a treatment to the full moon, NSSG Club reported. Travellers pick departure dates from the lunar calendar and reserve resorts in deserts or mountains for a clear view of the sky. On site they join emotional-release ceremonies, sound baths, night meditation and full moon yoga. The piece placed the trend inside noctourism, where the night rather than the sun becomes the point of the trip. Mii Amo, a resort in Sedona, Arizona, runs a "Spirit of the Full Moon" treatment in the days around the full moon, NSSG Club reported. It opens with a sage cleansing ceremony, in which guests write down fears or stale thoughts and burn them, and follows with a full-body massage in sage oil. Similar programmes now run widely, from gratitude meditations and astrological journaling to Tibetan bowl sound baths and full moon yoga. In California, the Surf & Sand Resort in Laguna Beach holds a monthly moonlight yoga session. Enchantment, also in Sedona, runs night hikes through Boynton Canyon by moonlight. In Greece, Cape Sounio offers night excursions and sea bathing as the moon rises behind the Temple of Poseidon. Hotel Californian in Santa Barbara marks the full moon with DJ sets, themed cocktails and tarot readings. ## From biohacking to the night sky NSSG Club framed the trend as a turn away from clinical wellness. Modern wellness culture is moving from supplements, longevity clinics and biohacking toward symbolic, ritual and contemplative practice, the piece said. Luxury spas are folding in full moon ceremonies, singing-bowl sound baths, chakra work and guided meditation under the stars. The full moon, in the piece's account, stands in as a monthly emotional reset. The appeal rests partly on the sky itself. A 2016 study linked stargazing to a sense of flow, fascination and a loss of the sense of time, NSSG Club reported, and suggested that "star bathing" could grow as familiar as forest bathing. Away from city light, the piece said, the night sky offers a rare stretch of mental space in a crowded, always-connected world. ## Astrotourism widens the market Full moon tourism sits inside a wider rise in astrotourism, NSSG Club reported, which centres on watching the sky where light pollution is low. Astrotourists head for deserts, mountains, remote islands and certified dark-sky reserves, often staying in transparent domes or glamping sites. Chile's Atacama Desert, Namibia and Finnish Lapland are leading destinations, the piece said, and Joshua Tree in California pairs desert scenery with dark skies. A related strand, astrological tourism, plans trips around birth charts, planetary transits and astrocartography. Booking.com has noted a rising share of travellers, especially Gen Z and millennials, who weigh solstices, eclipses or full moons when they plan a holiday. The list of destinations runs wide, and Italy is the newest entry. NSSG Club reported that Italian regions from Tuscany to Sicily are now marketed for lunar wellness travel, with set-piece outings such as a "Full Moon from the Sea" excursion on the Adriatic coast. The same experiential turn is showing up elsewhere in the trade, from resorts that [sell wellness as the new luxury](/news/thailand-s-strategic-evolution-redefining-luxury-in-global-health-and-wellness-tourism/) to survey work on [what wellness clients now want](/news/rising-patient-demand/). The through-line is that people are paying for a mood and a setting as much as for a treatment. ## What to watch The reporting is a lifestyle trend feature, and its hard numbers come from the Global Wellness Institute and Booking.com rather than from booking data for lunar trips, so the size of full moon tourism cannot be read off this piece. Most of what it describes is existing spa and hotel capacity rebranded around the lunar calendar, which is cheap to announce and hard to fill on a fixed date. The test is repetition. The destinations that turn a single full moon event into a standing line of business will show it in occupancy on the nights around each full moon, and the ones that ran a one-off will not. Whether lunar wellness travel shows up as a measurable segment when the Global Wellness Institute next sizes the wellness tourism market will be the clearer signal than any single resort's programme.

Seoul Casino Operator Signs Medical Tourism Deal

editorial@health-tourism-news.com (Christian El-Khouri) — Wed, 13 May 2026 00:00:00 GMT

Grand Korea Leisure, the state-run operator of Seven Luck Casino, has signed a memorandum of understanding with the Korea Medical Tourism Association. That deal folds medical tourism content into the experience the casino sells to its foreign-only customers, Sedaily reported. Its stated aim is to lengthen visitor stays and lift overall tourism spending in South Korea. The agreement was signed on Wednesday, 12 May 2026, at the Korea Medical Tourism Association's main conference room in Seocho-gu, Seoul. It seeks to generate fresh tourism demand by tying medical, cultural and tourism content together for the international guests who already pass through Seven Luck. The move widens the casino visit beyond shopping and lodging to take in medical and wellness offerings, Sedaily reported. Under the memorandum, the two partners will jointly develop medical, cultural and tourism-linked products for foreign visitors. They will also run combined marketing and promotion behind them. The agreement provides for continuing information exchange and network cooperation meant to invigorate tourism. It frames South Korea as a destination that pairs entertainment with health services for an inbound audience it already holds. ## Staff training and a medical tourism theme hall Two concrete initiatives sit inside the memorandum. From June, the association will run "K-Wellness & Hospitality" training for the operator's customer service staff, Sedaily reported. This programme is meant to sharpen their grasp of medical tourism products for foreign visitors and to improve on-site service. Grand Korea Leisure also plans to build and operate a "K-Medical Tourism Theme Hall" at Seven Luck Casino. The hall is a dedicated space where visitors sample medical tourism content directly rather than read about it. Grand Korea Leisure's president, Yoon Doo-hyeon, tied the agreement to spending and satisfaction. He said the casino would provide "differentiated content to foreign visitors of Seven Luck." He added that the operator would keep working to expand tourism spending and improve regional tourism infrastructure through public-private cooperation, Sedaily reported. The framing is deliberate, and it treats the casino's existing foreign footfall as a source market for medical tourism rather than a new one to be won. ## Where a casino sits on the health tourism spectrum Health tourism is best read as a spectrum rather than a binary. It runs from high clinical involvement at one end to self-guided wellness at the other, with hybrid forms such as longevity medicine, reproductive care bundled with a recovery stay, or an elective procedure paired with rehabilitation blurring the middle. A theme hall and a hospitality-training programme sit near the low-involvement end, where they introduce, market and refer, but do not diagnose or treat. What the two partners have described is a demand-generation channel, a way of converting a captive leisure audience into medical tourism enquiries. The clinical work still happens somewhere else, in an accredited hospital or clinic that the memorandum as reported does not name. That distinction matters, because the value of medical tourism is settled at the clinical end, on outcomes and safety, and not at the point of first contact. A casino can raise awareness of medical tourism among foreign visitors it already serves, and it can shorten the distance between a leisure trip and a consultation. It cannot stand behind the result of a procedure. The standing risk in any facilitation channel, whether a theme hall, an agency or an app, is that it sells visibility rather than trust, and steers patients by who is promoted rather than by who is safe. A theme hall is only as sound as the referral pathway behind it, and the reported agreement describes the shop window and not the clinic. ## The wellness end sets the near-term ceiling The wellness end of this deal deserves naming precisely. Wellness tourism carries little clinical supervision and works on an already-sound state of health through prevention and lifestyle rather than treatment. It tends to sit in resorts and spas rather than in hospitals, and a casino programme branded around "K-Wellness" points squarely at that end. This is not a criticism, because wellness and cosmetic care are the most natural entry points for a leisure audience. They carry a foreign visitor from an evening at the tables toward a spa, a dermatology clinic or a diagnostics screening far more readily than toward cardiac, oncology or orthopaedic surgery. That reading sets a ceiling on what the memorandum can deliver in its first year, and the ceiling is a fair test of the deal. ## What operators should watch The test here is measurable and close. Grand Korea Leisure's own figures will show, within a year, whether casino visitors introduced to medical tourism content actually book procedures, or whether the hall works as branding that lengthens a stay by an afternoon. The June training cohort is the first checkpoint, and the theme hall's early visitor engagement is the second. A programme that produces enquiries but no completed treatments has built a marketing asset rather than a medical tourism channel. A concentration point is also worth holding. Grand Korea Leisure is building this on foreign-only casino customers, a single and self-selected source market, and the mix of that market decides the mix of medical tourism demand it can generate. A source market chosen for its appetite for gaming is not obviously the same one that seeks oncology, cardiac or orthopaedic care. Wellness and cosmetic care are the likelier near-term fit. For an operator that already holds the inbound audience, the sensible move is dull. It is to track how many enquiries convert, which specialities they convert into, from dermatology and dentistry to oncology, and whether the accredited providers behind the referral can absorb them. The memorandum sets the shop window, and the arrival figures will show whether anyone walks through to the clinic.

Thailand Expands Longevity and Healthspan Tourism

editorial@health-tourism-news.com (Christian El-Khouri) — Wed, 13 May 2026 00:00:00 GMT

Thailand wants its next wave of medical tourists to come for extra years of good health. Thailand's official government portal reported that the country is widening its medical tourism focus toward longevity travel, with new programmes and visa changes arriving by 2026, and that the aim is to draw international visitors who want to improve their healthspan. Healthspan is the number of years a person lives in good health, rather than simply the number of years lived. The portal tied the shift to a fast-ageing population at home and a wider move toward proactive health, built on personalised nutrition, regular check-ups, mental well-being, and early action on chronic disease. The portal reported that Thailand's long-running Medical Hub strategy has grown into a broader wellness message. Under that banner, the Tourism Authority of Thailand now promotes the idea that "Healing is the New Luxury", and it sells a mix of advanced healthcare, resort-style hospitality, and cultural habits said to support long-term well-being. Bangkok is the centre of this push. The portal described modern longevity clinics in the capital that use artificial intelligence, cloud systems, predictive diagnostics, precision medicine, and regenerative treatments, with programmes shaped around each visitor's goals, lifestyle, and length of stay. One physician-led longevity house in Bangkok offers fly-in options that run from a one-day executive health audit to a seven-day regeneration programme. The offer spreads well beyond Bangkok. The portal cast Bangkok as a precision-medicine hub for treatments such as hyperbaric oxygen therapy, stem-cell applications, and ozone therapy in an urban setting. It placed Chiang Mai as a home for slow living and nervous-system recovery, where wellness resorts blend mindfulness, forest bathing, and modern physiotherapy for retirees and working professionals. It described established wellness resorts in Hua Hin and Ko Samui that pair hospitality with biohacking rooms such as cold plunges and infrared saunas. It cast Phuket as a beach base for biohacking retreats offering NAD therapy, stem-cell rejuvenation, and biological-age testing. Two practical facts sit underneath the marketing. The portal reported that streamlined medical visas now let foreign patients and their companions stay for up to 90 days, with multiple entries allowed, which matters because regenerative programmes often need longer or repeat visits. It also reported a cost claim, that in 2026 a full longevity assessment in Bangkok, with full-body scans and genomic sequencing, is estimated to cost around 60 per cent less than in the United States or Europe. Alongside those two facts, the portal added softer selling points too, from almsgiving as a source of daily purpose to Thai dishes rich in galangal, turmeric, and lemongrass, ingredients linked to anti-inflammatory benefits. ## Healthspan tourism between medicine and marketing Longevity tourism is the newest hybrid on the health tourism spectrum, and it is the hardest to read honestly. It borrows the language and setting of medicine, the scans, the clinics, the physician-led programmes, but much of what it sells is prevention and lifestyle rather than treatment of a diagnosed condition. That makes longevity a borrowed-authority field, and the fair way to report it is to separate the parts that rest on evidence from the parts that rest on hope. Some of the menu is sound. Full-body diagnostics, genomic testing, and structured lifestyle change have real clinical value when a doctor acts on the results. Other parts of the menu sit well ahead of the evidence. NAD therapy, ozone therapy, and hyperbaric oxygen are marketed for longevity far more confidently than the trials support, and biological-age testing is a young science that can promise more than it can yet deliver. None of this is unique to Thailand. The global longevity market runs on exactly this blend of real diagnostics and speculative add-ons, and the honest operator is the one who tells a visitor which is which. A genomic scan is medicine. An infrared sauna is a nice afternoon. ## Where longevity tourism sits on the spectrum The spectrum is the useful frame here, because a single Thai itinerary can cross it end to end. A visitor might start with a hospital-grade assessment in Bangkok, high in clinical involvement, and finish with forest bathing in Chiang Mai, low in clinical involvement and firmly in wellness. Both are sold as longevity, but only one carries clinical risk and clinical value. Thailand has always marketed across that whole spectrum, from its Medical Hub hospitals at the clinical end to its spa resorts at the wellness end, and healthspan is the label that now ties the two together. For the visitor, the spectrum is also a buying guide. The clinical end deserves the same scrutiny as any medical travel, on the operator, the outcomes, and the follow-up care back home. The wellness end can be judged as a holiday, enjoyable and probably good for you, without pretending it is treatment. One mistake is to pay clinical prices for wellness marketing, or to drop clinical caution because a programme is wrapped in spa branding. ## What Thailand gets right, and the risk Strip away the biohacking gloss and Thailand's real advantage is unglamorous and durable. The 90-day multi-entry visa is a genuine structural edge, because longevity programmes need time and repeat visits, and most rival destinations have not fixed that plumbing. A cost gap on serious diagnostics is a real draw for the visitor, if the government's 60 per cent estimate holds up. And two decades of Medical Hub investment mean the hospitals, the specialists, and the accredited infrastructure already exist. Thailand fixed the dull machinery first, then built the brand on top, which is the right order and the one most aspiring destinations get backwards. The risk is overclaiming. A longevity brand that leans too hard on unproven therapies invites the same backlash that has dogged wellness marketing elsewhere, and a single high-profile disappointment travels fast among affluent patients. Thailand's smartest move is to sell what it can prove, the diagnostics, the specialists, the cost, and the visa, and to let the sauna and the turmeric be pleasant extras rather than the headline. Healthspan is a strong story for Thailand. It is strongest when it stays closer to medicine than to marketing.

NOHIL Cuts Nigeria's Outbound Orthopaedic Medical Tourism

editorial@health-tourism-news.com (Christian El-Khouri) — Mon, 11 May 2026 00:00:00 GMT

The National Orthopaedic Hospital, Igbobi, in Lagos has cut Nigeria's outbound medical tourism for orthopaedic and trauma care over eight decades of work, its medical director said, The Nation reported. Dr Wakeel Lawal set out the hospital's record in specialised care, workforce training and medical education at a press conference in Lagos, held ahead of the hospital's 80th anniversary. Known as NOHIL, the hospital opened in 1945 as a rehabilitation centre for soldiers injured in the Second World War, and it has grown into a leading orthopaedic and trauma centre for Nigeria and the wider West African sub-region. ## Specialised services and outcomes NOHIL now runs a range of specialised services that let it handle cases once sent abroad, The Nation reported. These take in joint replacement surgery, minimally invasive spine surgery, deformity correction, orthopaedic oncology, arthroscopy, sports medicine, and plastic and reconstructive surgery. A decade or fifteen years ago most joint replacements, deformity corrections and complex trauma cases went overseas, Lawal said, and today "we can confidently manage such procedures in Nigeria with excellent outcomes." He described NOHIL as a national referral centre. ## A training pipeline behind the numbers Much of the hospital's weight sits in training. More than 70 per cent of the orthopaedic surgeons practising in Nigeria were trained at NOHIL, The Nation reported, and the hospital runs subspecialty programmes and works with international partners so that its surgeons meet global standards. It also trains allied staff through its College of Nursing Sciences, projected to graduate nearly 100 students next year, and its Federal College of Orthopaedic Technology, which teaches prosthetics, orthotics and orthopaedic cast technology. NOHIL is among the country's main sites for fabricating these devices for patients with limb challenges. ## Challenges, cost and expansion Beyond the wards, NOHIL runs medical outreaches, free surgeries for poor patients and public health campaigns, The Nation reported, and it has brought in appointment booking to ease overcrowding and long waits. The hospital still faces inadequate infrastructure, funding limits and a shortage of health workers. Lawal said NOHIL spends between N50 million and N60 million each month on electricity alone, and struggles with equipment maintenance and upgrades. To meet rising demand it is expanding its accident and emergency complex, its rehabilitation centre and its outpatient department, and Lawal appealed to government, donors and companies for support, acknowledging past gifts of wards, staff quarters and patient hostels. ## The 80th anniversary The anniversary programme runs to thanksgiving services, awareness walks, community outreach and lectures, with the main event set for May 24, The Nation reported. Former Lagos State governor Babatunde Fashola is expected to speak, and the Minister of State for Health and Social Welfare, Iziaq Salako, will attend as guest of honour. Dr Francis Nwachukwu, the head of clinical services, said the outreach would offer free health screening, along with orthopaedic consultations and referrals. ## Patient retention follows specialist retention There is a lesson in the order NOHIL describes. Patients leave home for care that is better, best, cheaper, faster or simply not to be had, and complex bone and trauma work sat for years in that last box for Nigeria. Closing it did not start with a marketing campaign. It started with surgeons. This is a simple point, and it is easy to miss. It takes a generation, and it takes money. The figure that carries the story is not a patient count but a training one, that more than 70 per cent of the country's orthopaedic surgeons passed through NOHIL, because patient retention follows specialist retention. A country keeps its joint-replacement and spine cases at home only once it has the surgeons, the operating theatres and the fitting rooms to take them. NOHIL has spent 80 years building that stock, and there is no fast way to build it. That is the lasting way to keep care at home, and it holds across borders. A hospital that trains most of a nation's specialists in a field becomes the first place patients are sent in that field, and the flow abroad shrinks as a result. The claim can be tested, and it is a strong one. It predicts that the fields where Nigeria still loses patients abroad are the ones with no NOHIL-scale training base behind them. There is a wider point here, and it is easy to state. Money and new buildings move fast, but people do not. A new wing can go up in a year, and a machine can be bought and shipped in months. A surgeon takes ten years to train, and a whole class of them takes far longer than that. So the places that keep their patients at home are the ones that started on the slow work early. NOHIL started in 1945. That gap in time is the real edge, and it is why the training number matters more than the building plans. ## The dull machinery before the brand NOHIL's stated aim is to become a globally competitive orthopaedic centre. That would turn a hospital that stops patients leaving into one that draws them from abroad. The gap between those two is measured in the plain items on Lawal's own list. A hospital that spends up to N60 million a month on power alone, and struggles to keep its equipment running, is not yet ready to advertise for foreign patients, however good its surgeons. The money is the hard part here, not the will. A destination is built from the dull machinery first, from power, staffing and safe standards, and only then from the brand. The sensible reading is that NOHIL has already done the harder half. It has changed where Nigerian patients are treated, a shift in habit and in medicine that takes decades, and it holds the training base to keep the gain. That is a fair place to stand, but it is only half of the job. The tests from here are plain. Whether the expanded emergency, rehabilitation and outpatient units open on schedule will show if the buildings are catching up to the clinical record. Whether the power and equipment problems ease will show if the machinery can carry that aim. And the share of Nigeria's orthopaedic surgeons trained at NOHIL, tracked over the next decade, will show whether the pipeline that closed the outbound flow can widen into the other fields where patients still travel.

Querétaro Medical Tourism Hub to Open in 2027

editorial@health-tourism-news.com (Christian El-Khouri) — Mon, 11 May 2026 00:00:00 GMT

A US$145 million medical complex in Querétaro is betting that a Mexican city better known for aerospace and car plants can become a medical tourism hub, Mexico News Daily reported. The St. Austin Medical District, a 2.5 billion peso development that is about 35 per cent built, is due to open in September 2027 and means to compete for North American private patients with established centres in Houston, Rochester, Tijuana and Mexico City. It is being developed by Solidity Group Investments and Pómpano Desarrollos along the Fray Junípero Serra corridor, one of the fastest-growing urban and financial districts in the state. ## What the medical district will contain The clinical core is a two-storey hospital of more than 4,500 square metres, Mexico News Daily reported, with six operating rooms, an imaging area, clinical laboratories and over 50 rooms for inpatient care. Beside it sits a 2,000 square metre speciality centre holding 180 consulting rooms, with dental, metabolic and physical rehabilitation clinics and a research unit focused on regenerative medicine. Commercial space makes up the rest of the plan. It will also carry 54 commercial premises, a hotel and more than 600 underground parking spaces, Mexico News Daily reported. That mix, a mid-sized hospital wrapped in retail, lodging and parking, is worth holding in view, because it says something about the kind of project this is. ## Internationalisation through referral networks Cross-border reach is the stated strategy. St. Austin plans to connect abroad through an alliance with an international care network, and to sign medical networks and hospital agreements across the United States and Latin America, Mexico News Daily reported, arrangements meant to move patient referrals, clinical training and joint work in various specialities. Daniel Rifel, the chief executive of Solidity Group Investments, told Forbes México that the project would place Querétaro in a network with international reach, at a time when medical tourism and "the mobility of high-profile patients grow year after year." ## Why Querétaro Rifel said the location was chosen for reasons that have little to do with medicine. He pointed to the city's economic growth on the back of nearshoring, to industrial stability from the state's aerospace and automotive sectors, and to security conditions and tourist appeal for Mexican nationals and visitors from the United States and Canada. He said the state's stability showed legal certainty and favourable conditions for investment across successive administrations, Mexico News Daily reported. ## A property play with a hospital at its centre There is a familiar question to ask of any new destination, which is whether the dull machinery has been built before the brand. A destination is made from clinical outcomes, accreditation and continuity of care, and only afterwards from buildings. The composition of St. Austin puts the question sharply. Six operating rooms and 50 inpatient rooms sit alongside 54 commercial premises, a hotel and 600 parking spaces, and the property programme is the larger part of the plan. That is not disqualifying, because a hospital anchor can carry retail and lodging that serve patients and their families. It does mean the medical claim rests on a fairly small clinical footprint. A six-theatre hospital is a district clinic in scale, not a match for the institutions in Houston or Rochester that St. Austin names as rivals. Those rivals compete on reputation and results built over decades, not on square metres opened in 2027. Houston and Rochester draw patients because their outcomes and their accreditation are trusted, and a new building in Querétaro cannot buy that in its first year. The honest near-term comparison is not with them, but with the private hospitals of Mexico City and Tijuana, and with Querétaro's own rising demand. ## Who actually fills the beds first That demand thesis is worth separating out. Rifel's own reasons for choosing Querétaro, nearshoring, aerospace and automotive, describe a booming regional economy with a growing professional population and a stream of North American business travellers. That is a strong case for private domestic and regional care, and a weaker one for classic inbound medical tourism, in which a patient flies from the United States for a specialised procedure. Dental and cosmetic work, which are price-led and among the most elastic segments, are the likeliest cross-border draw in the early years. The regenerative medicine unit sits at the emerging, less proven end, where claims should be read with care. The specialised hospital work that would justify competing with Houston will take longer to build, and it rests on accreditation and outcomes data that a 2027 opening cannot yet show. ## What to watch The tests are concrete. The first is whether St. Austin secures the international accreditation that North American patients and their insurers look for, because without it the medical tourism claim is marketing. The second is the balance of patients once the doors open, in how many come from within Mexico against how many fly in from the United States and Canada. The third is the mix of specialities that fill the 180 consulting rooms, and whether they reach past dental, cosmetic and rehabilitation work into the complex surgery the district advertises. A September 2027 opening gives a clear date to measure against, and the patient mix, not the ribbon-cutting, will show whether Querétaro has built a medical tourism hub or a well-located private hospital with shops attached.

Indonesia Medical Tourism Targets Bangladeshi Patients

editorial@health-tourism-news.com (Christian El-Khouri) — Sun, 10 May 2026 00:00:00 GMT

Four Indonesian hospitals, among them Siloam Hospitals Group, joined the International Health Tourism and Services Expo in Dhaka from 7 to 9 May 2026, and the trip closed with a deal aimed at routing Bangladeshi patients toward Indonesia. Bangladesh Post reported that the Embassy of the Republic of Indonesia in Dhaka, known as KBRI Dhaka, arranged and backed the delegation as part of Indonesia's economic diplomacy in the health sector. The agreement was signed on 8 May 2026 between Siloam Hospitals Group and a Bangladeshi medical travel facilitator, and it sets out to draw patients from Bangladesh, a country of more than 170 million people, toward Indonesia as a medical destination. That last figure is the whole story. Bangladesh is one of the largest single source markets in South Asia, and its patients already travel in volume for care that is faster, cheaper, or simply not on offer at home. Indonesia now wants that outbound flow, with an embassy opening doors and a hospital group signing the deal. This is medical tourism as economic diplomacy. A state is trying to turn goodwill into booked patients. ## Indonesian hospital delegation in Dhaka Siloam Hospitals Group, a large private operator, travelled alongside three national public hospitals: the Dr Cipto Mangunkusumo National Referral Hospital, known as RSCM; the Harapan Kita National Cardiovascular Center; and the Dharmais National Cancer Hospital. That line-up is deliberate. Bangladesh Post reported that KBRI Dhaka set up the visit to show off Indonesian medical services and to build on an existing health pact between the two countries. One private group beside three specialist public centres tells a buyer what Indonesia wants to sell. Heart disease and cancer are high-value service lines, the kind of complex care that pushes patients across borders when waiting lists or skills fall short at home. Set those centres next to a private group that can handle flights, language, and aftercare, and you have a clear offer to a South Asian patient. Indonesia is not pitching wellness here. It is pitching hospitals. ## Economic diplomacy and the ministry meeting Bangladesh Post reported that at the Business Gathering and Networking Session on 7 May, the Ambassador of Indonesia to Bangladesh, Listyowati, said the event was about "building bridges and strengthening partnerships between the two countries." She cast the visit as a way to link hospitals in both countries through shared training and expertise, and as a chance to open new work in medical services, health tourism, and staffing. The envoy and the hospital delegates also paid a courtesy call on the Secretary of the Health Services Division at Bangladesh's Ministry of Health and Family Welfare. They talked over ways to deepen bilateral health ties and put real programmes in place. Talks at ministry level matter here. Outbound medical travel runs on referral paths, insurance rules, and visa terms that sit with government, not with any single hospital. ## Facility visits and the signed agreement The delegation also toured several hospitals in Bangladesh, among them national heart and neuroscience institutes and two private hospitals, a normal step in building the referral ties that move patients. The one hard output of the visit was the deal signed on 8 May 2026 between Siloam Hospitals Group and the Bangladeshi facilitator, which seeks to send patients from Bangladesh to Indonesian providers. That deal is where the diplomacy meets the facilitator, and the facilitator is worth a hard look. A facilitator is a middleman who markets a place and books the patient, and its pull is volume, not the outcome on the ward. It sells trust and logistics; its risk is that it trades on visibility rather than on real quality. For Siloam Hospitals Group, the channel only pays off if the patients it sends are treated well enough to spread word of mouth, because a market of 170 million rewards a good name and punishes a bad result faster than any brochure can mend. ## HTN analysis: what to watch The move is a state-backed push by Indonesia into one very large source market, and that focus is both its strength and its risk. Betting the plan on one neighbour of 170 million works while relations stay warm and bites when a visa rule, a currency swing, or a cold spell shifts the terms. The health pact and the meetings are scaffolding; the signed deal is the first load-bearing beam. The rest is intent until patients move. Three things will show whether it converts. First is volume, whether the Bangladeshi facilitator really sends patients to Siloam Hospitals Group across 2026 and 2027, and in which fields. Second is spread, whether RSCM, Harapan Kita, and Dharmais sign channels of their own rather than leaving one private group to carry the trade. Third is follow-through, whether the ministry talks yield real programmes on visas, referrals, and staff exchange, since those are the levers that turn a photographed handshake into a lasting patient corridor.

Korea Medical Tourism Nears 2 Million Foreign Patients

editorial@health-tourism-news.com (Christian El-Khouri) — Sun, 10 May 2026 00:00:00 GMT

Korea's medical tourism sector is projected to reach 2.01 million foreign patients in 2025, the first time annual arrivals have passed two million since national tracking began in 2009. Maeil Business Newspaper reported that the 2025 total would mark the third consecutive year of record foreign patient volumes. Recovery has been steep. Foreign patient numbers fell to 120,000 in 2020, climbed back to 610,000 in 2023, reached 1.17 million in 2024, and are forecast at 2.01 million in 2025. Since 2009, more than 7.06 million foreign patients have travelled to Korea for medical treatment. The curve tells a familiar story about medical tourism demand. Volume collapses when borders close. It then returns faster than domestic planners expect, because the drivers behind it do not go away. Patients travel for care that is better, cheaper, faster, or unavailable at home, and Korea has spent two decades building supply against all four. The 2.01 million projection is less a rebound than proof that Korea has rebuilt its foreign patient pipeline and pushed it past the pre-pandemic ceiling. ## Korea medical tourism economic impact The Korea Institute of Industrial Economics and Trade calculated that foreign patients and their companions spent KRW 12.5 trillion in Korea last year. Medical treatment accounted for KRW 3.3 trillion of that total, and the rest flowed into hotels, shopping, dining, wellness, and local tourism. Domestic production inducement from medical tourism is estimated at KRW 22.8 trillion. Foreign patients stay an average of 7.2 days and spend an average of KRW 7.75 million each. Those figures explain why Korea treats medical tourism as economic policy and not as a hospital revenue line. A patient who pays for treatment, then for hotels, retail, dining, and wellness across a week, generates trickle-down demand that a domestic patient does not. The bulk of it sits outside the clinic. The KRW 7.75 million average spend is the number that matters for positioning, because it ranks the market by yield rather than headcount and steers policy toward higher-spending foreign patients. ## Korea Tourism Organization marketing The Korea Tourism Organization, or KTO, has driven much of this growth through targeted international marketing. Maeil Business Newspaper reported that the KTO ran 17 overseas marketing sessions across 10 countries last year, each tuned to local treatment demand, and that these produced 12,882 consultations and KRW 19 billion in sales. For 2025 the KTO plans to expand to 20 sessions across 12 countries, adding the United States, Thailand, Uzbekistan, and Saudi Arabia as new target markets and reaching into second-tier cities beyond the main capitals. Lee Dong-seok, who leads the medical wellness team at the KTO, described medical tourism as "a high-value-added tourism sector" built on public-private cooperation. He said the organisation intends to diversify by country, region, and medical field, and to expand convergence products that combine medical care, wellness, shopping, and local tourism. The convergence language places Korea deliberately in the hybrid middle of the health tourism spectrum. A cardiology or oncology admission sits at the clinical, high-involvement end of that spectrum; skin care, K-beauty, and wellness add-ons sit toward the self-guided wellness end. Bundling the two is a yield strategy, because it lifts the per-patient spend figure and widens the market beyond patients with a strict clinical need. The mix is the point. ## Source markets and concentration risk China led foreign patient numbers last year with 619,000 visitors, followed by Japan with 600,000, and the two markets together supplied more than 60 per cent of the total. Taiwan grew sharply to 186,000 visitors, a 122.5 per cent rise on the year before, and the United States reached 173,000, its highest level since 2009. In Southeast Asia, Thailand recorded 58,000 medical tourists and Singapore 43,000, while Indonesia rose 104.6 per cent and Malaysia 106.8 per cent year on year. Two markets supplying more than 60 per cent of arrivals is concentration risk. It is the structural weakness behind the expansion plan. A destination economy that leans this heavily on China and Japan is exposed to a bilateral dispute, a currency swing, or a visa change in either market. That push into the United States, Saudi Arabia, and Uzbekistan reads as a deliberate hedge against the concentration, and the sharp growth in Taiwan and Southeast Asia suggests the diversification is already taking hold. Regional dispersal is happening inside Korea as well. Maeil Business Newspaper reported that non-metropolitan areas grew strongly last year, with Busan up 151.5 per cent, Jeju up 114.7 per cent, and Daegu up 31.4 per cent, spreading medical tourism beyond Seoul. The report also cited a high-value package for Mongolian government officials priced at KRW 2 million per person, pairing medical check-ups and skin care with sightseeing in Gyeongju, yachting in Haeundae, and K-beauty shopping in Daegu, an illustration of the convergence product the KTO is scaling. ## What to watch These projections are real, but they remain projections, and three tests will show whether the 2.01 million figure holds. Conversion is the first, whether marketing sessions in Saudi Arabia, Uzbekistan, and the United States turn into confirmed foreign patient volumes rather than consultations. Yield is the second, and it matters more, because Korea's economic case rests on the KRW 7.75 million average spend and not on headcount alone; watch which specialities draw the highest-spending patients from the Middle East and the United States. Durability is the third, whether growth in Busan, Jeju, and Daegu can decentralise medical tourism into a national capability rather than a Seoul concentration with regional spillover.

Malaysia's Medical Tourism Revenue Reopens a Specialist-Drain Debate

editorial@health-tourism-news.com (Christian El-Khouri) — Sun, 10 May 2026 00:00:00 GMT

Malaysia's medical tourism generated RM3.3bn in direct medical revenue last year and contributed to roughly RM13bn in total economic activity, Aliran reported. The figures have reopened a domestic argument over who benefits from that revenue, and at what cost to the public hospitals that train the country's doctors. The socialist party PSM has argued that the growth of medical tourism, by catering to foreign patients, risks diverting specialist doctors away from Malaysia's public hospitals. That argument runs against the more familiar case for medical tourism, which rests on the revenue and the jobs it brings in. Aliran, a Malaysian civil-society website, framed the question as one of distribution rather than headline growth, and gave the workforce objection most of its space. ## Where the doctors go The Malaysian Medical Association put a different reading on the same shortage. Its president, Dr R Thirunavukarasu, attributed the departure of doctors from the public sector mainly to problems inside that sector rather than to medical tourism. He cited limited career progression, a lack of transparency in promotions, and unsustainable workloads as the factors driving specialists out. On that reading the remedy is to repair the public system, the article said, rather than to restrict where doctors are allowed to work. The Malaysian Medical Association's account and PSM's account point in different directions from the same fact. Doctors are leaving public hospitals. Whether medical tourism pulls them out, or a strained public system pushes them, is the point in dispute, and the source settles it with argument rather than with figures. ## A question of who healthcare is for The Association for Welfare, Community and Dialogue took the argument further. The organisation argued that the problems in Malaysian healthcare run beyond structural faults to philosophical ones, and that care should be judged from the position of ordinary patients rather than that of providers. It argued that healthcare is a common good and a fundamental human right, and that adequate care should not depend on a patient's ability to pay. When access to the best care tracks the ability to pay, the organisation warned, the incentive shifts toward treating medicine as a business rather than as healing. That framing sets the moral terms of the debate, but it does not supply the operational numbers the debate needs. The organisation dealt in principle. PSM dealt in a specific claim about specialist movement. Neither produced a count of doctors who crossed from public wards to private ones. ## The multiplier and its limits Behind the RM13bn total sits a multiplier. Every ringgit spent on medical care generates around RM4 across the wider economy, Aliran reported, spread through hotels, airlines, restaurants, ground transport and retail. On that arithmetic the RM3.3bn in direct medical revenue last year produced the roughly RM13bn in total economic activity that the figures now cite. It is the same hospitality multiplier that has Malaysian [hoteliers preparing for the growth](/news/malaysia-s-strategic-ascent-how-medical-tourism-is-reshaping-its-global-hospitality-landscape-in-2026/) ahead of Visit Malaysia 2026. PSM's question is where that money lands. PSM asked whether public hospitals had seen any of it, given the movement of doctors toward the private hospitals that serve foreign patients. Official statements have stayed on the revenue side of the ledger; the finance minister has said medical tourism demand [stays strong despite a new consumer tax](/news/malaysias-medical-tourism-demand-remains-strong-says-finance-minister-amir-hamzah/), without addressing the workforce question PSM raised. ## A symptom, and the strategy under it Medical tourism revenue is easy to count and hard to place. The RM3.3bn in direct medical revenue is a real figure, recorded at the point of sale, and the RM4-per-ringgit multiplier is a standard tourism calculation. Neither number shows how much of the gain reaches the public hospitals, or how many specialists moved from public wards to private ones to earn it. That gap is the whole of the dispute. A specialist drain is a symptom, and the strategy question under it is whether a country plans its medical workforce across the public and private systems at once, or lets the higher-paying side recruit from the lower-paying one. Malaysia's public hospitals train the specialists, and its private hospitals bill the foreign patients, and the source offers no figure for how many doctors crossed between them. The specialist-drain claim is politically potent and, on the evidence supplied, factually unproven. Aliran concluded that structural reform in Malaysian healthcare is necessary but must rest on human dignity and social justice, rather than on revenue alone. The test of that is a set of numbers Malaysia has not published: how many public-sector specialists move into private medical tourism work each year, which specialities lose the most, and how much of the RM3.3bn is reinvested in public hospitals or in workforce training. Until those figures appear, the RM13bn total will keep being cited without a public ledger of who received it.

Nigeria Moves To Curb Military Medical Tourism

editorial@health-tourism-news.com (Christian El-Khouri) — Sat, 09 May 2026 00:00:00 GMT

Nigeria's Ministry of Defence plans to strengthen military healthcare and cut the Armed Forces' reliance on overseas medical treatment for its personnel. Gazettengr reported that the Minister of Defence, Christopher Musa, made the pledge during a visit to the African Medical Centre of Excellence, or AMCE, in Abuja, where he pressed the case for a self-reliant and efficient healthcare system for the military. The commitment came in a statement issued by Capt. Moses Yare for the Director of Information and Public Relations at the Ministry of Defence. The stated aim is to lift personnel welfare and build a resilient military healthcare system inside Nigeria. Read plainly, this is a source-country problem, not a destination pitch. Nigeria loses money and clinical continuity every time a soldier is flown abroad for care, and overseas medical treatment on that scale is a symptom of gaps in the health system at home. Patients, military or civilian, travel for treatment that is better, faster, cheaper, or simply unavailable locally, and Nigeria has long sat on the sending side of that trade. The plan is an attempt to close the gap by treating people in Nigeria rather than exporting them, which is a harder task than any single speech can deliver. ## Military healthcare focus areas Gazettengr reported that Mr Musa set out several priorities for military healthcare. The government wants better medical screening, earlier diagnosis, and stronger capacity to manage critical conditions, cardiovascular disease among them. He also pointed to a mental health framework for personnel who carry the psychological load of operations, an area military systems have long under-served. The Minister said the Armed Forces would harmonise their medical reporting systems to improve coordination and to better protect medical staff deployed in conflict zones. Those are unglamorous, back-office fixes. They are also the kind of dull machinery that decides whether a health system works, and a source country that wants to keep its patients has to fix that machinery before it can sell a brand. Screening, diagnosis, and reporting are cheaper than a flagship building and they cut the outbound flow faster, because most patients travel for want of a reliable pathway at home, not for want of a landmark hospital. "We must build confidence in our own institutions," Mr Musa said, tying the reform to reliable services that meet global standards. ## Security logic behind self-reliance There is a security calculation layered on top of the health economics. A defence ministry that routinely sends senior officers abroad for treatment exports foreign exchange and, with it, information about the readiness of its own people. It also accepts a continuity-of-care risk each time a patient is handed between health systems partway through treatment, a well-known failure point in medical travel. Building cardiac, trauma, and mental health capacity at home addresses all three exposures at once, which is why military healthcare self-reliance tends to draw political backing that civilian reform rarely gets. Military medicine sharpens that logic. Battlefield triage, deployable field capacity, and rehabilitation for wounded personnel are its demanding service lines, and each case treated at home is one fewer patient handed across a border mid-recovery, one fewer source of avoidable morbidity in the ranks. A harmonised reporting system feeds that machine, because you cannot allocate scarce surgical capacity to the AMCE or anywhere else without knowing, in near real time, who needs what. ## Collaboration with AMCE During the visit, Mr Musa praised AMCE's management for its professionalism and its facilities, and said he expected the partnership to improve healthcare delivery within the military. Gazettengr reported that AMCE's Chief Medical Officer, A'isha Umar, had earlier confirmed the centre's readiness to work with the Ministry of Defence, with the goal of high-quality medical services on a par with global standards. The choice of partner is telling. AMCE is a domestic high-standard facility, and leaning on the AMCE rather than on government-owned military hospitals alone points to a build-internal-capacity strategy that buys results faster than constructing from scratch. That is a reasonable route. It also concentrates a national ambition on one centre, and the questions of who treats which cases, at what price, and under what contract are exactly what a ribbon-cutting speech does not answer. ## HTN analysis: what to watch This is a political proposal at the speech stage, not a costed programme with budgets and timelines. The direction is clear enough. Nigeria wants to reduce overseas medical treatment for its Armed Forces and to build domestic military healthcare capacity, with the AMCE as an early anchor. The commercial weight of the plan depends on how large the current military outflow is and on whether the intent survives contact with procurement. Three things will show whether this converts. The first is money, whether the Ministry of Defence attaches real budget lines to military healthcare and to the AMCE partnership rather than leaving it at commendation. The second is scope, whether a signed agreement names patient volumes and defined service lines, since screening, cardiac care, and mental health are very different builds. The third is disclosure, whether Nigeria publishes any figure for the current cost and volume of military medical tourism, because a country cannot manage an outflow it has never measured.

Guangzhou Opens International Medical Tourism Service Centre

editorial@health-tourism-news.com (Christian El-Khouri) — Fri, 08 May 2026 00:00:00 GMT

Guangzhou has opened a state-backed centre to organise its pitch to foreign patients, China Daily reported. The city is the capital of Guangdong province. It has launched the Guangzhou International Medical Tourism Service Center to build what officials called a globally competitive destination for international medical tourism. The centre will work with seventeen pilot hospitals across Guangzhou. It will offer diagnosis and treatment for foreign patients, and will also run brand marketing, medical agency work, travel arrangements and wellness provision, China Daily reported. The programme is pitched at the wider region. It draws on the cultural, commercial and tourism assets of the Guangdong-Hong Kong-Macao Greater Bay Area, and folds medical care, tourism and city services into one offer. Lai Zhihong, vice-mayor of Guangzhou, said international medical tourism had become an important growth driver in the global health industry. Demand for treatment in the city had kept growing, Lai said, supported by its medical resources, its Lingnan culture, its open setting and its status as a transport hub. Lai urged medical staff to hold to high standards of service, expertise and ethics. The demand claim rests on a single headline figure. Official data showed that inbound visits by foreigners to Guangzhou passed 3.2 million in 2025, China Daily reported, with foreign residents' demand for medical services rising fast. That 3.2 million is a general inbound-travel count, not a tally of medical patients. The gap between the two is exactly the gap the new centre has been built to close. ## Twelve measures target talent and TCM Chen Bin, director of the Guangzhou Municipal Health Commission, announced twelve measures to support international medical services. Chen said the measures would focus on "building an international medical service brand", alongside industrial layout, an international medical centre and stronger specialist disciplines. The measures make it easier for foreign doctors and nurses, and for practitioners from Hong Kong, Macao and Taiwan, to hold multisite practice in Guangzhou. Pilot institutions may also create special posts to recruit senior international medical talent. Traditional Chinese medicine sits at the centre of the pitch. Hospitals are urged to promote TCM and to set up high-level acupuncture centres for foreign patients, Chen said. That is a deliberate choice, and a sound one. Patients cross a border for five reasons: better care, the best care, cheaper care, faster care, or care unavailable at home. Acupuncture and TCM belong to the last, the treatment a patient cannot get in the same form at home. Guangzhou is not competing with Delhi or Bangkok on the price of a hip replacement here. It is selling a speciality that is genuinely local, and the acupuncture and TCM centres are the part of the programme least exposed to price competition from other Asian corridors. The corridors that move orthopaedic and oncology patients compete on price and speed, and telemedicine can carry much of their consultation; a TCM speciality competes on something a rival corridor cannot copy or stream. Hospitals say they are ready. A vice-president at one of the participating university hospitals said the measures gave a firm guarantee for efficient international care, and that hospitals would keep improving their diagnosis environments, their multilingual systems and their multidisciplinary capabilities across specialities for patients from Hong Kong, Macao, Southeast Asia and Belt and Road Initiative countries. The spread of target markets is worth marking. Guangzhou is aiming at the Greater Bay Area, Southeast Asia and the Belt and Road countries at once, a deliberately broad basket rather than one dominant source market. ## The machinery matters more than the brand Wu Chen, general manager of the centre, said it brought together the city's medical resources, its cultural tourism assets and cross-border commercial insurance, and would work with major hospitals to give overseas patients one-stop services. Those services, China Daily reported, run from visa help and remote pre-consultation through multilingual translation and travel to postoperative follow-up. That list is the real test, and it tells more than the brand campaign beside it. A medical tourism destination is not made by marketing. It is made by the dull machinery a patient touches: the visa letter that arrives on time, the interpreter in the consultation room, the insurance claim that clears across a border, the postoperative follow-up that reaches a patient after they fly home. Guangzhou has named all four in its own service list, which is the encouraging part. The centre is, in effect, a state-run facilitator, and that shifts the usual complaint about facilitators, who tend to sell visibility rather than trust. A government body carries an accountability that a private middleman does not. Marketing does not clear an insurance claim, and telemedicine does not carry a patient to a theatre; the facilitator that solves the dull logistics is the facilitator that keeps the patient. Whether that accountability turns into cleared insurance claims and staffed multilingual desks across seventeen hospitals is the question the coming year will answer. The programme also blurs the line the sector usually draws. Diagnosis and treatment sit at the clinical end. The TCM, wellness and healthcare services sit nearer the wellness end, and Guangzhou is selling both from one desk. That hybrid is common now, but it carries a coordination cost, because the accredited clinical work and the wellness work are judged on different things, safety and outcomes on one side, experience on the other, and one centre now has to hold both standards at once. A postoperative check and a TCM wellness stay are booked from the same desk yet measured on different scales. ## What operators should watch The measurable tests are close. The first is whether the twelve measures arrive with budgets and dates rather than as a framework, because a framework without funding does not staff a multilingual desk. The second is whether named international insurers sign up to the cross-border settlement the centre has promised, since that is what turns a foreign enquiry into a booked procedure. The third is the count of foreign and Hong Kong, Macao and Taiwan clinicians who actually take up multisite practice in Guangzhou, the clearest early sign that the talent measures are more than an announcement rather than a working facilitator. If those three move, the 3.2 million inbound visits could begin to convert into medical arrivals. If they stall, Guangzhou will have a brand and not yet a destination.

Phyathai 2 Wins Thailand Medical Tourism Award

editorial@health-tourism-news.com (Christian El-Khouri) — Fri, 08 May 2026 00:00:00 GMT

Phyathai 2 International Hospital has been named Medical Tourism Hospital of the Year for Thailand at the Healthcare Asia Awards 2026, a regional industry awards programme. Healthcare Asia Magazine reported that the award cited the Bangkok hospital's work in orthopaedic care and in handling international patients. Phyathai 2 is a tertiary hospital within the Phyathai-Paolo Hospital Group, and it aims at patients from South Asia, the Middle East, and nearby ASEAN countries. An award is a marketing asset before it is a clinical one. This one is about how Phyathai 2 runs its overseas patient business, not about any new treatment. That is worth saying plainly, because the source is a co-written partner article and the claims below are the hospital's own. The question is not whether Phyathai 2 markets itself well. It is whether the model it sells is one that other medical tourism providers should copy. ## Single Gateway international patient system The heart of the pitch is what Phyathai 2 calls its Single Gateway International Patient System, a single channel that guides the patient from the first review before arrival through to follow-up after treatment, what the hospital frames as an "integrated, end-to-end patient journey". Healthcare Asia Magazine reported that the system groups work across marketing, medical coordination, and operations, and that it gives patients a set medical review, a clear price, and booked travel before they fly. Strip away the branding and this is an answer to the two things that lose international patients: doubt and handover. A medical traveller books blind, unsure of the price, the plan, or who is in charge once they land, and every pass between departments is a chance for a case to slip. One channel with a price set up front attacks both. A price fixed before travel is the strongest trust signal a medical tourism provider can send. The idea is not new. Running it well, every time, is rare, and that is most of what an award like this really measures. ## Market-specific speciality strategy Phyathai 2 says it matches specialities to markets rather than selling one standard package everywhere. Healthcare Asia Magazine reported that the hospital pairs its harder specialities, cardiology, oncology, orthopaedics, and women's health, with markets that are more ready for them, while offering standard packages to patients who want speed and a lower price. That split maps onto the health tourism spectrum. Cardiology, oncology, and orthopaedics sit at the clinical, high-involvement end, where the patient is treating a serious illness and judges the hospital on outcomes and safety. The standard, price-led packages sit nearer the elective end, where speed and cost decide. Selling both from one building works only if the hospital keeps the two patient flows apart, because the reassurance a heart patient needs is the opposite of the quick, light touch an elective patient wants. Pairing hard cases with the markets most ready for them is a sound way to handle that strain. ## Partnerships, technology, and the trust problem Phyathai 2 also leans on ties with overseas hospitals, insurers, embassies, and accredited agents, backed by onboarding, multilingual staff, and cultural training. On the technology side, the hospital reports digital case management, teleconsultation, and dashboards that track outcomes, efficiency, and revenue in near real time. The partnership layer is where medical tourism usually goes wrong, because it runs through agents whose interest is volume, not the outcome. A hospital that builds its own onboarding and checks around those agents is trying to keep the trust in-house, not hand it to whoever sends the patient. Whether that holds comes down to enforcement, not the training slide, and the source offers no proof either way. ## HTN analysis: what to watch The award describes strong inside process, not proven market share. Healthcare Asia Magazine reported that Phyathai 2 sees steady growth in international patient numbers and better case quality, yet the source carries no figures for either, which leaves the claim unproven. A hospital can run a fine Single Gateway and still lose patients to a cheaper rival in Bangkok, and none of these systems settle that. Awards are not audits. Three things would turn this from a good story into a measured one. The first is volume, real international patient numbers from South Asia, the Middle East, and ASEAN, split by field. The second is retention, whether the orthopaedics and cardiology lines the hospital leads with hold their share as rivals sharpen. The third is disclosure, whether the dashboards Phyathai 2 already runs are ever turned outward, because a provider sure of its numbers tends, in the end, to publish them.

US Grief Retreats Grow as a Wellness Market

editorial@health-tourism-news.com (Christian El-Khouri) — Fri, 08 May 2026 00:00:00 GMT

The wellness industry has built a set of dedicated grief retreats around a population that conventional bereavement care leaves underserved, The Ethos reported. The market has grown alongside formal medical recognition of complex grief, after prolonged grief disorder was added to the DSM, the Diagnostic and Statistical Manual of Mental Disorders, in 2022. An estimated 12.5 million Americans experience grief each year, The Ethos reported, and about ten per cent of bereaved adults develop prolonged grief disorder. Rates run higher after traumatic or sudden loss, reaching as high as 49 per cent, and reach roughly 30 per cent among bereaved parents. Those figures describe a clinically defined group that once-weekly counselling serves unevenly, and that increasingly looks for [what clients now ask of a wellness stay](/news/rising-patient-demand/), namely immersive, experiential care rather than a standing appointment. ## Programme models Grief retreat programmes vary widely. Claire Bidwell Smith, a therapist and author, leads the Conscious Grieving Retreat, a multi-day immersion that combines guided grief work, group reflection, somatic practice and time in nature, with a high staff-to-participant ratio for individual attention. In Costa Rica, TwoCan Retreats runs an ocean-based programme called Mourning Surf, whose founders describe the approach as moving "the issues out of the tissues" through physical engagement with the sea. Sedona Sacred Earth, in Sedona, offers four-day land-based retreats that fold together Western therapy, Eastern practice and American indigenous tradition, with equine therapy, acupuncture, medicine wheel teachings and breathwork. Golden Willow Retreat, near Taos in New Mexico, runs five- to ten-day retreats for individuals and small families, with grief therapy led by licensed staff in the mornings and spiritual-care counsellors in the afternoons. Miraval Resorts, in Arizona, Texas and Massachusetts, runs grief and loss programming led by dedicated grief specialists, folding private sessions into a broader wellness stay. ## Why the format Modern neuroscience treats grief and trauma as more than cognitive events, The Ethos reported, holding that they are stored in the body and the nervous system. Evidence-based modalities such as EMDR, Internal Family Systems and somatic therapy are built on that premise, and are designed to reach what talk therapy alone may not. A retreat that runs for consecutive days lets those processes move at their own pace. Rita A. Schulte, a licensed counsellor, told PopSugar that the retreats give people "permission to feel all the emotions of the loss". The natural settings are part of the method rather than the scenery. Research shows that time in natural environments aids psychological healing, The Ethos reported, lowering cortisol, slowing heart rate and easing the anxiety and depression common in acute grief. Costa Rica's Pacific coast, Sedona's red rock terrain and Mexico's Riviera Maya put people in a physical setting far from the daily places where grief is usually held back. Group size is the third factor. Most grief retreats cap groups at fifteen people or fewer, which the piece said makes shared vulnerability easier to reach than a therapist's office or a family setting. Claire Bidwell Smith told the Good Life Project that the work helps people "go back into your life and take care of the regular day-to-day things". ## Reading the market The Ethos, a wellness publication, drew a line between clinically grounded programmes and general healing weekends. The best grief retreats are led by licensed grief counsellors, somatic therapists or psychologists with bereavement training, the piece said, not by general wellness practitioners. Credentials such as LCPC, LCSW, LMFT or board certification in traumatic grief mark that training. Enquirers should ask whether the modalities such as EMDR, Internal Family Systems or ART carry peer-reviewed research, and whether the groups are small enough for close support. The best grief retreats are explicit about their limits, the piece said, as they are not a substitute for ongoing therapy and do not promise resolution. A grief retreat is not therapy, and the best ones say so plainly. That same test is spreading across nearby parts of wellness travel, where [psychedelic retreats face the same call for clinical scrutiny](/news/psychedelic-retreats-a-new-frontier-in-medical-and-wellness-tourism-demanding-critical-industry-scrutiny/) over who is qualified to run them and what the evidence supports. ## A recognised need, an unmeasured market A recognised diagnosis and no accreditation is a market in tension. Prolonged grief disorder entered the DSM in 2022, which gives the demand a clinical name, yet the retreats answering it carry no shared standard, no comparable outcomes data and, in most cases, no route to insurance. That is the difference between a symptom and a strategy. The symptom is 12.5 million grieving Americans and a once-weekly model that reaches them unevenly. The retreats answer with days at a time, not an hour a week, and that is their pitch. A strategy would be a body that accredits grief-retreat providers, a set of published outcomes and a payer willing to fund the format for prolonged grief disorder. None of those yet exists, and until they do the offerings range from clinically intensive programmes to loosely supervised weekends under the same word. The checkable signs are specific. They are the first accreditation body or shared standard for grief-retreat providers that claim clinical efficacy, the first pilot pairing a grief-retreat operator with a private insurer or an employee assistance programme on cost per case of prolonged grief disorder, and the first move by an established hospital group or mental-health network to buy or build an integrated grief-care model with a retreat component. Until at least one of those appears, the market stays a set of individual programmes sharing a name, a diagnosis and no common measure of whether they work.

Armenia Tourism Grows 34% as Russian Share Falls

editorial@health-tourism-news.com (Christian El-Khouri) — Thu, 07 May 2026 00:00:00 GMT

Armenia's tourism grew by more than a third early this year, and its reliance on a single source market fell with it, Armenpress reported. Data presented at a Cabinet meeting showed strong growth in April and across the first four months of 2026, alongside a clear shift in where visitors came from. Prime Minister Nikol Pashinyan said tourist numbers rose 39 per cent in April 2026 against the same month last year, and 34 per cent across the January to April period. The more telling number sat underneath the growth. It was the falling share of one country. ## Russia's share falls as the base widens Economy Minister Gevorg Papoyan set out the shift. Visitors from the Russian Federation still grew in absolute terms, Papoyan said, but their share of the total kept dropping. In the January to April period of 2023, the Russian Federation accounted for 52 per cent of Armenia's tourists. By the same period of 2024 that share was 42 per cent. For January to April 2026 it stood at 36 per cent. Papoyan said the share of a single country had fallen "from more than 50 percent to around one-third." The absolute figures moved the other way. Pashinyan confirmed that the total number of tourists from Russia had risen even as its share fell, and Papoyan put the count at 245,178 this year against 183,700 last year. The wider base came from a longer list of countries. Papoyan named India, Italy, France, the United States, China, Germany, Ukraine, Iran and Georgia as growing markets, and noted that Italy's share, around 0.4 per cent a few years ago, now passed 1 per cent. ## Concentration is the risk, not the headline growth The growth rate will lead the coverage, but the diversification is the part worth reading closely, and it carries a lesson that reaches past general tourism into medical travel. A destination that draws half its arrivals from one country is exposed to that country in full. When a single source market supplies most of the high-value visitors, its economy becomes the destination's economy and its politics become the destination's politics. Armenia has spent three years moving from 52 per cent to 36 per cent, and that is the slow, deliberate work of reducing single-market dependency rather than a quarter's marketing win. Medical tourism runs the same concentration risk, usually in a sharper form. A hospital that builds its international patient book on one neighbouring country inherits that country's currency, its travel rules and its willingness to let patients leave for care. The corridors that looked strongest in a calm year are the ones that fall hardest when a border tightens or an airspace closes, because the arrivals were never spread. Medical travel carries four standing risks: the clinical risk, the legal risk of redress abroad, the continuity-of-care risk, and the logistical and geopolitical risk that the corridor itself closes. Source-market concentration feeds that fourth risk directly. A destination that fixes it in advance, as Armenia is trying to do for tourism as a whole, is buying insurance against the quarter when its main corridor stops. ## What the data does not show The source is a general tourism briefing, and it does not separate medical travel from leisure and business. None of the figures show how many of Armenia's arrivals came for treatment, whether the new markets of India, China or the United States bring patients as well as holidaymakers, or whether the country is building the clinical capacity to serve them. Health tourism is a spectrum, from high-intervention medical care at one end to self-guided wellness at the other, and a headline arrivals figure hides which end a visitor sits at. Without disaggregated numbers, the medical-travel share of Armenia's 34 per cent is unknown, and it would be a mistake to read the growth as a medical tourism result on this evidence. The market list complicates any medical-travel reading further. India and China are among the growing markets Papoyan named, and both are large medical tourism destinations in their own right, exporters of the model rather than obvious senders of patients to a smaller neighbour. Armenia's realistic medical-travel catchment is regional, the nearby markets that already cross its borders for cost, access or a specific procedure, not the long-haul leisure markets that lift a general arrivals count. Reading the growth as clinical demand would confuse a holiday statistic with a hospital one, and the diversification that looks healthy for tourism tells an operator little about where the next patient will come from. That gap is itself the actionable point. If Armenia wants medical and wellness travel to count as a distinct part of its tourism economy, its statistics agency has to measure it as one, and its health ministry has to say which specialities it is building for the new markets Papoyan listed. A destination that cannot count its medical arrivals cannot manage the concentration risk inside them, and it cannot tell an investor whether the growth is durable or borrowed from one neighbour. ## What operators should watch The tests are specific and measurable. The first is whether Armenia publishes tourism data that separates medical and wellness travel from general arrivals, which is the only way the 34 per cent figure becomes useful to the health-travel sector. The second is whether the government or private operators announce clinical capacity or bilateral health agreements aimed at the growing markets, particularly India, China and Iran. The third is whether the Russian Federation's share keeps falling toward a genuinely diversified base or settles near one-third, which would still leave a single country as the largest source by a wide margin. Diversification that stalls at 36 per cent is progress, not safety.

Assocham Symposium Pitches Northern India Wellness

editorial@health-tourism-news.com (Christian El-Khouri) — Thu, 07 May 2026 00:00:00 GMT

Assocham organised the third Health, Beauty and Wellness Symposium in Chandigarh, bringing officials, health experts and industry figures together to discuss health care, wellness and medical tourism, Devdiscourse reported. The event was pitched as a platform for regional and national health priorities, and its speakers returned again and again to preventive care, wellness and the AYUSH systems of traditional medicine. No investment figure and no funded programme were announced, and the report named none. ## Government priorities at the symposium Punjab Governor and Union Territory Administrator Gulab Chand Kataria attended as chief guest. Kataria called for "collective efforts towards building a TB-Free India" and for a drug-free Punjab, Devdiscourse reported. He acknowledged Assocham's support for Chandigarh's TB-Free drive and urged stakeholders to help tuberculosis patients through awareness, nutrition and treatment programmes. He also honoured industry members for their work in the sector, the report said. The public-health themes Kataria raised were domestic ones. TB control and drug-addiction campaigns sit inside India's own health system, and neither was tied in the reporting to a plan for foreign patients. That gap ran through the day. The symposium talked up medical tourism as a goal and preventive care as a selling point, but it set out no costed route from the one to the other. ## Industry speakers and the northern India pitch Manik Batra, who chairs the Assocham J&K council, made the sharpest medical tourism case, pointing to health tourism and wellness across northern India. Other council figures spoke on jobs and investment in preventive care and pressed for closer work between industry and government, and an Ayurveda expert argued for holistic wellness. The northern India framing matters because the region is trying to position itself against established hubs further south. Uttar Pradesh has made a comparable pitch, [pushing wellness and medical tourism alongside MICE events](/news/uttar-pradesh-pioneering-the-next-frontier-in-global-health-and-mice-tourism/), and the Chandigarh symposium leaned on the same combination of traditional medicine and preventive care. Whether any of it converts into arrivals depends on capacity that a conference cannot supply. ## AYUSH, sessions and the accreditation question The symposium ran three sessions, Devdiscourse reported. One covered wellness policies and AYUSH, one the role of artificial intelligence and startups in preventive care, and one women's leadership and enterprise. AYUSH, India's umbrella for traditional medicine, was the thread through the day, offered as the thing that sets India's wellness pitch apart from the cheaper surgical hubs in the rest of Asia. That pitch is not new. India's traditional-medicine systems have been marketed abroad for years, and Ayurveda in particular has [gone global as a wellness draw](/news/ayurvedas-global-moment/). The harder part is trust. Foreign patients and their insurers weigh accreditation, and AYUSH clinics that want foreign custom face the same questions on quality as any hospital. A symposium can name the opportunity. It cannot certify a single treatment room. There is a settled way to read events like this one. In medical tourism an announcement is not capacity, and a conference is the cheapest announcement of all. India's headline numbers are large, with the country's medical tourism market [projected to nearly double to 16.2 billion US dollars by 2030](/news/india-medical-tourism-market-projected-to-reach-162bn-by-2030/) on the strength of AYUSH and easier medical visas, but those forecasts rest on hospitals, accreditation and air links rather than on the count of symposiums held. The Chandigarh event produced dialogue and an awards ceremony. It did not produce a bed, a certification or a funded corridor. ## What to watch The test is whether the talk in Chandigarh leaves a paper trail. Watch for a costed northern India wellness or medical tourism scheme with a budget line, rather than another symposium. Watch for AYUSH facilities in the region seeking NABH or equivalent accreditation aimed at foreign patients. And watch whether Assocham or the state governments publish arrival or revenue figures for northern India, because until they do, the region's medical tourism case rests on the speeches its own councils gave.

Spencer Travel Hosts Sydney Wellness Event

editorial@health-tourism-news.com (Christian El-Khouri) — Wed, 06 May 2026 00:00:00 GMT

Spencer Travel hosted a one-day wellness event in Sydney that gathered wellness practitioners, exhibitors and four international retreats under one roof, Travel Weekly reported. The event, The Wellness Collective, ran on Saturday 23 May at a venue in Redfern, from 9am to 4pm, and cost A$30 a head. That price covered canapés, tea, coffee and juices, along with a programme of expert-led sessions, Travel Weekly reported. ## A programme built around wellness disciplines The day moved through a spread of wellness practices rather than a single theme. A traditional Chinese medicine practitioner with more than two decades of experience led seated yoga and Ayurveda. A breathwork facilitator ran guided sessions, a practitioner presented on intravenous drip therapy, and another spoke on biohacking. A classically trained cellist and accredited sound-bath facilitator closed the day with a sound-healing session. That mix is a fair snapshot of where commercial wellness sits now, part ancient practice, part clinical add-on, part performance. An Australian wellness figure, the founder of a wellness magazine, moderated the day and joined a panel titled "Ancient Medicine Meets Modern-Day Science." The panel looked at how traditional healing shapes contemporary wellness travel, Travel Weekly reported, and drew in a biohacker, the head of an aromatherapy company and the co-founder of a wellness centre. That framing is the interesting part. It puts ancient practice and laboratory language on the same stage and sells the tension between them as the product. ## Luxury retreats court the Australian consumer directly Four international properties appeared as exhibitors and sponsors: luxury wellness retreats in Thailand, Vietnam, India and New Zealand. A co-founder of the New Zealand retreat presented on the role of nature, food and community in what the report called transformational travel. The presence of established overseas retreats at a A$30 consumer day in Sydney is a strategy worth naming. These are properties that have long relied on business-to-business distribution through agents and specialist operators, and here they were meeting Australian travellers face to face in a feeder market. That direct-to-consumer turn is the real signal in the story. Australia is a mature outbound wellness market, and a retreat in Thailand or India that wants a share of it can either pay for agency shelf space or build its own relationship with the traveller. This event let them do the second. The retreats gain a warm list of high-intent prospects, and the agency, Spencer Travel, moves from selling a booking to curating the experience that leads to one. For a facilitator, that is a shift from moving inventory to owning the demand, and it is the more defensible place to stand. The house view of facilitators is sceptical, because too many sell visibility rather than trust, a listing fee dressed as a recommendation. An event like this is the better version of that model. Spencer Travel is not selling a ranking here; it is putting travellers in a room with the retreats and letting the wellness properties make their own case. That is closer to distribution than to advertising, and it is the kind of facilitator work that earns its margin. Whether the retreats treat the day as a real channel or a photo opportunity is the test the next year will settle. ## Where the day sits on the health tourism spectrum Health tourism is a spectrum rather than a category, running from high-intervention medical care to self-guided wellness, and this event sits close to the wellness end. Yoga, breathwork, Ayurveda and sound healing involve little or no clinical supervision and aim to improve an already-sound state rather than treat a disease. Two elements pull the other way. Intravenous drip therapy is a clinical procedure wherever it is delivered, and biohacking borrows the language of medicine for a largely unregulated wellness market. Both sit in the blurred middle of the spectrum, where a wellness setting hosts an intervention that would usually need a clinician, and both deserve more caution than a resort programme note tends to give them. That caution is where the trade should be honest with itself. Wellness travel is a borrowed authority for anyone whose training is in medical travel, and the fair posture is to hedge rather than prescribe. The claims made for breathwork or sound healing belong to the experience, not to the clinic, and the intravenous and biohacking elements are the ones a serious operator should defend on safety rather than atmosphere. An event that puts modern-day science in its panel title invites exactly that test. ## The open question about the format The source does not give attendance, conversion or any read on whether the retreats booked business from the day, and the A$30 ticket sits awkwardly against the premium positioning of the properties on show. A price that low builds reach, not qualification, and it leaves the event's purpose unresolved between lead generation for high-value stays and plain brand building. Both are legitimate, but they call for different follow-up, and only Spencer Travel and the four retreats know which one they were buying. ## What operators should watch The tests are practical. The first is whether Spencer Travel or other agencies run more events like this, which would confirm a real move from booking desk to curated experience rather than a one-off. The second is whether any of the four retreats reports bookings or a qualified pipeline traceable to the day, the only figure that turns a A$30 gathering into a distribution channel. The third is whether the content stays broad lifestyle wellness or moves toward the clinical elements, the intravenous and biohacking end, where the duty of care is higher and the marketing claims are harder to stand behind.

Canada Adds Asylum Health Co-Pays as Costs Climb

editorial@health-tourism-news.com (Christian El-Khouri) — Tue, 05 May 2026 00:00:00 GMT

Canada revised its Interim Federal Health Program on 1 May, introducing co-pays for a range of services provided to asylum claimants, National Post reported. Until then, asylum claimants had received their health-related services free, a benefit that National Post noted was not extended to Canadian citizens. National Post columnist Jamie Sarkonak framed Canada as "the medical resort of the developing world", a polemical reading of a public-health-financing decision rather than a medical tourism one. ## What the asylum co-pays cover The Carney government in Ottawa announced the revision last autumn, National Post reported, in response to public argument over the cost of the program. Under the previous arrangement asylum claimants received free doctor visits, eye and dental care, physiotherapy and psychotherapy, mobility aids and prescriptions. That coverage often continued even after a refugee claim was refused. The revised policy now asks asylum claimants to pay 30 per cent of the cost of several services, among them eye exams, new glasses, dental care, counselling, physiotherapy and home care. Prescriptions carry a new $4 co-pay. A second tier of services stays free of charge for asylum claimants. Emergency room visits, doctor visits, hospital stays, surgery, vaccinations, birthing care, scans, tests and X-rays remain fully covered, National Post reported. The co-pays therefore fall on lower-cost outpatient care while the high-cost hospital work is left untouched. That split decides how much money the change can actually recoup. ## The billion-dollar projection The Parliamentary Budget Officer assessed in February that the Interim Federal Health Program was on course to cross $1 billion a year, National Post reported. That same study traced a steep rise in both use and cost of the program between 2016 and 2024. Asylum claimants drawing on it multiplied by seven over those years, and the average outlay per person tripled across the same period. Before the co-pays were introduced, the program was projected to reach $1.5 billion by 2029. The budget officer's report did not fold in the financial effect of the new co-pay charges, National Post reported, so the headline projection still describes the program as it ran before 1 May. That gap matters for reading the policy, because the co-pays sit on outpatient services while the sevenfold rise in asylum claimants and the tripling of per-person outlay are driven by the whole caseload. No actuarial estimate of the co-pays' net effect has yet been published, which leaves the billion-dollar figure unaudited against the new policy. ## Fraud and the origin of claims National Post also reported a single case of fraud inside the program. In March a therapist admitted to double-billing for counselling sessions with asylum seekers and to handing the work to interns, and she was suspended and fined $4,700. National Post presented the case as one instance rather than as a measured rate, and no program-wide figure for fraud was offered. That same column set out its own account of why asylum claims have risen. It named students from India who claim refugee status once study permits lapse, people from Nigeria who allege persecution on grounds of sexual orientation, former gang members from Mexico and Latin America, and residents of European countries who say police protection at home is insufficient. That list is Sarkonak's polemical characterisation, and it should be read as the argument of an opinion piece rather than as verified case data. ## Why this is not medical tourism There is a category error at the heart of the medical-resort framing, and it is worth naming plainly. Health tourism runs along a spectrum defined partly by intent, and a medical tourist chooses to travel and to buy care abroad because it is cheaper, faster, better or unavailable at home. An asylum claimant is not making that purchase. Their care follows from where the person already is and from what a domestic program covers, not from a cross-border transaction sold to a paying patient. Folding asylum health provision into the language of medical tourism conflates two flows that behave differently and answer to different levers. The distinction is not academic for policymakers. A medical tourism market responds to pricing, accreditation and waiting times, and a government can grow it or cool it by adjusting those. A domestic health entitlement for asylum claimants answers instead to immigration policy and to the size of the caseload. Yet the Carney government has reached for the one instrument that treats the entitlement as a market, a co-pay, when the sevenfold rise its budget officer recorded belongs to the caseload. Co-pays on eye exams and physiotherapy recoup money at the margin, and they leave the driver of the projection untouched. ## What to watch This policy faces a measurable and near-term test. Future reports from the Parliamentary Budget Officer will show whether the co-pays bend the cost curve or merely trim outpatient billing. They will also show whether use of the newly charged services, dental, ophthalmic and physiotherapy care among them, falls once a 30 per cent share applies. The origin-of-claims argument will be settled by immigration and refugee data, not by a program that reimburses treatment after arrival. For a government facing a $1.5 billion projection by 2029, the honest question is whether it is managing the cost of the Interim Federal Health Program or the politics around it. The co-pays as designed answer more of the second than the first.

Egypt Launches African Sustainable Medical Tourism Label

editorial@health-tourism-news.com (Christian El-Khouri) — Tue, 05 May 2026 00:00:00 GMT

Egypt has launched a new medical tourism quality label aimed at the whole African continent, Egypt Today reported. Egypt's national standardisation authority introduced the African Sustainable Medical Tourism Label on 5 May 2026, in partnership with a pan-African standards organisation. The scheme is meant to raise the quality of medical and logistical services across Africa, the report said, and to strengthen Egypt's standing as a medical tourism destination. Officials framed the label as more than a certificate. Its head said the programme reflected Egypt's commitment to quality and sustainability standards in Africa, Egypt Today reported, and described the work as building an integrated system to help medical institutions and spas compete in global markets. Aligning national rules with African and international standards, the authority said, was a foundation for Egypt's position in medical tourism while keeping services efficient and sustainable. ## How the certification is meant to work A dedicated certification unit inside the authority runs the review, evaluation and award process, and is presented as an independent and impartial body, Egypt Today reported. Its job is to check that medical institutions meet African standards drawn from international specifications, which the authority says should raise the confidence of international insurers and medical tourism facilitators. Its director set out what a facility gains from the label. The label promises wider market access, better operational efficiency, and stronger credibility on patient protection and social responsibility. The label also promises alignment with Egypt's Vision 2030 and the Sustainable Development Goals, access to funding, and lower risk in handling international patients. That list is the label's own prospectus, and it should be read as an aim rather than a result. Every one of those benefits depends on two things the launch cannot supply by itself: facilities choosing to adopt the label, and payers choosing to recognise it. ## Accreditation is only worth what payers price off it A medical tourism accreditation earns its keep at the moment an insurer or a facilitator treats it as a reason to send a patient. Until then it is a logo. The market for cross-border care already carries several international accreditations and quality marks, and a new African label enters a crowded field where recognition, not existence, is the scarce thing. Its designers appear to understand this, since the stated point of the scheme is to lift the confidence of international insurers and facilitators rather than to impress patients directly. That is the right target. Recognition is the whole game. A label that international insurers recognise routes patients; a label they ignore does not. Facilitators follow the same rule. The certificate is not the asset. Recognition is the asset. Whether a single named insurer or a large facilitator begins to price or route business off the label within a year or two is the measure that counts. Accreditation speaks to two of the standing risks that make patients hesitate to travel for care. Clinical risk is that the treatment itself goes wrong. Redress risk is that winning compensation abroad is hard. Both are partly answered by a credible quality floor, one a patient can check before booking an orthopaedic, oncology or reproductive procedure abroad. A label does not remove either risk, but it lets a nervous payer and a nervous patient move part of the due diligence onto a body that inspected the facility. The value of that transfer rises only when the inspecting body is itself trusted, which is why recognition matters more than the certificate. Telemedicine can carry a pre-assessment and a follow-up across a border, but neither telemedicine nor a certificate can vouch for an operating theatre a facilitator has never seen. ## A continental floor, not a Cairo patient-drive The scope is the most interesting part of the announcement. This label is pitched across Africa and takes in spas as well as hospitals, which places it across the health tourism spectrum, from clinical care and its specialities at one end to self-guided wellness at the other. That breadth signals a long play for a continental quality floor rather than an immediate scheme to move patients into Egypt this year. Across Africa the specialities that move patients, orthopaedic and reconstructive surgery, oncology, paediatric and reproductive care, are spread unevenly between countries, and a shared standard is one way to level that floor. Medical tourism has always tracked the world's health inequalities, and a shared African standard is an attempt to build capacity and trust where both have been thin, so that intra-African medical travel does not default to Europe, the Gulf or India. The risk in a continent-wide standard is the usual one for accreditation: a floor that too few facilities cross, or that international payers never learn to trust, becomes a document rather than a market. Egypt is not short of a brand as a medical tourism destination. The harder, duller work is the machinery underneath a label, the inspections that stay consistent, the register that insurers and facilitators can query, the postoperative pathway that reaches a patient at home, and the redress process that works when a case goes wrong. A label that gets that machinery right is worth more than one that gets the marketing right. ## What operators should watch The tests are concrete. The first is the number of named facilities in Egypt and across Africa that actually hold the label a year from launch, which separates a live scheme from a launch event. The second is whether any international insurer or major facilitator publicly recognises the label or writes it into its network rules, the single clearest sign that the standard has market value. The third is whether the certification body publishes its criteria and inspection results openly, along with disaggregated data on the facilities it has assessed, because a quality mark that cannot be audited by the payers it courts will not earn their confidence, and the whole case for the label rests on that confidence.

Busan Medical Tourism Tops 70,000 International Patients

editorial@health-tourism-news.com (Christian El-Khouri) — Mon, 04 May 2026 00:00:00 GMT

Busan has moved into the front rank of South Korea's medical tourism industry, and for the first time the numbers put a non-capital city within reach of the national leader. Seoul Economic Daily reported that Busan drew more than 70,000 international patients in 2025, a first for the city, lifting it to the second-highest medical tourism ranking nationwide. The precise figure sharpens the story. Seoul Economic Daily reported that 75,879 foreign medical tourists sought care in Busan in 2025, a 151.5 per cent increase on the 30,165 recorded a year earlier. Busan Metropolitan City, which released the data, described it as an all-time high, more than three times the pre-pandemic peak of 19,748 international patients recorded in 2019. Read against that 2019 benchmark, the recovery is not a rebound to trend but a step change in the city's medical tourism base. ## Busan medical tourism climbs the national ranking The ranking is the headline that will travel. Seoul Economic Daily reported that Busan rose from third place in 2024 to second nationwide in 2025, a first for the city, while holding its lead among non-capital regions for a second consecutive year. In a medical tourism market where the capital usually absorbs the demand, a provincial city reaching second place is the more interesting signal, because it suggests patients are now sorting by hospital and speciality rather than by the pull of the capital alone. Medical tourism is not one product. A patient flying in for reconstructive surgery, orthopaedic work or convalescence weighs a destination differently from one booking cosmetic dermatology. A city that wants to hold second place has to stay credible across several of those specialities at once. Reconstructive and orthopaedic caseloads bring longer stays and heavier aftercare than dental or dermatology work, and the mix a destination attracts shapes the wards it has to staff. The growth curve behind the ranking is steep. Seoul Economic Daily reported arrivals of 12,912 in 2023, roughly 30,000 in 2024 and more than 70,000 in 2025, a near-sixfold rise across two years. Growth of that speed is rarely organic, and Busan's own account credits a deliberate recruitment strategy rather than a favourable market. ## Where Busan's international patients come from The source markets explain both the surge and its main risk. Seoul Economic Daily reported that Taiwan supplied 37.4 per cent of Busan's international patients, ahead of Japan at 22.2 per cent, China at 15 per cent, Russia at 4 per cent, the United States at 3.7 per cent and Thailand at 2.7 per cent. The report attributed the sharpest gains to East Asia, with Taiwan up 293 per cent on 2024, China up 219 per cent, Japan up 129 per cent and Thailand up 105 per cent. That spread is broader than it looks and narrower than Busan would like. Six markets is a diversified book by the standards of a young destination, yet a single market supplying 37.4 per cent of arrivals is a concentration a planner should watch. Medical tourism demand is unusually sensitive to currency moves, visa rules and airline capacity on the routes that feed it, and a destination that leans on one neighbour for more than a third of its patients inherits that neighbour's risks. The diversification is real, and it is not yet finished. ## The economics that make medical tourism worth chasing The reason Busan is investing at all sits in the spending gap. Seoul Economic Daily reported that a medical tourist spends about 8.11 million won a visit, roughly four times the 2.05 million won a general tourist spends. That ratio is the core of the case for medical tourism as a high-value, stay-based industry, because the patient stays longer, spends on treatment and convalescence rather than souvenirs, and often brings companions who spend as ordinary tourists do. The public policy has been built around that arithmetic. Seoul Economic Daily reported a programme that designates high-performing medical institutions to recruit international patients, runs joint promotion, upgrades medical reception infrastructure, targets country-specific marketing, hosts familiarisation tours for overseas buyers and develops region-specific projects. This is the machinery of a destination that has decided medical tourism is worth running as public policy rather than leaving to individual hospitals. ## Busan's plan to reach 100,000 by 2030 Busan intends to keep the curve moving. Seoul Economic Daily reported that Busan Metropolitan City will publish a "Basic Plan for Revitalizing Medical Tourism" this year, backed by 2.4 billion won and built on three pillars the city labels flow, identity and trust: strengthening the medical tourism industry, integrating treatment with tourism, and branding Busan internationally. The target is explicit. Acting Busan Mayor Kim Kyung-deok said the city expects to reach "100,000 medical tourists to Busan by 2030 ahead of schedule", framing the goal as a convergence model that combines treatment with tourism to lift the local economy. On the current curve the number looks reachable, and the harder task is the one the three pillars only gesture at. The pillar that matters most is trust, and it is the slowest to build. Volume and marketing can be bought, while clinical reputation is earned case by case, and it is what keeps a destination on the map once the currency advantage narrows. Busan's five-year run has shown it can attract international patients in quantity. The next test of Busan's medical tourism is whether the outcomes, the aftercare and the accredited standards behind those numbers hold as the volume climbs toward 100,000, because a destination is remembered for its worst results rather than its headline count.

Uzbekistan Proposes Central Asia Tourism Ring

editorial@health-tourism-news.com (Christian El-Khouri) — Mon, 04 May 2026 00:00:00 GMT

Uzbekistan has put medical tourism on a regional agenda that, for now, remains a proposal rather than a funded programme. President Shavkat Mirziyoyev has called for the creation of a "Central Asia Tourism Ring", a cross-border initiative that would connect tourism assets across the region and draw co-financing from the Asian Development Bank and other partners. Zamon Uzbekistan reported that he made the proposal during a meeting of the Asian Development Bank Board of Governors, framing it as a response to global instability that has pushed millions of tourists to seek safe destinations. Medical tourism appears in that pitch, though not on its own. Zamon Uzbekistan reported that Mirziyoyev listed medical tourism alongside pilgrimage, cultural, gastronomic, ethno and extreme tourism, presenting the region's potential as a broad portfolio rather than a single specialised offer. The distinction matters for how the announcement should be read. A head of state naming medical tourism among six categories signals intent and little else, and the substance will depend on which projects attract capital and which do not. ## Central Asia Tourism Ring stays a proposal The Central Asia Tourism Ring, as described, is an invitation to co-operate rather than a committed budget. Zamon Uzbekistan reported that Mirziyoyev urged neighbouring countries, the Asian Development Bank and other partners to form a portfolio of tourism development projects and to secure co-financing for them. That sequencing is telling. The portfolio comes first and the money second, and medical tourism sits inside a portfolio that has not yet been itemised. Uzbekistan has real tourism momentum to build on. Zamon Uzbekistan reported a sixfold rise in foreign tourist arrivals over the past decade, reaching 12 million, driven by infrastructure improvements, service enhancements, visa liberalisation, transport network expansion and a focus on tourist safety. The report cited new cultural anchors such as the Center for Islamic Civilization in Tashkent and the Imam Bukhari Memorial Complex in Samarkand, with similar complexes under construction in neighbouring Central Asian countries. The Central Asia Tourism Ring is meant to connect these regional assets into a single itinerary. ## Where medical tourism sits on the spectrum None of that momentum is, in itself, medical tourism. Health tourism runs along a spectrum, from high clinical involvement at one end to self-guided wellness at the other, and the two ends demand very different infrastructure. Pilgrimage routes, cultural complexes and gastronomic trails sit at the leisure end of that spectrum. Medical tourism sits at the clinical end, where patients weigh accredited hospitals, surgeon volumes, continuity of care and legal redress before they weigh scenery. A tourism ring can move a visitor between cities. It cannot, on its own, build the operating theatres, the accreditation and the aftercare pathways that medical travellers require. That gap is where the proposal will be tested. Cultural and pilgrimage tourism can grow on visa reform, flight connectivity and marketing, the same levers that lifted Uzbekistan's arrivals to 12 million. Medical tourism grows on clinical outcomes, and outcomes are slow, capital-intensive and hard to co-finance through a regional bank. Naming the segment is cheap. Building the accredited capacity behind medical tourism is not, and the announcement offers no detail on which hospitals or clinical specialities the region would put forward. ## What the Asian Development Bank would actually fund The Asian Development Bank's involvement is the part worth watching. Development banks fund airports, roads and hotels far more readily than they fund clinical capacity, and a portfolio assembled around cross-border tourism could easily route capital toward the leisure segments that show quick returns. If medical tourism is to be more than a line in a speech, the region's health ministries, not its tourism boards, would need to bring specific projects to the table, with accreditation and patient-safety standards attached. There is also a concentration risk that the Central Asia Tourism Ring framing tends to obscure. A shared regional brand helps every member market itself, yet medical travellers choose a hospital, not a region, and demand tends to concentrate on whichever destination builds credible clinical outcomes first. The Ring could lift arrivals across Central Asia while medical tourism accrues to a single country, most plausibly Uzbekistan, given its head start on infrastructure and its 12 million arrivals. That is a familiar pattern in destination economics, where a regional initiative delivers uneven clinical dividends. None of this means the plan is empty. A ring that can move a visitor from one city to the next, on a single visa and a single ticket, is a real thing to build, and it is the kind of project a development bank likes to back. The point is narrower: a visitor on a cultural trail is not a patient on a ward, and the two ask for very different things. One asks for a bus, a guide and a good hotel. The other asks for a surgeon, a bed and a clear plan for the weeks after surgery. Medical tourism will rise or fall on the second list, not the first. For now, the honest reading is the modest one. Zamon Uzbekistan reported a proposal, a set of partners and a request for co-financing, and that is the whole of it. Medical tourism has been named, which is not nothing for a landlocked region still building its health-travel credentials, but naming is the easy part. The measure of the Central Asia Tourism Ring will be the first funded project that puts a clinical speciality, an accredited facility and an aftercare pathway behind the word.